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ABSTRACT 
 
Methods for the Syntheses of Compositionally Diverse Dendrimers  
Using Chemoselective Routes. 
(August 2004) 
Mackay Bagley Steffensen, B.S., Southern Utah University 
Chair of Advisory Committee:  Dr. Eric E. Simanek 
 
 Dendrimers are a unique class of macromolecules that present perfect branching on a 
molecular scale.  The pattern of branching at the atomic scale is compared to the branching of 
trees, from whence dendrimers get their name.  Dendrimers have been attractive synthetic targets 
for the past twenty years.  The methods and building blocks used in the synthesis of dendrimers 
vary, but molecules of this class of polymeric materials all possess symmetrical branching 
emanating from the core.  At each branch point the number of groups increases exponentially.  
Efforts directed toward the synthesis of dendrimers presenting multiple functional groups at the 
surface and within the dendrimer structure are described.   
 Methods are described which provide access to dendrimers in a one-pot per generation 
fashion, with triazines as the common moiety.  Chemoselective routes utilize the temperature 
dependant substitution of cyanuric chloride to construct dendrimers, obviating the use of 
protected monomers or the need to manipulate functional groups during the synthesis.  These 
methods are atom economical, as the only by-products are HCl and a base to scavenge it.  The 
methods are efficient, with typical isolated yields of product in the middle to high ninety percent 
range, often on a multi-gram scale.  Methods are described for conducting three separate 
reactions in a single pot.  Specific emphasis is placed on structural control of the interior and 
surface groups of the dendrimers. 
 The synthesis of a G3 dendrimer of layered composition is described.  The use of a 
different difunctional linkage group for each generation of dendrimer growth produced a G3 
dendrimer with layered composition without the use of protecting groups or functional group 
interconversions. 
 A G3 dendrimer was synthesized presenting five different functionalities at the 
periphery on a 10 gram scale, resulting in approximately 70% overall yield.  The peripheral 
 iv 
groups are composed of orthogonal functionality, which can be independently and selectively 
unmasked or manipulated in the presence of the other functionality. 
 The syntheses of dendrimers incorporating the short linker hydrazine produce materials 
with interesting physical properties as well as a low ratio of carbon to nitrogen.  The use of 
dendrimers in the construction of novel macromolecular constructs is also described. 
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CHAPTER I 
 
INTRODUCTION  
 
1.1 From Polymers to Dendrimers 
 The history and development of organic chemistry is inextricably woven with the 
development of total synthesis.  Wöhler’s synthesis of urea opened the era of organic synthesis 
with the realization that construction of natural molecules could be carried out in a laboratory.1  
Organic chemistry developed quickly thereafter as it was realized chemists could accomplished 
what was considered only nature’s domain.  Methods for the structural elucidation of natural 
molecules by deconstructing them to smaller known compounds were rapidly followed by routes 
and synthetic tools to mimic nature and construct natural products.  To control the connectivity 
and placement of atoms in the construction of a molecule, especially if nature has already 
conquered its synthesis, is one of the appeals of organic chemistry.2  Nature produces a plethora 
of unique carbon skeletal arrangements which organic chemists pursue in their quest to mimic 
nature.  The variety of functional groups found appended to and imbedded within the carbon 
skeletons, with specific topological arrangement, attests to the fecundity of nature as an organic 
chemist.  The original driving force of total synthesis to construct a synthetic molecule to 
confirm the structure of a natural product3 is slowly being supplanted by more utilitarian 
endeavors such as the development of therapeutically relevant molecules.  Perhaps the greater 
contribution made, and which remains to be made, from total synthesis is the development of a 
well-defined discipline with an ever increasing collection of methods and tools for the 
construction of complex molecular structures.4  
 Polymers are ubiquitous natural products, fulfilling both structural and functional roles.  
The development of polymer chemistry as a discipline evolved in an asynchronous manner 
compared to organic chemistry.  As more was learned about the structure of natural products 
greater feats were accomplished through efforts to synthesize them.  Discoveries achieved in 
understanding natural polymers did not necessary translate into a more in-depth understanding of 
synthetic polymer chemistry, and vice versa.  The first macromolecules investigated in detail 
were the natural polymers rubber, cotton (cellulose), silk and wood resins, but the chemical 
                                                          
  This dissertation follows the style and format of the journal Tetrahedron. 
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structures of these materials were unknown before the first decades of the 20th century, and thus 
the pursuit of their syntheses before this period would have been absurd.   
 The initial foundation laid for polymer chemistry was framed from industrial pursuits to 
convert the natural polymers into manageable and functional materials.5  Perhaps the complexity 
of natural polymers inhibited their use as the founding molecules for understanding the basic 
principles of polymer chemistry.  It was the investigation of simpler synthetic macromolecules 
which provided the fundamental theories and intuition necessary for the development of polymer 
chemistry as a science. 
 
1.2 Difficulties in the Emergence of Polymer Chemistry as a Science 
 The initial derivation of the polymer concept began in 1826 with the discovery of butene 
by Faraday.  Butene was found to have a gas density twice that of the known molecule ethylene, 
but they both have the same elemental composition.  At the time it was thought the elemental 
composition of a material defined the properties of a chemical compound, but here were two 
compounds with the identical elemental composition, but markedly different properties.  
Berzelius suggested in 1827 and later refined in 1833 a concept similar to isomers.  A compound 
having the identical elemental composition as a reference compound, but possessing different 
physical properties, was termed a polymer of the reference molecule.  Butene is thus referred to 
as a polymer of ethylene, and even in some cases benzene and styrene assigned as polymers of 
acetylene (Figure 1.1).  It would take over a century before a concise definition and basic 
understanding was established of what truly constitutes a polymer.  The lack of a clear 
understanding concerning the connectivity of atoms until the late 1800’s hampered the scientific 
community’s ability to comprehend the essence of large polymeric molecules, nevertheless 
contemplate the construction of such molecules. 
 
 
CH2 CH2 CH CH
                        Name =    Ethylene    1-Butene                           Acetylene      Benzene       Styrene         
   Molecular Formula =      C2H4              C4H8                                                   C2H2             C6H6             C8H8
   Empirical Formula  =         ---  CH2  ---                                                                             -----      CH    -----
Figure 1.1.  Polymers according to the original definition of Berzelius.  Butene, with the empirical formula 
of CH2 was considered a polymer of ethylene.  Benzene and styrene with an empirical formula of CH were 
sometimes described as polymers of acetylene. 
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 1.2.1 Setbacks 
 Early progress was achieved in the production of polymeric materials and more 
importantly the ability to modify natural polymers, imparting new properties and uses for the 
natural products.  These industrial advances in polymer chemistry were accomplished at the turn 
of the 20th century in the absence of any sound theoretical basis.6  Kekulé began to advocate his 
theories concerning the connectivity of atoms just as the inimical colloidal theory devised by 
Thomas Graham in 1861 began to take hold.  For three-score years the colloidal postulate would 
poison the thought and hinder the development of an accurate theory to deal with polymers.  
Graham’s work distinguished between colloids (aggregates of small molecules held together by 
some undefined secondary valence force) and crystalloids (small organic molecules) on the basis 
of the ability of a solution of the molecule in question to pass through a membrane.  While 
Graham’s theory possesses some scientific merit, the persistent application of the colloidal 
theory in explanation of properties observed for macromolecular materials hindered the 
development of polymer chemistry.7  It was not uncommon at the turn of the 20th century for 
scientists to attribute phenomenon now understood to result from the structure and properties of 
polymeric molecules to an ill defined colloidal state. 
 Under the tutelage of Kekulé the theoretical groundwork was laid for organic chemists 
to define the atomic connectivity of natural products.  It was realized by the late 1800’s that 
atomic connectivity, and not only elemental composition, defines many of the observable 
physical properties of a molecule.  A second trend emerged in collusion with the colloidal theory 
which retarded the investigation into molecules of high molecular weight; the inclination to 
define real chemistry during this period by the standard of “the molecule and its representation 
by a concise graphical (or structural) representation (as) the prime object of all effort.”8  An early 
stimulus for organic chemists was the identification of a pure substance, ascribing to it a definite 
atomic composition with a single molecular formula and the establishment of a single atomic 
structure.  Flory described it best with “The investigator was obliged to adduce elementary 
analyses to confirm the composition, and to supplement these with molecular weight 
determinations for the purpose of showing the substance was neither more nor less complex than 
the formula proposed. Otherwise the fruits of his labors would not be elevated to an honored 
place in the immortal pages of the chemical compendiums.”9  
 With the conceptual framework and theory of atomic connectivity in hand, the erection 
of organic chemistry as an indomitable fortress and haven for fruitful discovery was well under 
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construction.  The compilation of techniques to deduce the structures of nature derived products 
accelerated efforts and the identification of tools and reactions for their total synthesis.  Polymers 
were relegated to a lower caste, considered assemblies of small molecules, held in a ‘colloidal 
state’ by ‘secondary valence’ forces.  How could a structural representation be assigned to such 
an ephemeral and evanescent ‘colloidal state’?  While experiment upheld theory regarding 
atomic connectivity, the ‘secondary valence’ forces responsible for holding matter in the 
colloidal state had no such experimental support. 
 Chemists are not entirely to blame for their slow discovery of polymers, as 
macromolecules are generally obtained as mixtures of molecules with a distribution of chain 
lengths and thus different molecular weights.  Polymers did not yield to the rudimentary 
techniques used to characterize organic molecules during this period.  A single concise 
molecular formula can not be determined for a mixture of molecules.  In addition polymers 
should have end-groups, but the identification of which overtaxed the analytical methods of the 
time.8  The inability to define a precise molecular formula and identify the nature of the ends 
groups, in conjunction with elemental analyses which provided data corresponding to the 
monomer or similar small molecule left the structures of polymers undefined.  Clever 
assumptions were made to account for the data which could be gleaned from the stubborn 
molecules, such as the common resolution concerning the identity of the end groups; the 
molecules were considered cyclic, and thus did not have end groups.  Others were clever enough 
to suggest that end groups might be present, but the molecules may be so large that their 
effective concentration would extend beyond the limits of detection.  Lourenço conceived this 
idea as early as 1860; however the common trend remained for half a century more to accept the 
idea of polymers as composed of small cyclic molecules held together by secondary valence 
interactions. 
  
 1.2.2 Advances 
 Small battles were won advancing chemists closer to the fortress encompassing the 
enigmatic polymer during the late 1800’s.  While the correct definition of polymers was slow to 
emerge, understanding their nature and properties was achieved early.  Berthelot was able to 
isolate the dimer, trimer, and tetramer of pentene, and presented the results in a lecture titled ‘la 
polymérie’ to the Chemical Society of Paris in 1863.  His discoveries were insightful, but the 
theory of atomic bonding was still in the developmental stage.  After expounding his 
 5 
experimental results Berthelot waxed more philosophical speculating the principles of 
polymerization may also apply to atoms, where sulfur may be viewed as a dimer, and tellurium a 
tetramer of oxygen.  Lourenço, who correctly offered a solution to the missing end groups of 
polymers, conducted a series of reactions between 1859 and 1863 on the polycondensation of 
ethylene glycol.  A series of oligomers containing up to six units (hexaethylene glycol) were 
isolated through distillation of the reaction.  Lourenço hypothesized the residue which remained 
could contain molecules with up to one hundred glycol units.  Lourenço’s work inspired the 
suggestion that the molecules remaining may be so large that the end groups are insignificant 
contributors to the composition and reactivity of the molecules as a whole. 
 
 1.2.3 The role of natural polymers in the development of polymer science 
 Natural polymers played an important part in the early stages of dendrimer evolution.  
Rubber was one of the first natural polymers to receive detailed investigation with the empirical 
formula deduced by Faraday in 1826.  Williams burned rubber in 1860 screeching to the 
realization that isoprene could be isolated from the destructive distillation of rubber.  Raoult’s 
freezing-point depression method, devised only a few years previous, was used by Gladstone and 
Hibbert in 1888-1889 to ascribe rubber a molecular weight of 6,000-12,000 “if the method holds 
good.”10  It was the efforts of Harries, initiated in 1904, which began to define the atomic 
structure of rubber.  Concern over the nature of the end groups almost caused Harries to erase the 
progress made to that point through his first proposal of rubber as a cyclic dimer of isoprene 
(dimethylcyclooctadiene, Figure 1.2).  In subsequent years the number was inflated to larger 
rings, composed of five, seven, and eventually nine isoprene molecules.  These small rings were 
thought to be held together by secondary valence forces, mostly attributed to the presence of the 
double-bonds. 
Figure 1.2.  The structures of isoprene and dimethylcyclooctadiene. 
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 Pickles did not accept the cyclic dimer idea, as the small molecule could not be distilled 
from the assumed aggregate.  In 1910 Pickles provided an intellectual dilemma, showing the 
bromination of rubber, with the concomitant removal of the double-bonds, did not affect the 
colloidal nature of rubber.11  Pickles suggested the true rubber molecule was much larger, but 
still accepted the idea that the ends were joined to form a ring, like the bands around a barrel.  In 
1922 Staudinger demonstrated reduction of the double-bonds in rubber by hydrogenation did not 
change the properties attributed to the ‘colloidal state.’  A light came on and Staudinger 
suggested the double-bonds played no role in defining the macromolecular structure of rubber.  
He bounced around the idea that rubber molecules were held together by primary valence bonds, 
and thus their structure could be explained by atomic connectivity theories employed at that time 
by traditional organic chemists.  The fortress of the polymer had been breached and the light 
shed by Staudinger soon illuminated the true nature of macromolecules, with organic chemists 
finding refuge and sustenance within her walls. 
 The idea that carbohydrates are polymeric materials dates back at least to 1871 when 
Hlasiwetz and Habermann suggested these compounds are mixtures of several isomeric and 
polymeric substances, differing from one another by the degree of molecular condensation.  In 
1889 Brown and Morris used Raoult’s method to obtain a molecular weight of 30,000 for 
amylodextrin.12  Such a large molecular weight, suggesting a very large molecule, was met with 
more than just skepticism leading to a decay in the confidence of Raoult’s method and later 
colligative properties in general for the analysis of colloidal solutions.  In 1921 the influential 
chemist Karrer laughed at the idea that nature would construct such large molecules as starch for 
the storage of sugar since “it is improbable that a plant in converting sugar to a reserve substance 
from which it might soon have to be recovered would perform such complex work.”  It was 
known that glucose could be obtained almost quantitatively by the degradation of cellulose as 
early as 1913, but the structure of cellulose was assumed to be a ring built up from glucose units.  
The common opinion held at the time concerning the structure of cellulose as expressed by 
Heuser in 1922 was “according to the most recent investigations the principle of the chain 
formula must be abandoned.”13 
  
 1.2.4 The role of analytical methods in advancing polymer chemistry as a science 
 Early X-ray diffraction studies indicated the unit cells of cellulose, silk and crystalline 
rubber were similar in size to those of known small molecules.  The unit cell was argued as a 
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confining feature of the compound and it was thought that natural polymers could be no larger 
than the molecules contained in the unit cell as determined through X-ray analysis.  Polymers 
were about to be relegated to an intellectual dungeon as the X-ray data was used as further 
support for the notion that rubber, cellulose, and silk were composed of small molecules.  
Sponsler and Dore provided X-ray diffraction data consistent with cellulose fibers composed of 
an indefinite number of units in 1926.  However, they also proposed a structure inconsistent with 
the chemical evidence present at the time concerning the constitution of cellulose.  From the X-
ray data they proposed a molecule composed of glucose units linked by alternating 1,1 and 4,4 
linkages (Figure 1.3).  Chemists had conclusively demonstrated that cellulose was composed of 
cellobiose, a disaccharide linked through a β-1,4 connection (Figure 1.3).  The incorrect 
assignment proposed in by Sponsler and Dore in their paper only further shed doubt of the 
validity of any claims made about the macromolecular structure of cellulose, and the 
applicability of X-rays in studying organic molecules in general. 
 
 
 
 
 Peptides and proteins were better understood then some of their simpler siblings, and 
this was facilitated by the ability to isolate homogenous, mono-disperse, and even crystalline 
protein samples.  In many ways protein chemists were a step ahead of their organic chemist 
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Figure 1.3.  The structure of cellobiose and the proposed structure of cellulose according to Sponsler and 
Dore.  Cellobiose is a disaccharide composed of glucose units joined by a β-1,4 linkage.  Cellulose is a 
polymer of glucose monomers joined by β-1,4 linkages.  Sponsler and Dore proposed a structure for 
cellulose composed of alternating 1,1 and 4,4 glucose linkages in 1926.  
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counterparts in understanding the macromolecular nature of proteins.14  Sulfur found in proteins 
from the amino acids cysteine and methionine provided an analytical handle for the 
determination of a proteins large molecular weight.  Since most proteins contain at least a single 
sulfur containing residue, and generally not too many more, the elemental analysis of pure 
proteins produces a low percentage of sulfur in relation to the carbon, nitrogen, oxygen, and 
hydrogen content.  The small percentage of sulfur translates into a large ratio of carbon to sulfur 
and a corresponding high molecular weight.  The elemental determination of other natural 
polymers composed entirely of carbon, hydrogen, and/or nitrogen and oxygen provides an 
empirical formula with approximately equal atomic abundance.  The result is a molecular 
formula more representative of the monomer than the polymer.  Using elemental analysis, 
including the determination of sulfur, twenty-four proteins were found in 1902 to have an 
average molecular weight of 15,000.15  The low abundance of iron in hemoglobin and the ability 
to obtain crystalline samples led to the reproducible determination of 0.4% iron in the 
hemoglobin sample.  Assuming one iron per monomer a minimal molecular weight of 16,700 
was proposed as early as 1886. 
 The use of X-rays was not the only analytical tool to expose the true nature of proteins.  
The development of the ultracentrifuge by Svedberg began to turn the tide in favor of a correct 
understanding of polymers.  Svedberg initially settled on conducting sedimentation experiments 
of true colloidal solutions.  The technique was valuable in determining accurate molecular 
weights of colloidal samples over a range from thousands to millions, but the value of the 
centrifuge did not stop there.  Information on the distribution of particle weights could also be 
obtained.  Svedberg, in turning his technique to the study of proteins, fully expected to see a 
disperse collection of molecules, but found exactly the opposite. The ultracentrifuge provided an 
analytical tool for the demonstrating the discrete monomolecular nature of proteins; they 
behaved nothing like known inorganic colloidal solutions.  Svedberg’s ultracentrifuge and 
sedimentation experiments settled the debate concerning hemoglobin; it turned out to be 
composed of discrete particles of large molecular mass.  The results cemented the foundation for 
the acceptance of proteins as large molecules composed of a single molecular entity, and not 
assemblies of smaller polypeptides.  The analytical ultracentrifuge, also pioneered by Svedberg, 
is used in the accurate determination of molecular weights of large molecules.  The development 
of sensitive analytical methods to dissect the nature and properties of natural polymers provided 
conclusive evidence for their existence as large molecules.  Beginning with Raoult’s method of 
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freezing point depression it was the development of analytical techniques which slowly 
decreased the animosity towards polymer chemists and turned the field in to a fruitful discipline. 
  
 1.2.5 Confusion abounds concerning the nature of proteins 
 It has been suggested that many protein chemists did not capitulate to the convoluted 
colloidal theory,16 but several noted chemists at the turn of the century still questioned the 
relationship between large molecules and proteins.  The polypeptide theory proposed in 1902 
correctly identified the principles involved in the bonding of amino acids to form peptides, but 
the relation of peptides to proteins and proteins to enzymes was still unclear.  Emil Fischer 
approached the structural elucidation of proteins by a classical organic approach, through their 
synthesis.  Fischer expressed doubts concerning the existence of proteins with molecular weights 
exceeding four thousand during a lecture as late as 1913.17  During this same lecture Fischer 
described the synthesis of a molecule with a mass of 4,021, claiming it was the largest substance 
to date produced wholly by synthesis.  He challenged the molecular physicists then studying 
high molecular weight substances to: “confine themselves to the synthetic products of known 
composition.”  Fischer called upon organic chemists to “accumulate larger and larger masses in 
the molecules, in order to see how far… matter can go.”  Fischer’s desire to pursue the 
construction of large molecules was evident, but the tools necessary for the synthesis of truly 
high molecular weight compounds of known composition was decades away. 
 Some protein chemists during Fischer’s time had ‘seen the light’, thus avoiding the 
pitfalls encountered through adoption and application the colloidal theory.  One such investigator 
was Sørensen, the developer of the pH scale, who measured the molecular weight of crystalline 
egg albumin by osmotic pressure, and concluded that many of the beliefs long held by colloidal 
chemists were inaccurate.  Sørensen issued a stinging condemnation of colloidal chemistry in 
1915, stating “colloidal chemistry has, in my opinion, not contributed to further progress, but 
rather the reverse.” 
  
1.3 Evolution of the Macromolecular Hypothesis   
 It was the persistence of Hermann Staudinger and the development of synthetic 
polymers which finally provided the push necessary to establish a correct definition and 
conceptual framework for discussing polymers intelligently.  Staudinger proved the force 
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necessary to establish a correct theory of polymers and macromolecules as large assemblies of 
covalently connected atoms.18 
  
 1.3.1 The doctrinaire of polymers:  Hermann Staudinger 
 At the beginning of the 1920’s much was already known concerning polymers; 
polymeric materials were in household use.  Cellophane, rayon, and Bakelite plastic dinnerware 
were common polymeric materials.  Colloidal chemists possessed the louder voice during this 
period and were the accepted school of thought among chemists at the time.  Hermann 
Staudinger left his research in organic chemistry, for which he had already established a sound 
reputation and developed a reaction which still bears his name,19 to fight for the acceptance of 
macromolecules as covalent assemblies.  His approach was to use simpler synthetic polymers as 
models of the natural counterparts, thus polyoxymethylene was used as a model for 
carbohydrates, polystyrene as a model for rubber, and polyacrylic acid as an analog of proteins. 
 Staudinger adhered to the initial definition of polymers proposed by Berzelius; a 
polymer has the same elemental composition as the monomer.  Staudinger reserved the term 
‘polymer’ to addition polymers such as rubber, excluding the condensation polymers of proteins, 
oligosaccharides, and DNA.  Macromolecule was a term introduced by Staudinger which was 
free from ambiguities associated with the inconsistent application of the term polymer.  
Macromolecule was more inclusive than Berzelius’ original term, including addition and 
condensation polymers.  His macromolecular hypothesis first proposed in 1920 was met with 
resistance.  He later refined his thoughts using his work on the hydrogenation of rubber with the 
definition of macromolecules as primary-valence chain systems.  A defining statement 
expressing the chemical community’s thoughts with regards to macromolecular chemistry during 
this period was made after a farewell lecture given by Staudinger in 1925 at the ETH in Zürich.  
A noted chemist compared Staudinger’s championship of large molecules to that of a traveler in 
Africa claiming to have seen a zebra 400 meters long.20  Such was the inability of organic 
chemists to accept the idea of large molecules at this time.   
 The identity of the end groups was a persistent thorn in framing the conceptual ideas of 
what constitutes a polymer.  Staudinger was the first to effectively champion the existence of 
large molecules, but he still perpetuated some errors.  To deal with the identity of the end groups 
Staudinger first suggested they may be composed of unfilled valences.  These radicals were 
suggested to be stable on the basis of spatial separation of the reactive groups by the length of 
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the polymer.  Staudinger later regressed, suggesting in 1929 that rubber and polystyrene were 
likely to be composed of very large rings; the same fanciful conclusion continued to come 
around and around.  Staudinger also viewed polymer chains as rigid rods, a theory later 
superseded by the chain entanglement model. 
  
 1.3.2 An organic chemist for polymers:  Wallace Carothers 
 It was perhaps the work of Wallace Carothers while at Du Pont that finally convinced 
chemists that macromolecules existed, and clarified the dilemma associated with trying to 
identify the end groups of polymers.  He set out specifically in 1929 to set aside some of the 
common misconceptions and to prepare polymers of definite structure through the use of 
established organic reactions.21  Carothers’ treatise in Chemical Reviews in 193122 defines many 
of the concepts and the current definition of polymers in use today; it is viewed as a turning point 
in the chemistry community’s acceptance of polymer chemistry.  Carothers efforts are 
comparable to the methodical approach utilized by Emil Fischer, “discarding, however, the 
unnecessary and severely encumbering insistence on pure chemical individuals under which 
Fischer and his colleagues labored.”23 
  
 1.3.3  The academic community begins to accept polymers 
 Polymer chemistry had arrived as a scientific discipline, but not to the open arms of the 
organic chemistry community.  The general opinion of macromolecules at the time was 
summarized by Willstaetter in 1926 after a conference which was organized to confront 
Staudinger.24  He commented that “such enormous organic molecules are not to my personal 
liking but it appears that we all shall have to become acquainted with them.”  By the “beginning 
of the 1930’s the existence of macromolecules was inescapable.”18  Over the next twenty years 
research on polymers would make invaluable contributions to science and humanity through the 
creation of new materials and the establishment of a new discipline in the field of chemistry. 
   
1.4 The Rapid Evolution of Polymer Chemistry as a Science 
 1.4.1  The movement of polymers from industry to academia 
 The Second World War spurred the industrial development of polymer science as the 
demand for novel technologies and materials arose.  The desire and need for a synthetic rubber 
and the United States backing of polymer research accelerated industrial efforts.  The goals of 
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polymer chemists became more utilitarian as functional materials were needed in short order.  
Research during this period focused on the ability to produce functional materials by controlling 
the composition of a polymer with subsequent control over the properties of the material.  
Details concerning the atomic structures of polymers were less important, and the materials 
synthesized typically relied on the use of established reactions.  Polymer chemists would 
experiment with reactants and catalysts until a polymerization would occur, followed by analysis 
of the products to determine what had occurred.  The ability to create new materials and tune the 
properties of the polymers for a specific application became as much of an art as that found in 
the synthesis of natural products. 
 The end of the Second World War allowed polymers to receive the academic attention 
they needed.  In 1946 the first polymer institute in the United States was established at the 
Brooklyn Polytechnic Institute, heralding the sustained investigation of polymer structures, 
properties, and composition.25  The institute’s founder, Hermann Mark, saw a need for journals 
in which to disseminate the rapidly generated experimental details.  Mark was the initial editor of 
the Journal of Polymer Science, the first American chemistry journal dedicated to the publishing 
of research on macromolecules. 
 
 1.4.2 Consensus on the structure of natural polymers 
 A general consensus on the structures of the natural polymers was beginning to be 
reached by the end of the Second World War.  Cellulose was proven to be composed of glucose 
units connected by β-1,4 linkages in 1928, showing no contradiction between chemical and X-
ray data.  It was conclusively demonstrated during the same year that rubber was constructed of 
isoprene units connected in a head-to-tail fashion containing all cis double-bonds.  Silk and other 
proteins were known to be composed of amino acids connected by planar amide linkages.  But 
the structure of DNA remained enigmatic, but not from lack of trying.  
 DNA was suggested to be composed of tetranucleotide units on the basis of a hypothesis 
first put forward by Levene in 1919.26  Levene and Schmidt published in 1938 results describing 
preparations of DNA with molecular weights between 200,000 and 1 million.  Upon storage or 
treatment with certain proteinaceous material smaller fragments would appear and this was 
suggested to occur by the depolymerization of DNA through the “dissociation of the 
tetranucleotides of high molecular weight to those of lower molecular weight.”27  It was the 
studies of Singer, Caspersson, and Hammarsten which straightened out the dilemma, 
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demonstrating the rod like nature of DNA.28  Chargraff set down the law with his rules 
describing the selective base pairing of the pyrimidine bases with the purine bases.29  It wasn’t 
until 1952 that the correct atomic connectivity of the nucleotides within DNA was deduced.30  
The tetranucleotide hypothesis, proposed for over three decades, was overturned in the early 
1950 to reveal the correct identification of DNA as a polymer. 
  
 1.4.3 The year of the polymer 
 Polymer chemistry was an irrefutable science and had assumed its place along side total 
synthesis by the 1950’s.  The year 1953 could be termed the year of the polymer.  In a scant 
quarter of a century polymer chemistry had moved from an ill-defined endeavor, lacking correct 
knowledge of concepts and a concise definition concerning the macromolecule realm, to a full 
fledged science with ample theories and techniques with which to probe the new domain.  The 
publication of the ‘polymer bible’ by Flory titled Principles in Polymer Chemistry31 in 1953 
illustrated just how far the field had progressed.  Polymer chemists had the tools necessary to 
describe polymer reactions and the products, and more importantly the theoretical methods and 
models necessary to deal with macromolecules.  In April of 1953 the atomic structure of DNA as 
deduced by Watson and Crick was published.32  DNA was a polymer composed of two 
antiparallel stands adopting a helical structure.  Nature again had constructed a novel 
architecture, but this time on a macromolecular level.  The claim to and inspiration born of 
unique molecular architecture was no longer just the domain of chemists studying and 
synthesizing natural products.   
 The Nobel Prize was awarded to Staudinger in the autumn of 1953, recognizing his 
contribution in understanding the nature and structure of macromolecules.  His efforts had paid 
off, a new disciple had been established, and his work recognized.  Carothers in all probability 
would have shared the stage with Staudinger for his methodical approach to the investigation of 
polymers, but his suicide at the age of 41 in 1937 not only cut too short a brilliant career, 33 but 
precluded his receiving this distinction.   
 In this same year that Staudinger received chemical history immortality the low pressure 
and temperature polymerization of ethylene was accomplished using Ziegler-Natta catalysts.34 
The value of this discovery is not only found in the profits gained through its industrial 
application, but the realization that controlling the properties of polymers can be accomplished 
through control of its composition, specifically in this case by the degree of polymer branching.  
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This discovery led to methods and catalysts providing control over the stereoarrangement of 
atoms within a polymer. 
 
 1.4.4 Controlling the polymer 
 Total synthesis reached new heights during the 1950’s, and this is no better exemplified 
then with Woodward’s synthesis of strychnine in 1954.35  This alkaloid was described in 1952 by 
Sir Robert Robinson as “for its molecular size … the most complex substance known,”36 and 
while his familiarity with the molecule might prejudice his view, Woodward describes the case 
as a good one with strychnine containing “six nuclear asymmetric centers and seven rings 
constituted from only twenty-four skeletal atoms.”35b  What makes the synthesis so remarkable 
and impressive is the demonstration of the synthetic chemist’s ability to mimic nature in 
controlling the placement of atoms within such a unique structure.  Similar advances were 
occurring simultaneously in polymer chemistry. 
 In 1940 it was realized through infrared (IR) spectroscopic studies that polyethylene 
produced under high pressure contained more methyl groups present in the sample then could be 
accounted for by the end groups of the polymer.37  This was the first realization that branching 
from the polymer backbone was occurring during the high temperature and pressure production 
of polyethylene.  To study the effects of branching on the physical properties of the polymer 
diazomethane was polymerized to produce polymethylene, a polymer structurally homologous to 
polyethylene, but without branching.  Polymerization of diazomethane in the presence of varying 
amounts of diazoethane gives a polymer with a controlled number of methyl branches.  The 
incorporation of an increasing number of branches into the polymethylene polymer decreased its 
density, leading to the conclusion that low density polyethylene has a relative high degree of 
branching.38  Rubber like polymers were produced when 15 or more methyl branches were 
incorporated for each 100 carbon atoms.  The incorporation of a branch from the polymer 
backbone introduces a stereocenter at that point and under the above reactions the configuration 
of these methyl side chains was random.   
 The polymerization of propylene produces a linear polymer with a methyl side chain on 
every other carbon, and thus a stereocenter on every other carbon of the backbone.  During the 
years 1953-1954 five patent applications were filed for the production of a stereoregular 
polypropylene polymer.39  The production of crystalline polypropylene as described in the 
patents was the result of forming a stereoregular arrangement of the methyl side chains during 
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the polymerization of propylene.  The importance composition of the polymer played in 
determining the physical properties of the final material was becoming evident; branching 
decreases the density of a polymer, while stereoregular features increase the crystallinity.  The 
value of controlling the architecture of the macromolecule was beginning to be realized and the 
consequences were astounding. 
 The first total synthesis of a natural polymer occurred in 1954 using the catalysts 
developed by Ziegler and Natta.  This work was conducted at the B. F. Goodrich Company by 
Horne and coworkers.40  They polymerized isoprene in a head-to-tail fashion, producing a 
macromolecule containing virtually all cis bonds, the natural configuration of Hevea rubber.  A 
few years later the Firestone Tire and Rubber Company produced polyisoprenes of very high cis 
content (>90%) using lithium as the catalyst.41  The total synthesis of the natural oligopeptide 
oxytocin also occurred in 1954,42 but being a nonapeptide it cannot quite be considered a 
macromolecule. 
 Two main factors separate synthetic polymers from their natural counterparts.  First, 
nature has developed methods to control the composition of polymers down to the atomic level.  
Through the use of natural catalytic macromolecules (enzymes) nature can construct, modify, 
and manipulate natural polymers with atomic precision.  Second, nature produces polymers, 
specifically proteins and ribonucleic acids, with low dispersity and even identical chain lengths 
and composition.  Stereoregular polymers were the synthetic chemists’ first success at 
controlling the structure of macromolecules.  Methods for conducting living polymerizations 
followed a few years later in 1956,43 further allowing chemists control over the composition of 
polymers and the ability to produce macromolecules possessing a narrow distribution of chain 
lengths.  Many different architectural types are accessible using living polymerization methods,44 
although these were not pursued until the 1980’s. 
  
 1.4.5 Polymer chemists' attempts at mimicking nature 
 The first efforts to control the atomic connectivity of a polymer at the monomer level 
came by way of inspiration from, or in desire to mimic nature.  As in the synthesis of natural 
products nature has devised methods to construct macromolecules of controlled composition and 
structure.  Nature’s most impressive feat in relation to polymers is the ability to construct 
discrete copolymers, such as proteins, DNA and RNA, were every molecule in the sample has 
the same atomic connectivity; such molecules are considered monomolecular.   
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 Synthetic copolymers have been known since the late 1800’s.  Copolymers allow the 
incorporation of multiple functionalities within in a polymer through the use of multiple 
monomers, but also result in an increased heterogeneity in the polymer sample.  Copolymers not 
only contain molecules of different lengths, but also molecules of different compositions and 
atomic connectivity by virtue of random assembly of the different monomer.  Under certain 
conditions it becomes possible that no two molecules are exactly alike within a copolymer 
sample. 
 It is requisite that in the chemical synthesis of a peptide or protein, that the not only the 
composition of the molecule and the connectivity of the monomers be controlled at the atomic 
level, but also the stereochemical arrangement of the atoms.  Little similarity between a biogenic 
peptide of choice and a peptide formed from the random polymerization of amino acids would 
be expected, and thus methods were devised to construct peptides in a step-wise manner.   
 The Nobel Prize winning Emil Fischer took the first steps to construct a truly 
monomolecular macromolecule.  Fischer began work on proteins in 1901 with the synthesis of a 
dipeptide, and his efforts later culminated in the synthesis of an octadecapeptide of defined 
chemical composition in 1907.  The molecular weight of Fischer’s peptide was 1,212, not what 
polymer chemists would consider large today, but the feat in its time was monumental.  Fischer’s 
goal was to construct an enzyme.  In a letter to Adolf Baeyer in 1905 he expressed this desire:  
“My entire yearning is directed towards the first synthetic enzyme.  If its preparation falls into 
my lap with the synthesis of a natural protein material, I will consider my mission fulfilled.”45  
 Fischer demonstrated that some physical properties of his synthetic peptides matched 
those of natural counterparts, in particular the synthetic peptides susceptibility to some 
proteolytic enzymes; however his peptides were composed only of leucines and glycines. 
 The first synthesis of a natural oligopeptide was accomplished in 1954 with the synthesis 
of the nonapeptide oxytocin by du Vigneaud,42 for which he received the Nobel Prize in 1955.  
In 1956 he completed the synthesis of vasopressin, also a nonapeptide.46  These peptides are 
considered small in relation to what nature can accomplish, containing ten less residues than the 
nonadecapeptide peptide constructed by one of Fisher’s students in 1919.  These efforts however 
paved the way for the successful synthesis of true macromolecular peptides.  Total synthesis of 
proteins became more of a reality with advances in peptide synthesis made by Merrifield.  Most 
notably he pioneered the solid supported synthesis of peptides by attaching them to an insoluble 
polymeric support, the union of synthetic polymers for the construction of natural polymers of 
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defined length, composition, stereoconfiguration, and atom connectivity.  Through iterative 
reactions first involving the attachment of a protected monomer to the growing polymer chain, 
followed by removal of the protecting group located at the end of the polymer, and subsequent 
attachment of a new monomer, synthetic peptides and proteins can be constructed which are 
identical to those from natural sources.  Merrifield received the Nobel Prize in 1984 for his 
efforts.  His group synthesized multiple peptides, some of which could be considered 
macromolecular.  The iterative nature of solid phase peptide synthesis quickly allowed the 
process to be automated. 
 True macromolecular proteins can be constructed by total synthesis routes.47  Enzymes 
are typically composed of approximately 300 amino acid residues, with the smallest (e.g. 
ribonuclease, lysozyme) containing around 125 residues.  The synthesis of sequences longer than 
one hundred residues is difficult by typical step-wise solid phase synthesis methodologies.  The 
introduction of total chemical synthetic methods, which employ the use of ligation reactions to 
join smaller peptide fragments forming larger constructs, provides synthetic access for the 
production of large proteins.48  The construction of novel enzymes containing all D-amino acids 
is a salient example of the current ability of chemists to control the composition, placement, and 
structure of macromolecules.49 
 Oligonucleotides succumbed to the same fate as proteins, that being the automated 
chemical synthesis of monomolecular biopolymers with the identical composition to those from 
a biogenic source down to the atomic connectivity and stereoarrangement.  Marvin Caruthers 
spearheaded this endeavor, proving its value through the sequencing of the Human Genome, 
what has been termed from a chemist’s perspective as the single largest undertaking for the 
structural elucidation of a natural product.  The DNA double helix is a beautiful example of 
macromolecular architecture, and the ability to construct higher ordered novel molecular 
architectures using DNA has been accomplished by Seeman.50  During the beginning of the 21st 
century reports began to surface regarding the automated synthesis of a third biopolymer: the 
oligosaccharides.51  
 The synthesis of linear biopolymers of known composition and atomic connectivity are 
now routinely conducted.  Peptides can be synthesized in a few hours to days, and even the total 
chemical synthesis of enzymes is possible.  Oligonucleotide synthesis is routine, greatly 
impacting research in the biosciences.  Automated oligosaccharide synthesis provides rapid 
access to macromolecules greatly impacting the fields of glycobiology and glycomics.52  
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Polymer chemists have succeeded in conquering the syntheses of the natural polymeric products, 
so where do they turn to find the next target?  Their imaginations. 
 
1.5 Polymers Are Not Just Straight Chain Molecules 
 Just as natural product chemists look for a new structure with unique architectural 
features to pursue, polymer chemist began to envision and seek unique macromolecules.  The 
results of Ziegler and Natta introduced chemists to the idea of stereocontrol.  Living 
polymerization offered opportunities for control over the size and molecular weight distribution 
of polymers.  Developments and advances in directing copolymerizations offered access to 
compositional control.  The stepwise synthesis of the natural macromolecules demonstrated 
control down to the atomic level in the construction of polymers  The ability and desire to 
control the architecture of macromolecules was last to develop.   
 Flory outlined multiple possible unique macromolecular architectures in his book in 
1953.  His treatment was theoretical in approach and dealt with the possibility of branching 
resulting from the use of multifunctional monomers in the polymerization process.  Networked 
and cross-linked polymers were well known at the time, but most materials result from random 
branching and do not provide access to discrete macromolecules.  One class of synthetic 
macromolecules has evolved to provide the construction of large assemblies of atoms in a 
controlled fashion, giving rise to discrete and monomolecular structures of known composition 
and atomic connectivity; these macromolecules are known as dendrimers.   
  
 1.5.1 Polymer chemistry begins to branch out 
 A high degree of branching is found in all levels of organization from the branching of 
trees (from whence the name dendrimers arises, from the Greek dendri-(branched tree-like) and 
meros-(part of), to the atomic level, where the efficiency of storage and access to sugars for 
metabolism is enhanced through the formation of highly branched oligosaccharides. The origins 
of dendrimer chemistry stretch back to the beginning of organic synthesis, and specifically the 
beginning of polymer chemistry, when it was realized that polymers could contain branching 
points, thus giving rise to branched structures.  The covalently linked linear chain of branched 
and cross-linked polymers remains the characteristic feature of so-called non-linear polymers.  In 
dendrimers branching becomes the dominant feature, and the synthesis of a dendrimer results in 
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the construction of a large monomolecular assembly of atoms presenting a perfect branching 
pattern. 
 The field of dendrimer chemistry is a young research area, and represents a union 
between the traditional organic chemistry’s ability and desire to control the connectivity and 
placement of atoms, with the subsequent production of a monomolecular structure, and the 
polymer chemist’s ability to construct large assemblies of atoms with unique structural and 
physical properties.53  Fischer would be proud, not only can molecules of extremely large mass 
be constructed, but a concise structural representation with atomic detail can be drawn for the 
dendrimer structure. 
 
 1.5.2 Dendrimer chemistry begins  
 The first generally accepted synthesis of a dendrimer occurred in 1978 by Vögtle.54  The 
products were termed cascade molecules, and occurred by the iterative application of two sets of 
reaction conditions.  While these molecules were not specifically pursed for their highly 
branched structures, and were relatively small in nature, the synthetic methodology for the future 
construction of dendrimers had been outlined. 
 The only report until 1985 on the utility of Vögtle’s ‘cascade synthesis’ methodology 
came in the form of three patents filed in 1979, 1981, and 1983 on the synthesis of lysine 
dendrimers.55  These patents describe the synthesis of polylysine dendrimers using the α and ε 
amino groups as the branching points for the structure.  The physical properties of the lysine 
dendrimers were characterized and the results published in a 1982 research paper.56  In 1985 
dendrimers received their name and the investigation began in earnest with the publication of 
two research papers.  Newkome and coworkers published the synthesis of a series of molecules 
termed arborols (arbor-Latin for tree), possessing three branching points at each generation.57  
Tomalia and coworkers reported the synthesis of a series of poly(amidoamine) (PAMAM) 
dendrimers while at Dow.58  The next advance in dendrimer chemistry, which supplied the 
methodology necessary to truly construct macromolecules with tailored structures, came with the 
publication of the convergent approach to the synthesis of dendrimers by Frèchet in 1990.  
Previous to this method dendrimers were constructed through what is termed a divergent 
strategy. 
 The divergent synthesis of dendrimers is likened to the way nature constructs trees 
(Figure 1.4a).  The initial construction of the structure begins at the trunk of the tree or core of 
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the dendrimer, and emanating from the core are appended a series of branches.  On the end of 
these branches are appended more bifurcations, continuing outward to the surface of the tree or 
dendrimer.  The branching at each level increases as a function of the number of branching 
points used.  In Newkome’s dendrimers the branching effectively tripled after the addition of 
each layer, while in Tomalia’s initial example the branching doubled at each stage.  The 
divergent method requires an exponential increase in the number of reactions at the dendrimer 
periphery which much be completed to ensure complete branching; incomplete reactions 
introduce defects and imperfect branching into the dendrimer structure. 
 The convergent method for the construction of dendrimers has been termed the organic 
chemist’s approach to dendrimer synthesis (Figure 1.4b).  The dendrimer is constructed from the 
branches toward the trunk utilizing a constant number of reactions for each generation of growth.  
The branching of the dendrimer is increased by connecting two (or more) branched molecules to 
a common core, effectively doubling (or more) the number of branches at the end of the 
molecule, but only necessitating two reactions.  In the case of incomplete coupling reactions 
using the convergent route, the by-products have a fraction (approximately one-half) of the mass 
of the completed product, and are generally easy to separate from the desired product.  
Byproducts resulting from incomplete couplings using the divergent approach typically differ 
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Figure 1.4.  Divergent (a) and convergent (b) dendrimer synthetic routes.  An increase in the number of 
branching units in the divergent route occurs through reaction at the peripheral layer of the dendrimer. 
The branching in the convergent route is doubled by reaction of two monomers with a core molecule. 
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from the desired product by only a small percentage of mass and thus are difficult, at the least, to 
separate from the desired product.  The real power of the convergent route arises from the ability 
to control the composition of the dendrimer at each generation.  
 Frèchet’s initial method used the bi-functional tri-substituted benzene 1, which contains 
two phenolic groups and a benzylic alcohol (Figure 1.5).  The phenolic oxygens are more acidic, 
and thus more nucleophilic than the benzylic alcohol under basic conditions, allowing selective 
modification at these two sites.  Each phenol is of equal nucleophilicity and little selectivity of 
reaction between the two can be obtained.  To accomplish modification of a single site on 
Frèchet’s core a substoichiometric amount of the given reagent is used, followed by separation 
of the desired mono-derivatized product from the unmodified and bis-modified molecule.  
Functional group interconversion of the benzylic alcohol into a reactive electrophile is required 
after reaction of the phenol groups. 
 A unique approach to the construction of dendrimers is the use of a triazine core, where 
the branching necessary for dendrimer growth results from direct substitution onto the core, 
rather than through functional groups appended to the core.  The nature of the functionality 
appended to the core can be altered by the selection of various nucleophiles.  The triazine 
contains three electrophilic sites in contrast to Frèchet’s monomer which has three nucleophiles 
of two different types (Figure 1.5).  The electrophilic sites on the triazines can be reacted in a 
sequential temperature dependent manner.  The first substitution introduces an electron donating 
group onto the ring, increasing the temperature or time required for subsequent reactions.  The 
temperature dependent nucleophilic substitution of triazines has been know for decades, 
resulting in the construction of novel molecular architectures and application in a plethora of 
disciplines. 
 
 
Figure 1.5.  Frèchet’s monomer contains three nucleophilic groups.  The phenols being more 
nucleophilic react preferentially, followed by conversion of the benzylic alcohol into an electrophile. 
Nucleophilic substitutions on triazines occur sequentially in a temperature dependent manner, thus no 
functional group interconversion step is required. 
OH OH
OH
RO OR
OH
N N
N
LG
LG LG
RO OR
Br
N N
N
LG
R R
Nu
E+
E+
E+
Nu
Nu*
FGIRXN RXN
E+
1
 22 
1.6 The Discovery of Cyanuric Acid:  The Start of Triazine Chemistry 
 As a representative of the class of compounds known as 1,3,5, triazines or s-triazines 
(symmetrical), cyanuric acid (2) is one of the oldest recognized synthetic organic compounds.  It 
was known as early as 1776 as ‘pyro-uric’ acid after its method of preparation by the pyrolysis 
of uric acid (Figure 1.6).59  The name cyanuric acid is derived from the initial assessment that the 
molecule was composed of C≡N groups and was derived from uric acid.  In 1820 cyanuric acid 
was again prepared from cyanogen in water by Serullas.  It wasn’t until 1830 that Wöhler found 
that pyro-uric acid and Serullas’ product were identical.  The first molecular formula was 
assigned through collaboration between Liebig and Wöhler as C6H6N6O6, but the correct 
formula, C3H3N3O3, was not determined until 1875.  To further complicate matters a product 
isolated from the oxidation of uric acid was given the name tetracarbonimid, and was later found 
to be similar to cyanuric acid isolated from soil samples.60  Soon researches confirmed the 
similarity of the two compounds and found that tetracarbonimid and cyanuric acid are the 
same.61  It is interesting to note that while Wöhler is credited in 1828 with the first synthesis of 
an organic compound from an inorganic compound1 an early but unrecognized natural product 
synthesis, that of cyanuric acid from inorganic precursors, occurred eight years earlier. 
 Only a few reports of the triazine structure being found in natural products are present in 
the literature.  The nucleotide analog aza cytidine (3) was isolated from fermentation broths in 
1966, where the carbon at position C-5 of cytidine is replaced by nitrogen.  Aza nucleotide 
analogs have found use as chemotherapeutic agents acting by inhibition of DNA synthesis.62  
The only additional reported natural occurrence of an s-triazine containing compound was a 
molecule isolated from an algae found off the coast of China; the product being named 
halimedin (4).63  Halimedin differs from the widely used herbicide cyanazine (5) only by a 
methoxy substituent at the chloride position of cyanazine.  The suggestion was later made that 
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Figure 1.6.  Destructive distillation of uric acid produces cyanuric acid, 2. 
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isolation of halimedin was simply the recovery of a synthetic compound from a natural source.64 
The questions as to the source of the cyanazine in the South China Sea, or how the substitution 
of the chloride by the methoxy group occurred remain unanswered.  Melamine (7, see below) 
was found in the Orgueil and Murchison meteorites, however it is not thought to arisen from a 
natural source.65 
 
 
 
 
 The parent compound of the triazine family, s-triazine (6) although originally 
synthesized in 1895 by Nef, eluded correct identification for nearly sixty years.  Methods for the 
synthesis of s-triazine were pursued for many years, typically by the reduction of other s-triazine 
analogs.  Grundmann and Kreutzberger convincingly demonstrated in 1954 the molecule 
prepared from the treatment of hydrogen cyanide with hydrogen chloride, long considered the 
dimer of hydrogen cyanide, was actually a trimer and the elusive s-triazine.66  In comparison to 
cyanuric acid and other substituted triazines, s-triazine displays instability unique to this 
heterocyclic family.  It is readily hydrolyzed in water, occurring immediately in the presence of 
dilute aqueous acids, producing ammonia and formic acid. 
 
 
 
 
 Cyanuric acid is found primarily in its oxo tautomer (Figure 1.7), and reactions with 
electrophiles tend to give N-substituted products.  Cyanuric acid is of limited commercial 
importance, and of the 80,000 tons produced annually (1997) more than 90% is used to make N-
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chlorinated isocyanurates.  N-Chloroisocyanurates are used as swimming pool sanitizers, 
disinfectants, detergents, and industrial cleaners.  Cyanuric acid finds limited use as a stabilizer 
for chlorine in swimming pools.67  Other commercial products originating from cyanuric acid 
include tri-N substituted reagents for cross-linking polymers, light stabilizers, antioxidants, and 
flame retardants.   
 
 
 
 
 1.6.1 Melamine:  The most widely used triazine 
 By far the most widely used triazine is that of cyanuric acids closely related structural 
cousin, melamine (7).  In 2001 over 700,000 metric tons were produced, with a value of $700 
million.  It is used as a crosslinking reagent in to formation of resins, most importantly those 
involving formaldehyde. 
 
 
 
 
 1.6.2 Cyanuric chloride:  A versatile molecule 
 The annual production of cyanuric chloride (8) exceeds 100,000 tons annually.  The 
synthetic utility and much of the industrial importance of the triazine heterocycle arises from the 
ease by which nucleophilic aromatic substitutions occur on halogenated triazines.  The tri-fluoro, 
chloro, bromo, and iodo 1,3,5-triazines have been prepared, but 1,3,5-trichlorotriazine, cyanuric 
chloride, is by far the most important commercially and the most widely used synthetically.  
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Figure 1.7.  Tautomers of cyanuric acid.  The equilibrium between the enol and oxo tautomers of cyanuric 
acid lies to the right, the oxo form. 
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Cyanuric chloride was first prepared in 1827, and its composition determined by Liebig in 1829.  
It is readily obtained through the cyclotrimerization of cyanogen chloride using activated 
charcoal as the catalyst.67  More than 70% of the cyanuric chloride produced is used in the 
production of pesticides and especially the triazine herbicides.  Nearly 70% of the cyanuric 
chloride produced annually is for the synthesis of the herbicide atrazine (9). 
 
 
 
 
 1.6.3 Triazine herbicides 
 The broadleaf herbicide atrazine (9) is one of the most widely used herbicides in the 
United States for weed control during the production of corn, sorghum, and other crops.68 
Although many European countries have banned its use, over 60 million pounds of atrazine are 
used annually in the United States.69 As a result, atrazine is the most commonly detected 
herbicide in ground and standing water. Atrazine has been linked to health risks in animals and 
humankind.70 
 
 
 
 
 Prior to the late 1980’s organotins were commonly used in antifouling paints on ships' 
hulls. Organotins such as tributyl tin (TbT) were found to be extremely toxic to marine 
organisms, particularly affecting the reproductive systems of shellfish. In the early 1990’s, TbT 
was banned from application on boats under 25 meters in length. A full International Maritime 
Organization ban on the use of TbT on all ships went into force in 2003.  The industry response 
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to the banning of TbT was the development of new antifouling paints formulated with copper 
and incorporating so called ‘booster biocides’ to prevent fouling.  The triazine herbicide Irgarol 
1051 (10) has become a common antifouling agent.  Irgarol 1051 is designed to leach slowly 
from the paint to prevent buildup of biofilms on boat hulls.  In 1993 Irgarol 1051 was found in 
costal waters off of France at levels of 1.7 parts per billion.71  Irgarol 1051 and other booster 
biocides are now detected in most coastal waters with shipping activity.72 Irgarol 1051 is 
environmentally persistent with a reported half-life in seawater of between 100 and 200 days.73   
 
 
 
 
 1.6.4 Triazine optical brighteners and tie-dyes 
 Optical brighteners or fluorescent whitening agents are compounds added to materials 
such as textiles and papers to impart a more desirable appearance to the product.74  The first 
optical brighteners appeared in 1941, and contained the triazine structure (Figure 1.8).  They find 
use in everything from detergents and fabric treatments to coatings, inks, paints and plastics.  In 
most cases they can be effective at concentrations ranging from 0.001 to 0.0001 of a percent by 
weight.  The whitening effect is due to the absorbance of ultra violet light in the range from 300-
430 nm and the emission of blue light between 400 and 500 nm.  The net effect is the object 
appears ‘whiter’ under normal lighting conditions. 
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Figure 1.8.  Typical structure of a triazine based optical brightener. 
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 The triazine ring has found extensive use in the production of reactive dyes, which 
generally contain a monochlorotriazine, dichlorotriazine, or even a monoflurotriazine appended 
to a chromophore (Figure 1.9).75  The dye is covalently bound to fabrics through a substitution 
reaction between the triazine and a hydroxyl or amine group present in the fabric.  The triazine 
simply acts to anchor the dye to the fabric.  The introduction of two dichlorotriazines, one on 
each end of the chromophore, shows a higher degree of fixation to the fiber, and is found as a 
component of many textile dyes.  Triazine dyes can be purchased for home tie-dye use. 
 
 
 
 
 Triazine dyes are not limited to use in the dying of fabrics and fibers, but have also 
found extensive use in protein purification.76  Dextran conjugates of the triazine dye Cibacron 
blue F3GA used to measure the void volume in gel filtration chromatography were found to 
selectively interact with some proteins during chromatography.  In 1968 the dye portion of the 
conjugate was demonstrated as the portion of the molecule responsible for the interaction.  Since 
the early 1970’s triazine dyes have been used as affinity absorbents in the purification of a wide 
variety of proteins.77  The triazine ring is used to affix the various dyes to different support 
matrices. 
  
 1.6.5 Triazine drugs 
 Triazines are found as components of some therapeutically useful drugs.  Much of the 
initial efforts of triazine chemists were toward the production of medicinally useful compounds, 
resulting in active compounds for the treatment of cancer and malaria.  Friedheim began research 
in the mid 1940’s on the use of triazines in the synthesis of therapeutic agents for treatment of 
parasites,78 producing arsenic and antimony containing substituted melamines, some of which 
are still in use today. 
Figure 1.9.  Typical reactive triazine dyes.  Brilliant red and brilliant yellow. 
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  1.6.5.1 Triazine drugs for parasites 
 Melarsoprol (11) was one of Friedheim’s initial discoveries for the treatment of parasites 
and was introduced in 1947.79  More water soluble forms have been developed including 
Melarsonyl (12) and Melarsamine (13), but as can be imagined these compounds have the risk of 
inducing arsenic poisoning. Another antiparasitic drug introduced in the late 1940’s was 
proguanil (14), which is converted to the active metabolite cycloguanil (15), which contains a 
triazine.  Knowing that cycloguanil was a pharmacologically active metabolite lead to its use in 
treating malaria, as well as the synthesis of analogs such as chlorproguanil and its active 
metabolite chlorcycloguanil (16).  The triazines belong to the class of antiparasitic compounds 
known as antifolates.  They loosely resemble folate, and act as inhibitors of dihydrofolate 
reductase resulting in the inhibition of DNA synthesis. 
 
 
 
 
 The development of antiparasitic agents based on the triazine moiety has continued at a 
steady pace, with multiple new potential drugs identified.  Two of these include WR99210 (17) 
and SIPI1029 (18).  One advantage of using triazines in the production of antiparasitic 
compounds, specifically those causing malaria and African sleeping sickness is the affordability 
of the building blocks and the ease with which such drugs can be produced.  The need for such 
drugs is generally highest in resource-poor settings; therefore cost is an important issue in 
developing drugs for such a market.  
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 A unique route for treatment of such diseases as African sleeping sickness was 
investigated using triazines,80  which offer a recognition motif similar to adenine for a unique 
nucleotide transporter in trypanosomes (Figure 1.10).81  Various substituted triazines were 
appending to polyamines, which are toxic to trypanosomes, to investigate the selective delivery 
of these toxic agents to parasites.  
 
 
 
 
  1.6.5.2 Triazine drugs in cancer treatment 
 Hexamethylmelamine (HMM, 19) is an antitumor agent that was discovered in the early 
1950’s,82 and showed limited activity against murine tumor models.  It was introduced into the 
clinic in 1965, even though the antitumor effects were described as marginal.83  HMM showed 
subsequent and significant solid antitumor activity which propelled it into clinical use, where it 
is still used today (Hexalin, altretamine).  The mode of action is known to include the in vivo N-
demethylation of HMM via a P450 mediated pathway, which occurs rapidly in the liver.84  
Significant antitumor activity is mediated by N-hydroxymethyl intermediates.  Knowing the 
active biological intermediate has lead to the development of various analogs of HMM. 
 Trimelanol (TM, 20) was a promising alternative due to its increased water solubility, 
and was selected for clinical trials.  The formulation of TM presented a problem as upon 
standing a white precipitate would form that was apparently due to polymerization of the 
compound.  The difficulties with formulation of TM could not be overcome leading to the 
suspension of clinical studies.85   
 In the search for more stable and active analogs of TM, the compound denoted CB7646 
(21) was discovered.86  It has one less hydroxylmethyl group and this modification appears to 
decrease the polymerization problems associated with TM, while increasing the water solubility. 
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Figure 1.10.  Common adenine receptor recognition motif.
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 The mode of action of methylmelamines is thought to occur by forming covalent adducts 
with DNA and the possibility of forming DNA-interstrand crosslinks, and DNA-protein 
crosslinks.  However, in vitro tests for the alkylating activity of HMM and it metabolites have 
been negative.   These drugs have found added value in the treatment of drug-resistant tumors, 
specifically tumors resistant to platinum drugs. 
 Another early application of triazine drugs in cancer treatment was a result of the 
isosteric replacement of carbon by nitrogen at the C-5 position of the nucleotide cytidine.  5-
Azacytidine (3) was synthesized first in 1964, and found two years later in bacterial ferments 
(vide supra).87  The incorporation of 5-azacytidine into DNA inhibits its methylation, and DNA-
methyltransferase becomes irreversibly bound to the azacytosine residue.62  Methylation of DNA 
is involved in gene regulation, and many cancers show increased or decreased levels of DNA 
methylation in relation to healthy cells.  5-Azacytidine has shown clinical efficacy in treating 
cancers such as metastatic lung cancer.88    Nucleotide analogues have also been pursued as 
antagonists for the P2Y receptor for potential therapeutic applications in the cardiovascular and 
endocrine system.89   
 Potassium oxonate (Oxo, 22) has found use in a combination treatment of cancer with 5-
fluorouracil (5-FU).  The mode of action requires the bioactivation of 5-FU, as 5-FU is not by 
itself cytotoxic.  The end result is the inhibition of the enzyme thymidylate synthase, the only 
route of de novo thymidylate for DNA synthesis.  To offset the rapid degradation of 5-FU by the 
liver, it is combined with 5-chloro-2,4-dihydroxypyridine (CDHP, 23), an inhibitor of the 
enzyme responsible for 5-FU degradation, thus allowing prolonged retention of effective 
concentrations of 5-FU in the blood.  One side effect of increased 5-FU levels is an increase in 
gastrointestinal (GI) toxicity.  Toxicity occurs from the phosphorylation of 5-FU in the GI 
mucosa resulting in a potent cytotoxic effect on the rapidly growing cells lining the GI tract.  The 
inclusion of Oxo inhibits the enzyme responsible for the phosphorylation of 5-FU in the GI tract 
without any loss of antitumor activity, thus decreasing GI tract cytotoxicity.90  The formulation 
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of Oxo (22) in combination with CDHP (23) and a produrg of 5-FU known as FT (24), in a ratio 
of 1-Oxo:0.4-CDHP:1-FT, is known as   S-1.91  This formula was developed and passed 
preclinical trials in Japan, and recently underwent a Phase I clinical trial in the United States.92 
 
 
 
 
 The series of compounds containing the 6-aryl-2,4-diamino-1,3,5-triazine chemotype 
show a variety of biological activities.  They show antimicrobial activity (vide supra), and a 
recent investigation demonstrated the therapeutic potential of 2,4-diamino-6-(pyridine-4-yl)-
1,3,5-triazine (4PyDAT, 25) using a metastatic tumor model.  The compound was administered 
orally, and had a moderate antimetastatic and antitumor activity, without toxicity to the host. The 
production of urokinase-type plasminogen activator was significantly inhibited by 4PyDAT, 
leading to the hypothesis that inhibition of angiogenesis may by responsible for the 
antimetastatic and antitumor effects, rather than directly acting in an antiproliferative manner on 
the tumor cells.93 
 
 
 
 
  Irsogladine (26), also containing the 6-aryl-2,4-diamino-1,3,5-triazine chemotype, is a 
triazine containing anti-inflammatory drug also used in the treatment of ulcers.  It was recently 
found that modulation of NO synthesis contributes to the gastroprotective effects of 
irsogladine.94  Irsogladine was investigated for the inhibition of cell proliferation and tubular 
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morphogenesis of vascular endothelial cells.  Irsogladine was found to significantly inhibit tumor 
growth of human glioma cells in mice, showing signs of angiogenesis inhibition.95  Structurally 
related compounds, but containing the 1,2,4-triazine ring are Lamotrigine (27), an antiepileptic 
drug,96 and BW-A256C (28) used as an antiarrhythmic agent.97 
 
 
 
 
 The compound S9788 (29) developed by Servier Laboratories is being pursued as a 
multidrug-resistance (MDR) reversal agent.98 The dipropenylpiperidyl-1,3,5-triazine does not 
belong to any class of known MDR reversal agents.  MDR is a result of the over expression of 
the mdr1 gene, resulting in the production of the multidrug transporter P-glycoprotein.  The P-
glycoprotein acts as an ATP-dependent drug-efflux pump, reducing the intracellular 
accumulation of certain drugs.  The compound S9788 was shown to be more effective than 
verapamil, the standard MDR reversal agent, in sensitizing MDR cell lines in vitro.99  It has been 
tested in a limited Phase I clinical trial with co-administration of doxorubicin.100  A related 
structure to S9788, marketed by the same company, is the drug almitrine (30), which is used in 
the treatment of oxygen deficiency. 
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  1.6.6 Potential triazine containing drugs 
 One of the driving forces for utilizing triazines in drug discovery is the ability to rapidly 
construct a large number of compounds and further conduct structure-activity relationship 
studies.  Three different moieties can easily be placed around the triazine core.  The abundance 
of available amine nucleophiles for attachment to the triazine allows a survey over a wide area of 
the chemical landscape.  This method has lead to the synthesis and screening of compounds 
containing the triazine ring for a variety of different and unrelated conditions.  The first efforts 
for finding medicinally relevant triazine compounds were directed towards antimalarials and this 
continues as an active endeavor.101 
 
 
 
 
 Aryl-substituted triazines were found to have antidepressant activity in the 1960’s.102  
Bristol-Myers Squibb recently patented several triazines as 5-HT7 receptor antagonists.103 
Compound 31 showed a dose dependent and significant suppression of rat pup vocalization, a 
reliable method for detecting potential antidepressants.104  An emerging route to the treatment of 
depression involves the development of inhibitors for the corticotrophin-releasing factor (CRF) 
receptor.  Hypersecretion of CRF has been linked to depression and affective disorders, and 
elevated levels of cortisol have been documented in many depressed patients.  Several triazine 
analogs were shown by researches at Bristol-Myers Squibb to have high affinity for the CRF 
receptor.105  
 Triazine containing inhibitors of dihydrofolate reductase in the treatment of human 
cancer have also been investigated.106  Inhibitors of the ester transfer protein for potential use in 
treating atherosclerosis have been identified which contain triazines.107  These compounds work 
through inhibition of the enzyme responsible for transferring cholesterol from HDL to LDL.  
Inhibitors of estrogen-modulated transcription factor activation containing triazines have been 
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identified.108 Inhibitors of inosine monophosphate dehydrogenase, with potential in the treatment 
of autoimmune disorders, were synthesized from cyanuric chloride.109  Nucleoside analogs, some 
of these containing triazines, have found efficacy in treating cancer and viral infections.  Triazine 
containing ATP analogs have been investigated as inhibitors of DNA gyrase, with potential use 
as antibiotics.  A trisubstituted triazine was also found to be an effective DNA gyrase 
inhibitor.110   
 Non-nucleoside reverse transcriptase inhibitors for treatment of HIV infections were first 
discovered upon screening of Janssen Pharmaceutica’s compound library in 1987.111 
Diaminotriazine (DATA, 32) containing compounds were found to be very potent, but have been 
replaced by diarylpyrimidine analogues which show better activity against some emerging 
resistant double mutant HIV strains. 
 
 
 
 
 A unique anti-viral compound that has found laboratory efficacy in the treatment of 
human respiratory syncytial virus (RSV) contains a dendrimer-like structure and two triazines.  
Wyeth-Ayerst found the compound RFI-641 (33) from a structure activity relationship study 
utilizing an initial hit identified from a high-throughput whole virus cell-based assay of 20,000 
compounds.112  The compound works by inhibiting the fusion of the virus to the target cell.  
Compound 33 is not viricidal and exerts its effects through disruption of virus-cell interactions. 
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 Resistance to macrolide antibiotics occurs through base-specific methylation of the 
bacterial 23S ribosomal RNA near the macrolide binding site.  Methyltransferases which are 
responsible for this site specific modification belong to the Erm family.  An NMR-based 
screening method was used to identify a series of triazine-containing compounds that bind 
weakly to ErmAM.113  Initial lead compounds were further optimized using parallel synthesis to 
construct 411 new triazine compounds, some of which inhibited the methylation of rRNA in the 
low micromolar range. Further NMR and X-ray studies were carried out and revealing the 
inhibitors bind to the Erm protein at the S-adenosylmethionine binding site. These triazine 
compounds represent novel methyltransferase inhibitors. 
 Treatment of diabetes may soon benefit from novel triazine based sorbitol 
dehydrogenase (SDH) inhibitors.  Mylari and coworkers constructed a family of novel triazine 
containing compounds, assaying them for inhibition of SDH.  Under instances of increased flux 
of sorbitol through the SDH enzyme, like conditions present in persons with diabetes, an 
imbalance in the cytoplasmic NAD+/NADH ratio is created.  It has been reported that inhibition 
of SDH can help restore the altered NAD+/NADH ratio.  The best compound, 34, was orally 
active and quite potent. 
 
 
 
 
 Patents abound on current efforts to utilize triazines in the identification of 
pharmaceutically active compounds.  Multiple new targets and potential triazine based 
therapeutics have emerged since 1981 when the last review of drugs in the 1,3,5-triazine series 
was published in a Russian journal.114 
  
  1.6.6.1 Triazine drugs by combinatorial methods 
 Many researchers have used triazines in the construction of combinatorial libraries.115 
Combinatorial methods used in conjunction with screening methods utilizing zebra fish have 
identified novel triazine compounds which destabilize microtubules.116  A similar combinatorial 
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method was utilized in the construction of a library containing 1536 triazine compounds.  A 
zebra fish embryo screening methodology was utilized; identify small molecules which induce a 
unique or novel phenotype.117  Combinatorial methods have also been used to construct libraries 
for the potential identification of lead compounds for treatment of malaria.101 
 The largest triazine library synthesized to date included 46,656 individual triazine 
compounds and was utilized in screening for novel antimicrobials.118 Beads containing the 
triazine compounds were placed on a plate of agar.  Photolysis of the photocleavable linker 
released the triazine molecules.  A ‘lawn’ of bacteria was then plated on the agar with active 
compounds identified by a white zone around a given bead.  Beads found in a region of no 
bacteria growth were isolated from the agar plate.  The beads were encoded using secondary 
amine tagging,119 and thus the chemical history for each bead and the corresponding structure of 
the triazine could be identified.  The compounds identified were only moderately active, but the 
approach identified unique structures not previously considered as antimicrobial agents. 
  
 1.6.7 Triazine explosives and industrial applications 
 Nitro derivatives of 1,3,5-triazines can be formed and are used and investigated as high-
energy compounds.120  The best known nitro-triazine derivative is RDX (34), a high density 
explosive with good thermal stability.  The first investigations using RDX was as a therapeutic 
agent in 1899.  In 1920 RDX was recognized as a possible explosive, and later used during the 
Second World War by both sides by mixing it with TNT (trinitrotoluene) to create more 
powerful bombs and shells. 
 The triethanol triazine 36, has found industrial use as a reagent for the removal of sulfur 
compounds from natural gas streams.  Triadine 3 is the trade name for 36 marketed as a biocide 
for the treatment of water based machining fluids, and also as an antiseptic. 
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 1.6.8 Academic exploration of triazines 
  1.6.8.1 Triazines as condensing reagents 
 Academic uses of cyanuric acid are plentiful.  Triazines have found extensive use as 
condensing reagents.121  The simplest condensing reagent is cyanuric chloride, which upon 
reaction with a carboxylic acid produces an acid chloride.122  Triflurotriazine has also been used 
to produce crystalline acid fluorides of amino acids.  The reagent 2-chloro-4,6-dimethoxy-1,3,5-
triazine (CDMT, 37) has found extensive use as an activating reagent.  The use of CDMT 
requires a tertiary amine, N-methylmorpholine (NMM) being the most commonly amine 
employed.  Activation is thought to occur in situ by substitution of the monochlorotriazine by the 
amine.  Addition of NMM to CDMT gives the reactive 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (38) which is used directly as an activating agent.123  These 
triazine condensing reagents show less epimerization then other coupling reagents and are useful 
in the formation of esters and are efficient in the coupling of sterically hindered substrates. 
 
 
 
 
 Chiral triazine derivatives have been utilized in the synthesis of peptides starting with 
racemic substrates.124 Other chiral substituted triazines have been synthesized as chiral 
discriminators and for use as chiral auxiliaries in High Performance Liquid Chromatography 
(HPLC).125 
 The immobilization of condensing reagents simplifies the reaction work up.  Triazine 
condensing reagents have been immobilized on solid supports.126  Solid-supported triazines have 
also found use as nucleophilic127 and proton scavengers128 for use in solid phase organic 
synthesis. 
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  1.6.8.2 Triazines in functional group manipulations 
 Triazines have found extensive use as reagents in the conversion of functional groups.  
As discussed previously they have found use in the activation/modification of carboxylic 
acids.121  Additional unique uses have been developed and refined by research conducted at the 
Università degli Studi di Sassari in Italy.  Using sodium borohydride and cyanuric chloride the 
reduction of carboxylic acids to alcohols under mild conditions was demonstrated.129  Primary 
alcohols were obtained in the range of 70-90 percent yield, and the method was compatible for 
use with protected amino acids.  Using the condensing reagent CDMT (37) activated with NMM 
carboxylic acids were converted to aldehydes or alcohols using H2 and Pd/C.130  Weinreb amides 
were produced using CDMT and NMM in combination with N,O-dimethylhydroxylamine.131  
Hydroxamates were formed using CDMT/NMM and a suitably protected hydroxylamine (O-
benzyl- or tert-butyldiphenylsilyl-).  
 Ketones were produced from N-protected amino acids using CDMT/NMM and 
Grignard/CuI reagents.132  The mild and chemoselective oxidation of alcohols to aldehydes or 
ketones using 1,3,5-trichloro-2,4,6-triazinetrione (trichloroisocyanuric acid) in the presence of a 
catalytic amount of 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) occurred nearly 
quantitatively on multi-substrates in 20 minutes.  The oxidation of primary alcohols occurred 
more rapidly than secondary, and the method was extended to the selective oxidation of a 
primary alcohol in the presence of a secondary alcohol.133  Cyanuric chloride was also shown as 
an activating agent of DMSO in the classical Swern oxidation of alcohols.134  The conversion of 
primary, secondary, and tertiary alcohols to the corresponding alkyl chloride occurs in high 
yields on a variety of substrates using cyanuric chloride in the presence of DMF.135  The 
selective protection of primary alcohols by formation of the formate ester occurs in the presence 
of cyanuric chloride and DMF with the addition of LiF, followed by the addition of water.136  
The Beckmann rearrangement of ketoximes to the corresponding amides was conducted using 
cyanuric chloride in DMF, generally in high yields.137 
 
 1.6.8.3 Triazines in molecular recognition, supramolecular, and materials 
 chemistry 
 Triazines can be used in the construction of novel supramolecular constructs held 
together through hydrogen bonding.  Melamine (M) and the oxo-tautomer of cyanuric acid (CA) 
have complementary hydrogen bonding patterns (Figure 1.11), and when mixed in aqueous 
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solutions form a stable 1:1 complex which can be heated to 450 °C without change.138  The 
complementary hydrogen bonding between M:CA has been used in the construction of such 
macromolecular assemblies as ‘rosettes’,139 polymeric rods,140 and tapes;141 Whitesides and 
coworkers pioneering the work.142  Reinhoudt has constructed and characterizing an 
enantiomerically pure M:CA hydrogen-bonded assembly,143 and recently reviewed the field of 
noncovalent synthesis, including M:CA constructs.144  
 
 
 
 
 Linus C. Pauling not only left behind a chemical legacy, he also left behind a chemical 
mystery.  Found on the blackboard in his office after his death was the unique structure 39, a 
molecule unknown at that time,145 containing a tri-s-triazine (other names include: s-heptazine 
and cyamelurine).  The reason for Pauling’s interest in the molecule and why it was on his board 
remains and puzzle, although theories abound.145b  Perhaps due to Pauling’s mystery molecule or 
just the intrinsic uniqueness of the tri-s-triazines several groups have pursued their syntheses.  
Several tri-s-triazines have been synthesized, including the cyanuric chloride analog 40, later 
used in the construction of novel macrocycles.146  Macrocycles have also been constructed 
containing the smaller s-triazine, and host-guest chemistry investigated.147  Triazines coupled 
together with piperazine were used to construct novel heteromacrocycles.  The ability of these 
macrocycles to encapsulate and recognize sugars was investigated.  The triazo-tri-s-triazine, 
containing an azide at each apical carbon, has recently been prepared and found to be a stable 
precursor for the production of nitrogen-rich materials.148 
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Figure 1.11.  Schematic representation of a melamine:cyanuric acid (M:CA) dimer. 
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 Considerable research efforts have been devoted to the synthesis of carbon nitride, C3N4, 
networks (Figure 1.12a).  These unique materials have the potential for high-performance 
materials possessing hard, lightweight, and thermally stable properties.  Nitrogen rich materials 
are derived from the thermal decomposition of compounds containing an equal to low 
carbon:nitrogen ratio.  Triazines, specifically those substituted with amines, hydrazines, and 
azides, have found particular application in this area.149  Novel one-dimensional hydrogen 
bonded arrays (Figure 1.12b) analogous to the hypothetical carbon allotrope graphyne (Figure 
1.12c) have also been constructed using triazines.150 
 
 
 
 
1.7 Triazine Dendrimers∇ 
 1.7.1  The 20th century 
 The first examples of dendrimers containing triazines are found in patents.151  The first 
extensive document concerned specifically with the construction of dendrimers by substitution 
of cyanuric chloride is a 1997 German patent.151d  The dendrimers described therein were 
constructed through both divergent and convergent methods using diamine linkers.  The 
appearance of triazines in dendrimers next surfaced in an extended abstract submitted to the 
Polymeric Materials Science and Engineering division for the Fall 214th national American 
                                                          
∇ Schemes outlining the syntheses of all the dendrimers referred to in this section and a complete listing of 
 the references in chronological order are given in Appendix A. 
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Chemical Society meeting.152  Fréchet demonstrated the self assembly of higher ordered 
dendrimer structures by attaching two complementary hydrogen bonding moieties to the focal 
point of the dendrons.  Melamine and cyanuric acid were separately appended to generation 2-4 
dendrons, and the supramolecular assembly of these dendrons with each other was investigated.  
Generation 2 dendrons formed the expected hexameric structure from the complementary 
hydrogen bonding of the melamine and cyanuric acid, but solutions of the larger dendrons 
appeared to be an equilibrium mixture of different aggregates. 
 The first research paper to report the incorporation of a triazine in a dendrimer was 
published in 1998.153  The dendrimer was only of generation one (G1), but the attachment of six 
surface groups to the triazine branching units through silyloxy phthalocyanine linkages was 
unique. 
 In 1992 Wyeth-Ayerst initiated a program to identify novel inhibitors of the human 
respiratory syncytial virus (RSV).154  The only active compound found from screening 20,000 
compounds using a whole virus and cell based assay was a dendrimer like structure.  The 
identified compound termed CL 309623 (41) contains a disulfonated stilbene core linked at each 
end to a triazine.  The compound was originally synthesized in the 1960’s by the American 
Cyanamid Organic Chemicals Division as a potential optical brightener (see Figure 1.8).  A 
patent was filed in 1997 for use of CL 309623 and similar derivatives for the treatment of viral 
infections.151e  In 1998 a comprehensive structure-activity relationship study was undertaken, 
identifying even more potent molecules.155 Further structure-activity relationship studies 
conducted in 2001 identified the lead molecule RFI-641 (33) as a potent and selective inhibitor 
of RSV.  It has been determined these dendrimer like compounds interrupt the F-protein 
mediated cell fusion of RSV with the target cell through specific interaction with the fusion 
protein of the RSV virus. 
 
 
N
H N
N
N
N
H
S N
O
O
CONH2
CONH2
N
H
S N
O
O
CONH2
-SO3
N
HN
N
N
N
H
SN
O
O
H2NOC
H2NOC
N
H
SN
O
O
H2NOC SO3-
H2NOC
CONH2
41
 
 42 
 One of the more unique approaches to the construction of triazine dendrimers, and 
arguably the first dendrimers constructed containing a triazine, incorporates the cycloaddition of 
nitriles with cyanoguanidine forming a 2,4-diamine-1,3,5-triazine, commonly known as a 
guanamine.  This work had been described in a Polish patent as early as 1994,151b referred to in 
reviews written by the principle investigator156 and a thesis, with the first research paper on the 
subject published in 2000.157  The corresponding author of the paper, Maciejewski, wrote one of 
the earliest theoretical papers on the subject of dendrimers in 1982.158  
 Cyanoethylation of the amines of guanamines forms a tetracyano dendron.  Elaboration 
of the dendron through cycloaddition between the peripheral nitriles and cyanoguanidine 
increases the dendrimer generation (Scheme 1.1a).  Cyanoethylation was the method used by 
Vögtle (Scheme 1.1b) in what is commonly described as the first dendrimer synthesis. A method 
resulting in a compound with strikingly similarities to that of Vögtle’s was described in a patent 
by Niederhauser in 1951,159 twenty-seven years prior to Vögtle’s work.  Niederhauser knew of 
the ability to reduce the nitriles to amines as he described such a method in a patent filed in 
1945.160  Either through reduction of the nitriles to amines (he did hydrolyze them to carboxylic 
acids), or further cycloaddition reactions with the nitriles and Niederhauser would have laid 
claim to the first dendrimer.  Here was a near miss to the beginning of dendrimer chemistry. 
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 Vögtle provides very little data for his molecule containing four amines besides an Rf 
value from thin layer chromatography (TLC).  He does observe a molecular ion peak (M+) for 
his compound containing four nitriles, but very similar compounds have been known since 
1942.161  Vögtle used diamines to produce molecules with eight nitriles, which were more 
thoroughly characterized by both TLC and mass spectral analysis.  Vögtle’s contribution to the 
evolution of dendrimer chemistry relies on the creation and definition of the term ‘cascade 
syntheses’ where he emphasized reactions could be “carried out repeatedly, whereby… a 
functional group is made to react in such a way as to appear twice in the subsequent molecule.”  
 In 1993 two groups published back-to-back papers on the successful optimization of 
Vögtle’s route162 to produce true dendrimers.  These methods eventually lead to the commercial 
production of this class of dendrimers known as poly(propylene imine) (PPI) dendrimers.163  The 
elaboration of Niederhauser’s tetracyanoethyl benzoguanamine to generation 4 dendrimer (vide 
supra), took over forty years to accomplish with the products containing some incomplete 
arising from incomplete cycloaddition reactions.  The cycloaddition/cyanoethylation method 
utilized requires no functional group interconversions or the use of protecting groups.   
  
 1.7.2 The 21st century 
 The year 2000 offered five additional efforts towards the syntheses of triazine containing 
dendrimers, with each offering a unique approach. 
 Burn and coworkers used the alkoxy and aryloxy substitution of cyanuric chloride to 
form the surface groups of a second generation (G2) dendrimer linked by a distyrylbenzene core.  
The electroluminescence of this dendrimer was investigated and the molecule used in the 
construction of an organic light-emitting diode (OLED).164   
 Zhang and Simanek described methods for the construction of what are termed 
melamine based dendrimers using diamine linkers in the substitution of cyanuric chloride.165  
Unique to this method is the lack of functional group manipulations or protecting groups 
required in the dendrimer synthesis; this approach is discussed further in Chapter II.  A third 
generation (G3) dendrimer was constructed by both convergent and divergent routes utilizing the 
chemoselective reactivity of p-aminobenzylamine with monochlorotriazines. 
 Takagi and coworkers published two papers on the syntheses of structurally related 
triazine dendrimers.  Their first paper described the convergent synthesis of a G2 dendrimer and 
generation 3 dendrons (D3).  The investigators substituted cyanuric chloride with the aromatic 
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amine of p-nitroaniline.  Reduction of the nitro group to reveal and amine was followed by a 
subsequent reaction with a dichlorotriazine to increase the generation by one.166  The second 
paper described methods for the convergent and divergent syntheses of triazine dendrimers using 
different linkage groups to accomplish each.  The result was the synthesis of G2 dendrimers.167  
The divergent route described in the second paper utilized the same methodology as the 
convergent route outlined in their first paper.166  The G2 dendrimer produced by the convergent 
route was synthesized starting with a single aryloxy substitution of cyanuric chloride.  
Subsequent generations of dendrons were achieved through the double substitution of the 
dichlorotriazine building block by the appropriate generation arylamine. 
 The synthesis of zero generation (G0) and G1 dendrimers were described in a report 
submitted to the Fourth International Electronic Conference on Synthetic Organic Chemistry.168  
The dendrimers were synthesized by the amine substitution of 2,4,6-trisphenoxy-1,3,5-triazine, 
but required temperatures of 260-280 °C to get complete substitution at all three positions of the 
triazine ring. 
 It should be noted that during this same time frame Kim and coworkers from the 
Hyperstructured Organic Materials Research Center in Korea published a series of papers on 
hyperbranched polymers utilizing triazines as the scaffold for the synthesis of AB2 type 
monomers.169  Hyperbranched polymers were synthesized by condensing these triazine 
containing monomers.  However, the hyperbranched structure of these materials arose from the 
reaction of functional groups attached to aryl groups appended to a triazine core, and not through 
direct substitution on the triazine ring. 
 Five papers were published in 2001 describing the synthesis of dendrimers containing 
triazines.  The first example demonstrating the solid phase synthesis of a triazine dendrimer was 
published by Marsh and coworkers.128  Simanek and coworkers demonstrated the ability to 
control the composition of melamine based dendrimer through the syntheses of G3 dendrimers 
having one or two unique sites at the periphery amenable to post-synthetic modification.170  
Simanek and Zhang published a paper illustrating molecular recognition properties of novel 
melamine dendrimers.171  Dehaen and Verheyde synthesized dendrimers containing oxadiazoles 
with a single triazine at the core.172  Later Dehaen and coworkers produced dendrimers 
containing triazines as the branching units.173  Their route was unique in that first anisole was 
substituted on the triazine ring by a Grignard reaction, giving a dichlorotriazine product.  Surface 
groups were attached to the triazine ring through aryloxy nucleophilic displacement of the 
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chlorides.  The methoxy functionality of anisole was unmasked to reveal a phenol, which was 
subsequently reacted with 0.5 equivalents of cyanuric chloride to arrive at the next generation of 
dendron.   
 The year 2002 saw the publication of only two papers describing the synthesis of triazine 
dendrimers.  The first paper published describes the synthesis of polydentate and polynucleating 
N-donor ligands containing the triazine ring as the branching and core group of G1 
dendrimers.174  Simanek published another paper on the molecular recognition properties of 
melamine dendrimers; specifically identify trends in triazine dendrimer composition which result 
in the gelation of organic solvents containing melamine type dendrimers.175 
 In 2003 nine papers were published containing original triazine dendrimers.  Simanek 
and coworkers were responsible for six of these publications including the syntheses dendrimers 
containing multiple disulfide linkages.  Kinetics of disulfide exchange within the dendrimer 
structure were monitored, correlating the rate of exchange to the size of dendrimer.176  The 
attachment of DNA177 and peptides to melamine dendrimers were separately described, 178 as well 
as preliminary studies into melamine dendrimers as drug delivery vehicles.179  New linking 
groups were identified for the construction of compositionally diverse dendrimers,180 along with 
the identification of a novel organoclay morphology from the frustrated intercalation of dendritic 
triazine molecules.181  
 Other triazine dendrimers reported in 2003 include the synthesis of a fourth generation 
triazine dendrimer on a silica solid support.182  Gamez, Reedijk and coworkers visited again the 
construction of triazine dendrimers containing multiple metal ligands at the surface.183  A triazine 
library was constructed on the solid support and later screened to identify lead compounds with 
antibacterial properties. 184  A modified G2 Newkome type dendrimer with nine surface amines 
was constructed on the solid support; increasing the loading capacity of the resin.  The surface 
amines were further modified to present a phenol and subsequently reacted with cyanuric 
chloride.  This resulted in the incorporation of nine dichlorotriazines at the surface of the 
dendron.  These were subsequently reacted with various amine nucleophiles to produce a library 
of compounds.  The triazines were liberated from the solid support after heating the resin in the 
presence of morpholine or piperidine.  Substitution of the aryloxy triazine bond by the secondary 
amine released the compound from the resin.  The triazines were only located at the surface of 
the dendrimer, and done as a way to increase the loading of the resin, not specifically for the 
construction of a solid supported triazine dendrimer.   
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 Other potential triazine containing dendrimers have been reported or could be argued to 
be present in the literature, but appear to be hyperbranched materials,185 or simply trisubstituted 
triazines. 186  Other examples of supramolecular complexes containing triazines are found but 
how to classify them is more ambiguous.187 A patent issued in 2000 to Isis Innovation Limited 
describes novel products for use in polymer chemistry.188  Several of these compounds were 
simply a single triazine appended to a multifunctional reagent, such as a triazine with substituted 
with three bis-(1,3-dihydroxyprop-2-yl)amines, a molecule containing a total of 12 primary 
hydroxyls around the triazine ring.  In the most generous sense such molecule could be 
considered G0 dendrimers.  However, the patent described other constructs which could be 
considered G1 dendrimers, containing a triazine at the core. 
  
 1.7.3 Future possibilities 
 Triazine chemistry offers access to a multitude of useful molecules, from medicinal 
chemistry to materials.  The use of triazines in dendrimer syntheses offer access to unique and 
tailored molecules possessing: multiple functionality (Chapters II and III), unique structural 
properties (Chapters II and IV), and for potential applications (Chapter V). 
 
1.8 Conclusion 
 The journey is now complete.  In roughly two centuries polymers emerged from the 
early work of Faraday and Berzelius through somewhat difficult times to molecules of much 
interest and use.  The study of polymers developed a rigorous science, full of theories and 
models to better comprehend the macromolecular realm.  The emergence of polymer chemistry 
from under organic chemistry is a journey littered with missteps and bad ideas.  Those brave 
enough or wise enough to pursue the idea and characterization of large molecules have been 
amply rewarded and offered historical immortality in the annuals of chemistry through 
distinction of winning the Nobel Prize.  It would take both hands and most of ones toes to count 
the winners of The Prize who achieved this distinction through working with polymers.  The 
names most easily recognized include Staudinger, Flory, Ziegler, Natta and the recent additions 
of Heeger, MacDiarmid, and Shirakawa, whose direct work on polymers was responsible for 
them receiving The Prize.  However, multiple others received their award for efforts in 
understanding the atomic structure and function of natural macromolecules.  Sanger earned two 
awards by developing methods to determine the sequence of the natural copolymers.  The 
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synthesis of the natural polymers, either in solution, on the solid phase, or using the polymerase 
chain reaction resulted in several Prizes.  Those who discovered analytical methods by which to 
better characterize natural polymers have been amply awarded this singular distinction.  Finally, 
those who have extended efforts to understand how nature uses these macromolecules and 
polymers, and the mechanisms by which they operate have not gone unnoticed.  If the Nobel 
Prize is any measure of what can be deemed important in chemistry, polymers must be near the 
top of the list (see Appendix A for a list of Nobel Prize winners who’s work dealt in some 
fashion with polymer chemistry, page 144). 
 The pursuit of novel atomic architectures is no longer just the domain of total synthesis.  
Polymer chemists have succeeded in mimicking nature’s production of macromolecules, 
including composition, atomic connectivity, and stereoarrangement, and are currently pursuing 
novel molecular architectures.  Novel macromolecular architectures are now abundant and 
pursued in earnest; the future prospects limited only by the imagination of the investigator.  
Polymer chemistry, at first misunderstood, is now a science sprouting branches of subdisciplines, 
dendrimer chemistry being one. 
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CHAPTER II 
 
CHEMOSELECTIVE SYNTHESIS OF A LAYERED TRIAZINE DENDRIMER 
WITHOUT FUNCTIONAL OR PROTECTING GROUP MANIPULATIONS∗ 
 
2.1 Introduction 
 The stepwise synthesis of a dendrimer is labor intensive and several drawbacks limit 
their commercial and academic application and production.  Dendrimer syntheses by divergent 
methods typically employ a large excess of reagent at each step to ensure the complete 
modification of the multiple peripheral groups.  The excess reagent employed may be recovered 
and recycled, but this is often impractical in academic pursuits.  Divergent routes tend not to be 
atom economical, as only a small percentage of the atoms used for the dendrimer synthesis are 
incorporated into the final product.  In both convergent and divergent methods functional group 
manipulations, including the removal or installation of protecting groups, are required.  Often 
activating agents must be utilized to effect the coupling of monomers for dendrimer growth.  
Every additional step contributes to the time, effort, and ultimately cost of producing a 
dendrimer.  Routes which limit the number of synthetic steps, while allowing rapid access to 
large dendrimers are attractive. 
 A variety of methods have emerged which reduce the number of steps and reagents used 
in dendrimer syntheses.  Notable efforts include orthogonal routes which limit the number of 
functional group manipulations required.189  The use of a ‘hypercore’ approach involves the 
coupling of convergently synthesized dendrons to a dendritic core containing multiple groups at 
the periphery and one or more generations of branching.190  The hypercore approach is a hybrid 
method, combining the convergent synthesis of advanced generation dendrons with coupling to a 
core containing multiple groups at the periphery in a divergent manner.  In 1995 Moore and 
coworkers devised another method taking advantage of both divergent and convergent 
techniques.191  The method was dubbed the ‘double exponential dendrimer growth’ method.  
Monomers with orthogonally masked focal and surface functionalities are subject to a three step 
                                                          
∗Reproduced in part with permission from “Chemoselective Building Blocks for Dendrimers from 
Relative Reactivity Data” by Mackay B. Steffensen, Eric E. Simanek.  Organic Letters, 5, 2359-2361.  
Copyright 2003 American Chemical Society. 
 49 
sequence involving dendron activation, monomer activation, and coupling; a route which 
doubles the dendrimer generation after completion of the three step sequence.192  One-pot multi-
step reaction sequences are attractive routes for the production of dendrimers while limiting the 
need for purification of intermediates.193   
 One unique aspect of triazine chemistry is the ability to control the degree of substitution 
on the triazine ring.  Controlled substitution has been utilized as an efficient method for the 
construction of melamine dendrimers.  The most efficient route for selective substitution of the 
triazine ring utilizes temperature controlled nucleophilic aromatic substitution of a 
trihalotriazine.  Substitution by an amine nucleophile on the triazine ring of cyanuric chloride 
increases the electron density of the aromatic system.  Subsequent substitutions on the ring 
require a greater energy of activation, and thus a longer reaction time or an elevated reaction 
temperature.  The general rule: is the first substitution on cyanuric chloride by a primary amine 
nucleophile occurs in minutes at 0 °C, while the second substitution occurs in 12-24 hours at 
room temperature.  The third substitution typically occurs in 12-24 hours at 70 °C (Scheme 2.1).  
These rules have been attributed to early studies by Moffat through his work on the syntheses of 
small triazine libraries to identify potential antimalarials.194  These trends are not stringent and 
indeed the choice of solvent, the concentration of reactants, and most importantly the nature of 
the nucleophile greatly affect reaction rates.  For example, cyclic secondary amines, such as 
piperidine, substitute all three positions of cyanuric chloride rapidly at room temperature, 
resulting in a triaminotriazine. 
 
 
 
 
 The synthesis of melamine dendrimers relies on the iterative reactions of cyanuric 
chloride with diamine linkers.  The degree of substitution on the triazine core is controlled by the 
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Scheme 2.1.  Temperature controlled substitution of cyanuric chloride.  The first substitution occurs rapidly 
while the reaction is cooled in an ice bath.  The second reaction typically occurs overnight at room 
temperature.  The third reaction requires elevated temperatures and 12-24 hours for the reaction to proceed 
to completion. 
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temperature of the reaction and stoichiometry of the amine employed.  Selective mono-
substitution is achieved through addition of one equivalent of an amine to an ice-bath cooled 
solution of cyanuric chloride, giving rise to a dichlorotriazine intermediate.  Subsequent 
reactions are likewise controlled by the temperature of the reaction and the equivalents of 
nucleophile used.  Judicious selection of diamines affords chemoselective routes to melamine 
dendrimers.  For example the benzylic amine of p-aminobenzylamine (pABA) preferentially 
reacts with monochlorotriazines (Scheme 2.2) to yield an aniline which can subsequently react to 
yield the next dendrimer generation.  This linker has been used in the construction of dendrimers 
by both convergent and divergent routes.165 
 
 
 
 
 While the choice of pABA was based on experimental experience, it could have been the 
result of a rationale search.  Indeed a small set of competition reactions were conducted to 
identify general nucleophilic trends in the substitution of a monochlorotriazine, and rationally 
identify bifunctional linkers with similar differential reactivity between the functional groups as 
found in pABA. 
  
2.2 Rationale 
 Routes for melamine dendrimer syntheses can proceed in a one-generation per pot 
(OGPP) approach, accomplishing multiple reactions in a single flask, using chemoselective 
linkers.  There is no need for protecting groups or functional group interconversions.  
Chemoselective routes for melamine dendrimer construction provide an attractive method for 
reducing the number of synthetic steps and reagents required in a dendrimer synthesis.  The only 
atoms not incorporated into a melamine dendrimer during synthesis are the byproduct HCl, and 
the base used to scavenge it.  These routes are therefore atom economical.  It is the use of 
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Scheme 2.2.  The chemoselective substitution of a monochlorotriazine by pABA.  Only the product 
corresponding to substitution of the triazine ring by the benzylic amine is observed. 
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temperature selective substitutions, one-generation per pot, and the utility of chemoselective 
linkers which make compositionally diverse dendrimer architectures readily tractable.   
 
 2.2.1  The one-generation per pot method 
 The OGPP method reduces the number of intermediates requiring purification by 
conducting multiple reactions in a single flask (Scheme 2.3).  The typical convergent approach 
installs the surface groups by reacting two equivalents of the desired molecule containing a 
reactive nucleophile, generally a primary or secondary amine, with cyanuric chloride.  After 
completion of the reaction the resulting monochlorotriazine is purified, characterized, and 
subsequently reacted with an appropriate linker, generally a diamine (Scheme 3a).  The reactions 
are conveniently monitored by TLC, and completion is noted by the disappearance of the UV-
active spot corresponding to the starting material and appearance of a single new spot. 
 
 
 
 
 The only difference between the traditional convergent route and the OGPP method is 
that upon completion of the first two substitutions on cyanuric chloride by the surface groups, 
the appropriate linker is then reacted with the monochlorotriazine in the same pot.  Completion 
Scheme 2.3.  Outline of convergent dendrimer syntheses routes.  a) The intermediate is purified and
characterized at each stage, the result being a G-2 dendron from four reactions with four purifications.  b) 
The OGPP (one-generation per pot) approach results in a G-2 dendron in four reactions with only two 
purifications.  
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of the third substitution is followed with purification and characterization, effectively removing a 
step to arrive at the same product (Scheme 2.3b).  The use of homobifunctional diamines as the 
linker requires an excess of reagent and large dilutions to avoid dimerization of the 
monochlorotriazines.  However, dimerization products are still evident when 
monochlorotriazines are reacted with 6-8 equivalents of piperazine as the diamine. 
 
 2.2.2 Chemoselective routes 
 The use of heterobifunctional diamine linkers, where one amine is more nucleophilic, 
and thus reacts faster with the monochlorotriazine, avoids side reactions resulting in triazine 
dimerization.  Differential reactivity acts as a ‘protecting group’ for the less reactive nucleophile, 
as reactions occur faster at the more reactive site.  The utilization of even a slight excess of 
diamine linker leads to selective fictionalization of the more reactive nucleophile exclusively if 
the difference in reactivity between the amines is large enough.  Such is the case for the diamine 
linker pABA, where only products corresponding to substitution by the benzylic amine are 
observed (vide supra).  The less reactive amine remains unfunctionalized and is available for 
subsequent reactions, obviating the need to activate, deprotect, or manipulate the dendron 
functionality for further reaction.  
 An additional advantage of temperature selective substitution and the use of 
chemoselective linkers is the ability to rapidly introduce multiple functionalities around a 
triazine core.  As depicted in Scheme 2.2 three different amines can be incorporated around a 
triazine core; this can be accomplished in a single pot.  Therefore, it is possible to incorporate 
two different surface groups and the requisite linking group by conducting three successive 
substitution reactions on cyanuric chloride in a temperature controlled manner.  Tailored 
dendrimers, containing multiple different functionalities at the dendrimer surface, are readily 
tractable utilizing such methods (Chapter III). 
 
2.3 Identification of Linkers for Use in Triazine Dendrimer Construction 
 General nucleophilic trends in the substitution of monochlorotriazines were investigated, 
identifying bifunctional linkers for the synthesis of a melamine based dendrimer without the use 
of protecting groups or functional group manipulations.  The dendrimer has a layered 
composition, where each generation linked through a different molecule.  The target dendrimer 
composed of four different linking groups was constructed in a one-generation per pot route, 
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using chemoselective linkers, avoiding the use of protecting groups, even at the terminal 
hydroxyl groups, or other functional group interconversions. 
  
 2.3.1 Competition reactions  
 Competition experiments were conducted to determine the relative reactivity of various 
amine nucleophiles in reaction with a monochlorotriazine.  These competition reactions were 
conducted in an analogous manner to methods used in polymer chemistry to determine the 
reactivity ratios of monomers used in copolymerizations.  Reactivity ratios define the relative 
tendencies of two monomers to self-couple or cross-couple when used together in a 
copolymerization.195  Monomers that have a reactivity ratio of one tend to produce random 
copolymers, while a ratio approaching zero suggests the monomers have no tendency to 
homopolymerize, and a truly alternating copolymer results.  A large ratio suggests one monomer 
would tend to be incorporated exclusively at first, and as its concentration diminishes, the second 
monomer is incorporated, producing a block copolymer.  To determine reactivity ratios the 
location and extent of incorporation into the polymer for each monomer must be determined, and 
NMR is currently the tool of choice.196 
 The competition reactions were conducted in the presence of 2-chloro-4,6-dimorpholino-
1,3,5-triazine (1), selected both on reactivity and analytical grounds.  Substitution of the triazine 
ring by two secondary amines strongly deactivates the triazine ring.  Through deactivation of the 
triazine ring the subsequent third substitution depends more strongly on the nucleophilicity of 
the amine rather than the reactivity of the triazine.  Second, morpholine has proton chemical 
shifts distinct from the amines utilized in the competition reactions. 
 Several different amines were identified containing a primary or secondary amine.  
Amines were also selected based on reactivity and analytical grounds.  The amines (2-9) cover a 
range of reactivity and structures, from secondary amines to anilines (Figure 2.1).  Substitution 
of an amine onto a triazine ring generally shifts the resonances of the protons α to the amine 
downfield.  For amines which have similar peak frequencies for the α-protons, such as amines 2-
4, other unique chemical shifts were identified corresponding to a given amine; for example the γ 
methylene of 2, the methyl of 3, and the acetamide protons of 4.  The relative amount of product 
resulting from substitution of the monochlorotriazine by each nucleophile was determined 
through integration of the unique peaks corresponding to a given amine and normalizing for the 
number of protons present.  Compounds 8 and 9 are structural isomers of each other and as such 
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result in substitution products with the identical mass.  Amine 7 was selected for competition 
reactions with 9 to avoid this degeneracy. 
 
 
 
 
 2.3.2 Materials and methods 
 Three different amines were selected for each experiment, and 3 equivalents of each 
amine were dissolved in tetrahydrofuran (THF) except for the reaction conduct at 120 °C where 
the solvent dioxane was used.  Reactions at elevated temperatures were closed and heated to ~50 
°C before addition of 1.  Monochlorotriazine 1 was added to the solution containing the amines, 
giving a concentration 0.1 M, and then stirred for 18 hours at the desired temperature.  Thin layer 
chromatography (TLC) confirmed the absence of any starting after 18 hours.  Silica gel 
chromatography was used to separate the products from the excess amines.  All fractions 
containing UV active spots that did not stain positive under use of ninhydrin were combined, 
followed by removal of the solvent.  Analysis by NMR provided the relative ratios of products 
using the chemical shift of the protons α to the amine or other diagnostic protons resonances. 
 
 2.3.3 Results 
 The results in Table 2.1 outline the percentage of product corresponding to the 
substitution by the respective amine.  For each trial conducted at a set temperature three amines 
were selected.  For example in trial 1 amines 2, 3, and 4 were combined with 1 and stirred at 
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Figure 2.1.  Outline of competition reactions and the amines used.  The general trend in amine reactivity 
is outlined from left to right with 2 being the most reactive.  
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room temperature for 18 hours.  A mixture of products resulted with amines 2, 3, and 4 
determined to react with 1 in a ratio of 55:34:11.  As expected an increase in reaction 
temperature results in a concomitant decrease in selectivity.  This is apparent by comparing trials 
2 and 4, where the less reactive amines are incorporated to a greater extent at elevated 
temperatures. 
 
 
Trial Temp. Amines Respective yield of 
amine addition to 1 
1 rt 2, 3, 4 55:34:11 
2 rt 2, 5, 7 98.2:1.2:0.6 
3 rt 4, 5, 7 75:17:8 
4 70 2, 5, 7 95.6:3:1.4 
5 70 4, 5, 7 70:19:11 
6 70 5, 6, 7 47:35:18 
7 70 5, 8, 9 72:28:0 
8 120† 5, 8, 9 68:32:0 
 
 
 
 The competition reactions involving p-toluidine, 9, were complicated by the inability to 
remove the unreacted portion.  p-Toluidine eluted with the trisubstituted triazine products.  
Consequently it could not be determined if the chemical shifts of p-toluidine originated from its 
presence in the sample or from substitution on the triazine ring of 1.  Mass spectral analysis of 
reactions conducted under the same conditions as trials 7 and 8, with amine 7 replacing amine 8, 
showed no product with a mass corresponding to substitution of 1 by 9  (Scheme 2.4).  It was 
concluded that p-toluidine was not incorporated to any appreciable extent in trials 7 and 8.   
  
Table 2.1.  Results from competition reactions.   
† Dioxane used as the solvent 
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 In selecting heterofunctional linkers for construction of a layered dendrimer the general 
nucleophilic trend established from the competition reactions was referred to.  Several molecules 
were identified and selected which contained at least two different functional groups showing a 
large difference in the propensity to substitute monochlorotriazines (Figure 2.2).  These linkers 
have found use as chemoselective building blocks in the convergent syntheses of melamine 
dendrimers. 
 
 
 
 
2.4 Synthesis of a Layered Dendrimer 
 2.4.1 Target molecule 
 To demonstrate the utility of chemoselective difunctional linkers in the construction of a 
dendrimer, a target was identified which contained a unique linking group incorporated at each 
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Scheme 2.4.  Competition reaction to determine if p-toluidine reacts.  The product corresponding to the 
addition of amine 9 to 1 was not identified by ESI-Mass spectral analysis of the crude reaction.  
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Figure 2.2. Structures of bifunctional linkers.  These linkers contain two functional groups with a marked 
difference in reactivity with monochlorotriazines.  The first five linkers (10-14) were used in the 
construction of a melamine layered dendrimer.  
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layer of the dendrimer.  The target was synthesized in a one-generation per pot approach using 
chemoselective linkers identified through competition reactions.  
 
 2.4.2 Materials and methods 
 The layered dendrimer synthesis was conducted in such a manner as to produce one 
generation of growth in a one-pot two step reaction sequence.  The reaction sequence is outlined 
in Scheme 2.5.  The primary amine of the surface group, 2-(2-aminoethoxy)ethanol (10, AEE), 
reacts selectively with cyanuric chloride.  Addition of two equivalents of AEE resulted in a 
monochlorotriazine containing two free hydroxyl groups.  The alcohols were left unprotected for 
the entire synthesis, and no competing or substitution reactions between the hydroxyl groups and 
cyanuric chloride were observed.  Completion of the first two substitutions, as monitored by 
TLC, was followed with addition of the chemoselective linker pABA (11).  Following 
completion of the reaction and purification, NMR analysis revealed exclusively the product 
corresponding to substitution by the benzylic amine.  The resulting hydroxyl terminated aromatic 
amine G1 building block 15 was isolated after purification by silica gel chromatography in 92% 
yield.   
 The linker 4-aminomethylpiperidine (12, AMP) is as a molecule which capitalizes on the 
increased nucleophilicity of secondary amines over primary amines.  After reaction of 15 with 
half and equivalent of cyanuric chloride, and completion of the reaction to form the 
monochlorotriazine as visualized by TLC, AMP was added.  The product, 16, was isolated in 
85% yield after silica gel chromatography.  NMR analysis showed a product corresponding 
exclusively to substitution by the secondary amine.  This was evident by the large shift in peak 
frequency of the protons α to the secondary amine.  There was no corresponding change in the 
chemical shift of the protons α to the primary amine. 
 The amino acid isonipecotic acid (13, INP) was identified as a bifunctional linker with a 
reactive secondary amine.  The presence of a free carboxylic acid provided further opportunities 
to modify the resulting dendron through manipulation of the acid at the focal point of the 
dendron.  Substitution by two equivalents of 16 on cyanuric chloride was followed with addition 
of INP to the reaction.  The resulting product, the dendron 17, was isolated in 87% yield after 
silica gel chromatography.  The resulting G3 dendron with four unique linkage groups was 
constructed in three steps and 68% overall yield. 
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 To further demonstrate the utility of temperature controlled substitution of cyanuric 
chloride a tetrafunctional G1 dendrimer, 18, was synthesized in a single pot (Scheme 2.6, steps a 
and b).  The rationale was to construct an amine terminated core molecule to which four 
dendrons could be attached, specifically the addition of dendron 17 by way of the free carboxylic 
acid.  This was to be an example of the ‘hypermonomer’ approach.  The substitution of the 
second chloride of cyanuric chloride with primary amines typically occurs in 12-14 hours at 
room temperature, suggesting the dichlorotriazine is more reactive than the monochlorotriazine.  
The dichlorotriazine being more reactive is therefore likely to result in less selectivity for 
substitution by competing amine nucleophiles.  To ensure chemoselective substitution of a 
dichlorotriazine using the heterobifunctional liker 1-(2-aminoethyl)piperazine (14, AEP) the 
temperature for the reaction began at -78 ºC and was slowly elevated to room temperature.  
Scheme 2.5.  Dendron synthesis.  Reagents and conditions:  a) AEE, DIEA, THF, 0 °C→rt, 24 h; b) pABA, 
80 °C, 24 h; c) CC, DIEA, THF, 0°C→rt, 24 h; d) AMP, rt, 24 h; e) CC, DIEA, THF-10% MeOH, 0°C→rt, 
24 h; (f) INP, NH4OH(aq), 50 °C, 24 h.  AEE = HO(CH2)2O(CH2)2NH2, DIEA = Diisopropylethylamine, 
pABA = p-aminobenzylamine, CC = cyanuric chloride, AMP = 4-aminomethyl piperidine, INP = 
isonipecotic acid. 
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 The synthesis of 18 was initiated with reaction of two equivalents of cyanuric chloride 
with one equivalent of the long chain diamine, 4,7,10-trioxa-1,13-tridecanediamine (TODA) 
(Scheme 2.6, step a).  The reaction was conducted at 0 ºC, and within five minutes TLC showed 
a single product, with no free amines present in the reaction as determined by ninhydrin staining.  
The reaction was then cooled to -78 ºC in a dry ice/isopropanol bath, followed by addition of 
four equivalents of AEP relative to cyanuric chloride.  The reaction stirred for one hour in the 
dry ice/isopropanol bath followed by slow elevation of the reaction temperature to ambient over 
4 hours.  The reaction stirred at room temperature for an additional twelve hours.  The tetraamine 
core 18 was isolate in 76% yield using silica gel chromatography.  The selective substitution of 
the secondary amine in the presence of the primary amine is proven by 1H and 13C NMR.  A 
distinct downfield shift of the protons and carbons α to the secondary amine of AEP is evident.  
The chemical shift corresponding to the protons α to the primary of amine of 18 remained the 
same as those found in the 1H NMR of AEP. 
 
 
 
Scheme 2.6. Dendrimer synthesis.  Reagents and conditions:  a) 7, 10-trioxa-1, 13 tridecanediamine, 
DIEA (TODA); THF-10% MeOH, 0 °C, 5 m; b) AEP, -78 °C→rt, 15 h; c) AEE, DIEA, THF-10% 
MeOH, 0 °C→rt, 8 h; d) INP, NH4OH(aq), 60 °C, 12 h. e) PyBOP, DIEA, DMF, 0 °C→rt, 18 h.  AEP = 1-
(2-aminoethyl)piperazine, PyBOP = Benzotriazol-1-yl-oxytripyrrolidino-phosphonium 
hexafluorophosphate.  
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 To form a dendrimer and demonstrate the selective amine condensation of 18 with a 
carboxylic acid in the presence of unprotected alcohols the attachment of dendron 17 to the core 
18 was attempted under several different coupling conditions.  The reactions proved unfruitful, 
and the attachment of even one dendron 17 to the core could not be proven.  To test the viability 
of the chemistry involved in coupling four dendrons to the core molecule 18 a smaller dendron 
was used.  The G1 analog, 19, of the G3 dendron was synthesized, proceeding cleanly in a one-
pot strategy, giving 19 in 96% isolated yield (Scheme 2.6, steps c and d).  Four equivalents of 19 
cleanly coupled to the core 18 yielding the G2 dendrimer 20.  The chemistry was viable, but 
divergent growth of dendrimers is notorious for the introduction of defects due to increased 
steric crowding as the generation of the dendrimer increases.  However, this does not explain the 
inability of even one G3 dendron 17 to couple to the core 18. 
 To further explore the possibility of coupling 17 together to form a dendrimer in the 
presence of free alcohols the long chain diamine TODA was used with the HATU (O-(7-
azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate) coupling reagent in a 
DMF solution.  A species present in the MALDI-TOF mass spectrum correspond to the desired 
product 21, while the major peak corresponded to a species with the diamine linker attached to 
only one dendron.  A satisfactory separation of the products could not be obtained due to the 
polarity of the compounds and the limited material available. 
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2.5 Conclusions 
 The dendrons 15-17 are isolated as fine white powders with limited solubility in organic 
solvents.  Equal mixtures of dichloromethane and methanol or tetrahydrofuran and methanol are 
most effective at solubilizing the products.  The material can also be dissolved in dimethyl 
formamide (DMF) and readily precipitated from solution using isopropanol.  As reactions occur 
between cyanuric chloride and DMF the synthesis of the dendrimer was conducted in mixed 
solvent systems.  Dendrimer 20 is soluble in methanol and acidic water.  The presence of free 
hydroxyl groups offers the potential for post-synthetic modification of the scaffold, and 
peracetylation of 17 has been achieved. 
 Chemoselective reactivity of triazines in combination with temperature controlled 
substitution provides rapid access to melamine dendrimers of controlled composition.  The 
synthetic methods described can be applied to the construction of a variety of melamine 
dendrimers with controlled composition within the dendrimer structure and at the out most layer.  
Efforts to control the surface functionality are further described in Chapter III. 
 
2.6 Experimental: Preparation and Characterization 
 General:  Solvents were reagent grade and used without further purification.  Cyanuric 
chloride, isonipecotic acid, diethylamine, p-toluidine, n-butylamine, and 1-(2-amioethyl)-
piperazine (Acros), DIEA, 2-(2-aminoethoxy)ethanol, p-aminobenzylamine, 4,7,10-trioxa-1,13-
tridecanediamine, N-methylpiperazine, p-methylbenzylamine, benzylamine (Aldrich), 4-
(aminomethyl)piperidine, 1-acetylpiperazine (TCI), morpholine (Fluka), and piperidine 
(Advanced ChemTech) were used as received from suppliers without further purification.   
 NMR spectra were obtained from the use of a Varian Mercury 300 MHz or Inova 500 
MHz spectrophotometer.  1H and 13C NMR chemical shifts are reported as δ (ppm = parts per 
million) relative to the residual solvent peak appearing from the deuterated solvent used.  Thin-
layer chromatography (TLC) was performed using EMD silica gel 60 F254 pre-coated plates (0.25 
mm). Flash chromatography was performed using EMD silica gel 60 (0.040 mm particle size). 
All compounds were judged pure by TLC analysis (single spot/ two solvent systems) using a UV 
lamp and/or ninhydrin staining.  All mass spectral analyses were carried out by the Laboratory 
for Biological Mass Spectrometry (LBMS) at Texas A&M. 
 
 
 62 
 
 
 
 
2-Chloro-4,6-dimorpholino-1,3,5-triazine (1). To a stirred solution of cyanuric chloride (5.00 
g, 27.1 mmol) in THF (250 mL) at 0 °C was added 2 eq. morpholine (4.75 mL, 54.2 mmol) and 
Hunig’s Base (DIEA) (10.4 mL, 59.8 mmol ).  The reaction stirred for 6 h, followed by filtration 
to remove salts, and removal of the solvent.  The crude product was then dissolved in hot 
methanol, and precipitated by cooling.  The product was recrystallized from methanol again to 
give a white solid (6.85 g, 88%).  
 1H NMR (300 MHz, CDCl3, δ):  3.68 (br t, J = 4.5 Hz, 8H), 3.60 (t, J = 4.5 Hz, 8H); 13C NMR 
(75 MHz, CDCl3, δ): 1 69.42, 164.17, 66.41, 43.63; MS (ESI): exact mass calcd for 
C11H16ClN5O2 = 285.10; found 286.10 [M+H]+. 
 
Typical Competition Reaction (Trial 1).  Piperidine 2 (179 mg, 2.10 mmol), N-methyl 
piperazine 3 (210 mg, 2.10 mmol), N-acetyl piperazine 4 (269 mg, 2.10 mmol) were added to a 
Parr vessel with THF (10 mL), (for trial 8, 10 mL Dioxane was used).  To this solution 1 (200 
mg, 0.700 mmol) was added, and the reaction was left to stir.  For those reactions at elevated 
temperature the solution was brought to ~50 °C before addition of 1, and then the vessel was 
sealed.  Each reaction was left to stir 18 hours, and TLC confirmed the absence of starting 
material 1 for all reactions.  The solvent was then removed, and the residue was passed through a 
silica gel column with CH2Cl2:MeOH (9:1) to remove excess amines.  All fractions containing 
UV-active compounds that were not positive to ninhydrin staining, (indicating the absence of 
free amines) were combined and then analyzed by NMR. 
 For Trials 7 and 8, unreacted p-toluidine could not be separated from the UV-active 
compounds that were negative to ninhydrin staining, so NMR was taken of the crude mixture.  
No large shift of protons corresponding to the addition amine 9 to 1 was observed.  To rule out 
the addition of amine 9 to 1 ESI-MS analysis was used on a crude reaction mixture conducted 
with amines 5, 7, and 9 and the monochlorotriazine 1.  While the [M+H]+ for the addition of 
amine 5 to 1 (exact mass calcd for C15H26N6O2 = 322.21; found 323.22 [M+H]+) and 7 to 1 
(exact mass calcd for C19H26N6O2 = 370.21; found 371.22 [M+H]+) were readily observed, no 
peak corresponding to the addition of amine 9 to 1 was observed (exact mass calcd for 
N N
NN N
O O
Cl1
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C18H24N6O2 = 356.20; nothing found ).  Under these conditions it was inferred that p-toluidine 
does not substitute when in competition with benzylic or aliphatic amines. 
 
 
 
 
 
 
Intermediate 15.  In a Parr vessel 2-(2-aminoethoxy)ethanol (2.20 mL, 21.7 mmol) and DIEA 
(3.80 mL, 21.9 mmol) were added with 75 mL THF.  The mixture was cooled in an ice bath, 
followed by addition of cyanuric chloride (2.00 g, 10.9 mmol).  The reaction was warmed to 
room temperature and stirred for 24 h. Next p-aminobenzylamine (5.00 mL, 43.5 mmol) was 
added.  The vessel was sealed, and heated to 70 °C for 24 h.  The salts were filtered off and the 
solvent was removed.  The product was purified by silica gel chromatography with 
CH2Cl2:MeOH (8:2) with 1% v/v conc. NH4OH to give a yellow oil (4.06 g, 92%). 
 1H NMR (300 MHz, DMSO-d6, δ):  6.95 (d, J = 7.5 Hz, 2H), 6.48 (d, J = 7.5 Hz, 2H), 
4.20 (s, 2H), 3.52 (br, 8H), 3.46 (t, J = 4.8 Hz, 4H), 3.39 ( br t, 4H); 13C NMR (75 MHz, DMSO-
d6, δ): 166.23, 147.70, 128.95, 114.36, 72.70, 69.89, 60.79, 43.52; 13C NMR (75 MHz, CD3OD, 
δ): 165.73, 146.22, 129.67, 128.23, 115.46, 72.33, 69.33, 61.13, 43.82, 40.30; MS (FAB):  exact 
mass calcd for C18H29N7O4 = 407.23; found 408.23 [M+H]+. 
 
 
 
 
 
 
 
 
Intermediate 16.  Intermediate 15 (3.93 g, 9.64 mmol) was dissolved in 100 mL CH2Cl2:MeOH 
(1:1) followed by addition of DIEA (1.6 mL, 9.2 mmol) in a Parr vessel.  The reaction was 
cooled in an ice bath and cyanuric chloride (890 mg, 4.84 mmol) was added.  The reaction 
warmed to room temperature and was stirred for 24 h.  4-Aminomethylpiperidine (2.3 mL, 19 
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mmol) was added to the reaction and stirred at room temperature for 24 h.  The solvent was 
removed and the residue was purified by silica gel chromatography with CH2Cl2:MeOH (8:2-
7:3) with 1% v/v conc. NH4OH to give a white solid (4.11g, 85%).   
 1H NMR (300 MHz, DMSO-d6, δ):  7.62 (d, 4H), 7.15 (d, 4H), 4.66 (d, 2H), 4.35 (s, 
4H), 3.40 (br m, 32H), 2.81 (br, 2H), 2.43 (br d, 2H), 1.74(br d, 2H), 1.55 (br, 1H), 1.01 (br q, 
2H); 13C NMR (125 MHz, DMSO-d6, δ):  166.24, 164.88, 164.64, 139.15, 134.62, 128.11, 
120.23, 72.65, 69.82, 60.80, 47.33, 43.61, 40.00, 30.07; MS (ESI) exact mass calcd for 
C45H69N19O8 = 1003.56; found 1004.57 [M+H]+. 
 
 
 
 
 
 
 
 
 
 
 
 
Dendron 17.  Intermediate 16 (300 mg, 0.299 mmol) was dissolved in 20 mL of CH2Cl2:MeOH 
(1:1) with approx. 0.2 mL of DIEA (~1.2 mmol) in a Parr vessel.  The reaction was cooled in an 
ice bath followed by addition of cyanuric chloride (27.0 mg, .147 mmol). The reaction warmed 
to room temperature and stirred for 24 h.  To the reaction was added isonipecotic acid (77.0 mg, 
0.597 mmol) with 1 mL conc. NH4OH.  The reaction was sealed and heated at 50 °C for 24 h.  
The solution was allowed to cool and the solvent was removed.  The residue was purified by 
silica gel chromatography with CH2Cl2:MeOH (8:2) with 1% v/v conc. NH4OH to give a white 
solid (0.28 g, 87%). 
 1H NMR (500MHz, DMSO-d6, δ):  7.64 (br, 8H), 7.17 (br, 8H), 4.65 (br, 4), 4.47 (br, 
2H), 4.36 (br, 8H), 3.42 (br, 64H), 3.13 (br, 4H), 2.85 (br, 6H), 2.47 (br, 1H), 1.82 (br, 4H), 1.72 
(br, 4H), 1.42 (br, 2H), 1.08 (br, 4H); 13C NMR (125 MHz, DMSO-d6, δ):  176.52, 166.27, 
165.96, 164.78, 164.62, 164.43, 164.35, 138.95, 134.23, 127.68, 119.86, 72.39, 69.54, 60.68, 
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45.61, 43.17, 42.27, 41.24, 39.92, 36.83, 36.44, 29.96, 28.13; MS (MALDI-TOF) exact mass 
calcd for C99H146N42O18 = 2211.18; found 2212.73 [M+H]+, 2234.72 [M+Na]+. 
 
 
 
 
 
 
 
 
 
Tetraamine core 18.  To 90 mL THF with 10 mL MeOH was added 4,7,10-trioxa-1,13-
tridecanediamine (598 mg, 2.72 mmol) with DIEA (3.00 mL, 17.3 mmol).  The reaction was 
cooled in an ice bath and cyanuric chloride was added (1.00 g, 5.43 mmol).  After 5 min the TLC 
showed consumption of cyanuric chloride and a single UV active spot with no free amines as 
detected by ninhydrin staining.  The reaction was then cooled in a dry ice/isopropanol bath.  1-
(2-aminoethyl)piperazine (4.20 g, 32.6 mmol) was added drop-wise while the solution was 
cooled.  The reaction was left to stir in the ice bath for 1 h, then was slowly allowed to warm to 
room temperature over 4 h.  The reaction was left to stir an addition 12 h, then the salts were 
filtered off and the solvent removed.  The residue was purified by silica gel chromatography with 
CH2Cl2:MeOH (8:2) with 3% v/v conc. NH4OH to give a white solid after drying (2.41 g, 76%). 
 1H NMR (500 MHz, CDCl3, δ):  3.61 (br, 16H), 3.52 (m, 4H), 3.47 (m, 4H), 3.42 (t, J = 
6 Hz, 4H), 3.30 (t, J = 6.5 Hz, 4H), 2.66 (t, J = 6.5 Hz, 8H), 2.33 (m, 24H), 1.70 (m, 4H); 13C 
NMR (125 MHz, CDCl3, δ):  165.95, 164.70, 70.30, 69.92, 69.03, 60.13, 52.90, 42.64, 37.83, 
37.71, 37.64, 29.98, 29.33; MS (ESI) exact mass calcd. for C40H78N20O3 = 886.66; found 887.67 
[M+H]+. 
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Intermediate 19.  In a Parr vessel cyanuric chloride (2.00 g, 10.9 mmol) was added to 75 mL 
THF with 10% MeOH. The mixture was cooled in an ice bath, followed by addition of 2-(2-
aminoethoxy)ethanol (2.20 mL, 21.7 mmol) and DIEA (6.0 mL, 34.5 mmol).  The reaction was 
warmed to room temperature and stirred for 8 h.  Isonipecotic acid (1.4 g, 10.9 mmol) was added 
to the solution with 5 mL aqueous NH4OH.  The reaction was heated at 60 °C for 12 h.  The salts 
were filtered off and the solvent removed.  The crude white solid was washed with water and hot 
CH3CN to give a white solid (4.32g, 96%).  
 1H NMR (300 MHz, CD3OD, δ):  4.58 (br, 2H), 3.67 (m, 4H), 3.60 (m, 4H), 3.55 (m, 
8H), 2.98 (br t, 2H), 2.53 (m, 1H), 1.91 (m, 2H), 1.57 (dt, 2H); 13C NMR (75 MHz, CD3OD, δ):  
179.45, 165.34, 73.44, 70.88, 62.23, 43.86, 43.06, 41.44, 29.47; 13C NMR (75 MHz, DMSO-d6, 
δ):  176.44, 166.01, 164.65, 72.37, 69.48, 60.47, 42.23, 41.15, 40.00, 28.12; MS (ESI) calcd for 
C17H30N6O6 = 414.22; found 415.33 [M+H]+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dendrimer 20.  Intermediate 19 (350 mg, .845 mmol) was dissolved in DMF (8 mL) and cooled 
in an ice bath.  PyBOP (450 mg, .865 mmol) and DIEA (0.2 mL, 1.2 mmol) were added to the 
solution, and after mixing this solution was added to core 18 (184 mg, .207 mmol) also in DMF 
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(5 mL).  The solution was removed from the ice bath and stirred for 18 h.  The solvent was 
removed and purified by silica gel chromatography with DCM:MeOH (8:2) and 2% v/v conc. 
NH4OH.  After drying the product was a white solid (418 mg, 82% yield). 
 1H NMR (500 MHz, CD3OD, δ):  4.74 (br, 8H), 3.75 (br, 16H), 3.66 (m, 16H), 3.62 (m, 
4H), 3.58 (m, 20H), 3.53 (m, 36H), 3.39 (t, J = 6.5 Hz, 4H), 3.35 (t, J = 6.5 Hz, 8H), 2.80 (br t, 
8H), 2.52 (m, 24H), 2.42 (m, 4H), 1.76 (m, 12H), 1.59 (m, 8H); 13C NMR (75 MHz, CD3OD, δ):  
176.62, 166.85, 166.28, 165.61, 165.15, 72.96, 71.12, 70.75, 70.53, 69.82, 61.77, 57.71, 53.56, 
44.04, 43.38, 40.90, 38.53, 36.64, 30.17, 29.13; MS (MALDI-TOF) exact mass calcd. for 
C108H190N44O23 = 2471.50; found 2472.74 [M+H]+. 
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CHAPTER III 
 
SYNTHESIS OF A MULTIFUNCTIONAL DENDRIMER CONTAINING 
ORTHOGONALLY PROTECTED SURFACE GROUPS 
 
3.1 Introduction 
 Copolymers can be classified by the arrangement of the monomers with in the structure, 
such as alternating, random or block.  Dendrimers containing multiple monomers can also be 
classified into three basic structural classes based on the organization and location of unique 
structural motifs.197  In segmented dendrimers the unique repeat units are segregated into wedge 
regions like pieces of a pie, where the slices are of different compositions, and can be compared 
to block copolymers (Figure 3.1a).198  The second general class is the layered dendrimer, where 
two or more different repeat units are symmetrically located in a radial fashion giving a layered 
composition to the dendrimer (Figure 3.1b).199  Layered-dendrimer can be likened to alternating 
copolymers and Chapter II describes the synthesis of such a dendrimer. 
 The final class of dendritic copolymers are the tailored dendrimers which have one or 
more unique groups placed within or at the outermost layer of the dendrimer (Figure 3.1c).  
Telechelic polymers (polymers with a reactive functional group at one or both ends of the 
polymer chain) are common in macromolecular chemistry, but by virtue of being linear chain 
molecules contain a maximum of one or two reactive end groups.  Tailored dendrimers are 
constructed in such a manner as to incorporate a single or multiple unique groups on the 
periphery of the molecule.  The Simanek group has described the syntheses of melamine 
dendrimers with one or two unique groups out of 16 or 32 surface groups.170 
 
Figure 3.1. Dendritic copolymers.  a) Segmented dendrimer.  b) Layered dendrimer.  c) Tailored dendrimer. 
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 Dendrimers presenting compositionally diverse surfaces are prepared by two general 
methods.  The first method employs the random multifunctionalization of a dendrimer surface.  
These dendrimers are not ‘tailored’ in the sense that the exact composition and number of 
modifications are known, but this methods still provides access to macromolecules containing 
multiple different functionalities.  Random functionalizing is achieved by treatment of a 
dendrimer having reactive surface groups with a substoichiometric amount of a derivatizing 
reagent.  Since a substoichiometric amount of reagent is used, complete derivatization is not 
accomplished and a percentage of the reactive surface groups remain unmodified.  The degree of 
modification of each molecule can not be controlled, and thus a population of products arises 
from some dendrimers having more surface groups modified than others.  The result is a cocktail 
of molecules with a statistical distribution of all possible combinations of surface group 
modifications.  Even dendrimers which have the same number of modifications are unlikely to 
have the same spatial distribution, giving a more complicated mixture of products when 
structurally isomeric products are considered. 
 Subsequent reactions can be conducted on dendrimers modified through 
substoichiometric treatment with a derivatizing agent.  The use of a different reagent can be 
employed to incorporate new groups located at the periphery through modification of another 
subset of surface groups.  Perfunctionalization can also be carried out to modify all the 
remaining reactive groups.  The end result is a population of dendrimers containing multiple 
different groups at the surface with a statistical and random distribution of the functionality 
arranged on the dendrimer periphery.200 
 The second method to construct tailored dendrimers focuses on the controlled placement 
and arrangement of surface functionality by employing a convergent synthetic route, 
incorporating multifunctional monomers at the dendrimer surface.  These truly ‘tailored’ 
dendrimers contain a single or multiple unique modifications at the periphery of the dendrimer 
structure.201  Notably tailored dendrimers have been constructed containing one, two170,202 or up 
to eight203 unique sites at the dendron or dendrimer periphery.  However, the ability to post-
synthetically and selectively manipulate each unique site in the current examples is limited.  A 
few cases of dendrimers possessing multiple copies of two different types of surface groups 
which are amenable to separate and selective post-synthetic modifications are present in the 
literature.204 
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3.2 Rationale 
 To expand and increase the potential for identification of dendrimer applications, a 
scaffold which can be post-synthetically and selectively modified is constructed.  The ability to 
selectively modify and tune a dendrimer’s surface for a specific application or to incorporate 
different ligands or multiple molecules of choice for a given experiment greatly expands the 
utility of the synthetic macromolecule.  The dendrimer product moves from just a target 
molecule, where applications are limited to the composition of the original dendrimer structure, 
to a flexible scaffold for the attachment of molecules and selective modifications of the 
periphery as new applications or experiments are devised.   
 Nature uses a limited number of building blocks to construct functional materials.  
Rubber starch, cellulose and glycogen are composed of a single type of monomer.  DNA is 
composed of four different monomers.  Proteins can be composed of up to 20 different 
monomers, providing access a wide array of architectural and compositional space.  Natural 
polymers are extensively modified post-synthetically, including the methylation of DNA and the 
phosphorylation or glycosylation of proteins.  Post-synthetic modification of RNA provides a 
variety of unique architectures with various functions, including tRNAs and rRNAs utilized in 
protein synthesis.  Nature tunes, regulates, and controls the function of biopolymers through 
post-synthetic modifications. 
 Polymer chemists typically employ a small number of monomers in the construction of 
dendrimers and polymers, much like nature in the synthesis of DNA, oligosaccharides, and 
rubber.  Dendrimers syntheses, while providing means to control the composition of 
macromolecules and define the exact atomic connectivity, typically rely on the iterative addition 
of a limited number of building blocks.  The rapid and efficient incorporation of multiple 
monomers into dendrimers is desirable to access functional materials and unique architectures, in 
a similar manner as that utilized by nature to construct proteins. 
 Representative of methods currently used to construct tailored dendrimers is the route 
employed by Fréchet in the synthesis of the first truly tailored dendrimer containing one, two or 
three unique sites at the dendrimer periphery.  The dendrimer was synthesized through a 
convergent route, and relied throughout the synthesis on the monoderivatization of a 
homobifunctional monomer.  The desired singly modified product was fished out of the reaction 
from the unfunctionalized and difunctionalized products.  This route is not atom economical: 
material is lost at each step either as the unfunctionalized or difunctionalized products. 
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 A method to control and ensure the incorporation of a single functionality on a 
dendrimer monomer during a synthetic route would be advantageous.  Temperature controlled 
substitution of cyanuric chloride using one equivalent of the desired surface group can be 
followed in the same pot by the addition of a second and different surface group.  A third group 
can subsequently be substituted on the monochlorotriazine ring (Scheme 3.1).  The method is 
efficient and atom economical, as purification is not needed between each reaction, thus 
shortening the time required to construct dendrimer.  By matching the stoichiometry of reagents, 
the only byproducts are HCl and the base necessary to scavenge it. 
 
 
 
 
 To demonstrate methods by which multiple functionality can be incorporated into 
melamine a dendrimer and to further illustrate the ease and efficiency by which such routes can 
be accomplished, a G3 dendrimer was synthesized that not only possesses a compositional 
diverse surface, but terminal groups bearing multiple functionality by the way of orthogonal 
protecting and functional groups.  The inspiration for such a project stemmed from work which 
introduced four different orthogonal protecting groups around a sugar nucleus, the most notable 
of these being Wong’s effort in 1998.205  The G3 dendron possesses two orthogonal electrophilic 
groups, and three orthogonal nucleophile protecting groups.  The surface of the G3 dendron (1) 
contains eight BOC-protected amines, a silyl protected alcohol, a levulinyl ester, a single free 
Scheme 3.1.  Schematic outline of steps for construction of a multifunctional dendrimer.  Two different 
surface groups are installed in a stepwise manner on the triazine core (step 1), followed by installation of 
the linker (step 2).  The result is a monomer containing two unique surface groups and a linker for further 
elaboration of the dendrimer.  A second dendron, containing the same or unique surface functionality can 
be incorporated into the dendrimer at this stage (step 3).   
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hydroxyl, and a thiopyridyl disulfide, with a monochlorotriazine located at the focal point of the 
dendron. 
 
 
 
 
3.3 Materials and Methods 
 The synthesis of 1 was carried out using a highly convergent method where three out of 
the four surface group building blocks originated from a common intermediate.  The reactions 
were efficient providing typical yields in the mid-nineties.  Multiple-functionality is incorporated 
in a single-pot taking advantage of temperature selective substitution of the triazine core, and the 
use of bifunctional linking groups which react chemoselective with chlorotriazines.  The initial 
stage for the synthesis of 1 resulted in the completion of the four building blocks which would 
eventually make up the periphery of the dendrimer.  Three of these four dendrons originated 
from a common precursor as outlined in Scheme 3.2. 
 The synthesis began with the selective BOC protection of the primary amines of 3,3'-
diaminodipropylamine with BOC-ON (2-(tert-butoxycarbonyloxyimino)-2-
phenylacetonitrile),206 giving the bisprotected triamine 2.  This AB2 type monomer would 
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compose one-half of the dendrimer periphery.  The protected triamine 2 was reacted with one 
equivalent of cyanuric chloride while the reaction stirred at 0 °C.  Upon completion of the first 
substitution of cyanuric chloride as visualized by thin layer chromatography (TLC) the second 
surface group was installed in the same pot.  Addition of the amino-alcohol (2-
aminoethoxy)ethanol at room temperature, followed by work-up and purification give 
intermediate 3 (Free-OH-Cl) in quantitative yield. 
 
 
 
 
Scheme 3.2.  Building block syntheses.  Reagents and conditions.  a) CC, DIEA, THF, 0 °C, 1 h; b) 2-(2-
aminoethoxy)ethanol, rt, 18 h; c) Levulinic acid, DCC, DMAP, THF, rt, 8 h; d) TBDPSCl, imidazole, 
THF, rt, 8 h; e) AMP, THF, rt, 8 h; f) CC, DIEA, THF, 0 °C, 2 h; g) 2, rt, 24 h. h) AMP, rt, 8 h.  CC = 
cyanuric chloride, DIEA = Diisopropylethylamine, TBDPSCl = tert-Butyldiphenylsilyl chloride, DCC = 
Dicyclohexylcarbodiimide, DMAP = 4-dimethylaminopyridine, AMP = 4-aminomethyl piperidine. 
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 The monochlorotriazine 3 was divided in triplicate for further elaboration to 
intermediates 6-8.  Intermediate 6 (Free-OH-AMP) was readily synthesized by the selective 
substitution of the chloride of 3 by the secondary amine of 4-aminomethylpiperdine (AMP).  
Intermediate 3 was subjected to silylation with TBDPSCl (tert-butyldiphenylsilyl chloride).  
After purification and characterization of intermediate 4 (TBDPS-Cl) addition of AMP afforded 
intermediate 7 (TBDPS-AMP).  Esterification of 3 using the DCC mediated reaction with 
levulinic acid gave 5 (Lev-Cl), which was subsequently reacted with AMP to give 8 (Lev-AMP). 
 Three different substitutions of cyanuric chloride were conducted sequentially in a single 
pot to synthesize fragment 10 (Pyr-AMP).  The synthesis commenced with the addition of the 
HCl salt of thiopyridylcysteine amine178 to a solution containing cyanuric chloride at 0 °C.  The 
reaction progress was monitored using TLC, and upon completion of the first substitution the 
bis-BOC-protected triamine 2 was added to the solution stirred at room temperature.  
Completion of the second substitution was followed with addition of AMP in the same pot.  
Workup and purification proceeded cleanly, isolating the product 10 in 93% yield. 
 With the dendrons 6-9 in hand, the second stage involving the syntheses of higher 
generation dendrons was undertaken.  Controlling the stoichiometry of the dendron and the 
temperature of the reaction were imperative for the synthesis of dendrons 10 and 11 (Scheme 
3.3).  The syntheses were again carried out in a single pot obviating the need for purification of 
the monochlorotriazine intermediate.  Synthesis of dendron 11 illustrates the effectiveness of 
monitoring the reaction using TLC.  Triazine compounds are UV-active on TLC plates 
impregnated with the F254 fluorophore.  One equivalent of intermediate 7 (which has an Rf = 0.3 
in 9:1 DCM:MeOH) was mixed with cyanuric chloride at 0 °C.  Completion of the first 
substitution was evident after appearance of a single new spot corresponding to the putative 
dichlorotriazine intermediate (Rf = 0.6 in 9:1 DCM:MeOH).  Subsequent addition of one 
equivalent of 6 to the solution at room temperature resulted over time in a single new spot (Rf = 
0.4 in 9:1 DCM:MeOH), the monochlorotriazine.  (This intermediate was isolated and 
characterized from a separate reaction sequence.  See Chapter V).  The final substitution was 
accomplished after addition of AMP to the same pot at room temperature.  The G2 dendron, with 
a free primary amine, appeared on the TLC with an Rf = 0.25.  Its purification was easy 
accomplished using silica gel chromatography in near quantitative yield. 
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 The dendron containing the levulinyl ester and pyridyldisulfide, intermediate 11, was 
constructed in a like manner to the synthesis of 10.  A reaction of cyanuric chloride using 
intermediate 9 was conducted at 0 °C.  Mixtures of cyanuric chloride and the levulinyl ester 
containing intermediate 8 resulted in an almost instantaneous yellow solution and degradation of 
the starting material, even when the solutions were cooled before mixing.  In subsequent 
reactions the fragment containing the levulinyl ester was never mixed with cyanuric chloride.  
Completion of the first substitution of cyanuric chloride using intermediate 9 was followed by 
addition of 8 to the solution.  Subsequent reaction with AMP afforded dendron 11.  The product 
11 was isolated in only 79% yield, the lowest by 14% for the entire synthetic sequence.  While 
TLC of the completed reaction revealed a single spot, upon work-up and silica gel 
chromatography several products could be isolated.  Upon standing NMR samples degraded, 
resulting in complicated spectra.  Mass spectral analysis revealed peaks corresponding to a mass 
twice that of the desired product, minus 18 or 32.  It was assumed from these results that 
condensation between the free primary amine of the dendron and the ketone of the levulinyl ester 
was occurring, giving rise to the observed by-products and resulting in the corresponding lower 
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Scheme 3.3.  Dendron syntheses.  Reagents and conditions.  a) CC, DIEA, THF, 0 °C, 2 h; b) 6, rt, 24 h; c) 
AMP, rt, 18 h; e) CC, DIEA, THF, 0 °C, 2 h; e) 8, rt, 18 h; f) AMP, rt, 18 h; g) 10, CC, DIEA, THF, 0 °C, 2 
h; h) 11, rt, 18 h. 
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and uncharacteristic yield.  Indeed 1H NMR analysis of a sample presumed to contain 11 gave a 
convoluted spectrum, but after incubation with a small amount of aqueous HCl yielded an NMR 
spectrum consistent with that of compound 11. 
 The G3 dendron 1 was constructed by the typical route, first reaction of intermediate 10 
with one equivalent of cyanuric chloride followed by substitution using one equivalent of 
intermediate 11.  Dendron 1 was isolated after silica gel chromatography in 95% yield.  The 
synthesis of 1 proceeded in a convergent route with typical yields in the high nineties.  The 
reactions were conducted on a multi-gram scale producing 10.5 grams and ~5 grams of 1 in 
separate reaction sequences utilizing 18 reactions in 8 convergent steps.  The overall yield was 
~70% when the lowest yielding step is included.  (The longest linear sequence starting with 
intermediate 2 provides an 80% overall yield). 
 Dendrimers can be constructed from the multifunctional dendron 1 by dimerization with 
an appropriate linking molecule using the reactive monochlorotriazine.  Piperazine was used to 
construct the full G3 dendrimer 12 (Scheme 3.4).  Due to the large differences in molecular 
weights between 1 and piperazine (3140.88 Da to 86.14 Da respectively) it would be difficult to 
ensure the correct stoichiometry of the two reagents.  A two-step route was devised to dimerize 
dendrons of nearly equal molecular mass.  Reaction of dendron 1 with excess piperazine resulted 
in substitution of the monochlorotriazine and the incorporation of a free secondary amine.  The 
excess piperazine was removed by extraction and size exclusion chromatography.  The G3 
dendron product with a free secondary amine was then reacted with one equivalent of the 
monochlorotriazine dendron 1 (Scheme 3.4 steps a and b).  The reaction was slow, but did result 
in a G3 dendrimer with a molecular weight of 6,855 Da, containing duplicates of each unique 
functional group at periphery. 
 The G3 dendron 1 was used to demonstrate the orthogonal deprotection and 
modification of the molecule.  The monochlorotriazine located at the focal point of the dendron 
provides a site for attachment of molecules of interest to the scaffold.  One such molecule could 
be a protein transduction domain (PTD) peptide to investigate the translocation of dendrimers 
across cellular membranes (for further efforts in this area see Chapter V).  To demonstrate the 
feasibility of attaching molecules of interest to the focal point a single amino-acid was linked to 
the AMP group and subsequently attached to the core of dendron 1 giving dendron 14.207 
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 The modified amino acid was constructed using AMP and the NHS ester of BOC-
alanine.  To prove that amide formation arose from the selective reaction with the primary amine 
of AMP, the piperidine analog was separately constructed.  1H and 13C NMR analysis of the two 
compounds revealed a clear difference in the chemical shift corresponding to the α-carbon, 
suggesting the reaction was selective for substitution by the primary amine over the secondary 
N
H
O
O
N
H
O
N
Si
O
O
S
N
O
OTBDPS
N
H
N
H
OH
N
H
H
S
OS
N
 
2 N
N
N
N
H
N
S R'''
N N
H
Boc
N
N
N
N
H
N
O O R''''
N
N
N
NH
NH
N
NH
N N
H
Boc
N
N
N
N
H
N
N N
H
Boc
N
N
N
N
H
N
O O R''
N
N
N
NH
NH
N
N N
H
Boc
NH
O O R'
N
N
N
R
 
 
 
 
1 R=Cl
14 R=
a, b  89%
c  97%
 #          R'                               R''                                                   R'''                                   R'''' 
14         H
15                                        TBDPS                                         Thiopyridyl                           Lev
16        Poc                              H                                              Thiopyridyl                           Lev
17        Poc                          TBDPS                                         Thiopyridyl                            H      
18        Poc                          TBDPS                                                                                     Lev
Thiopyridyl
Lev
Poc
d  96%
e  90%
f  92%
g, h  88%
12 R=
2
2
2
2
Scheme 3.4.  Dendrimer synthesis and dendron derivatization.  Reagents and conditions.  a) 
piperazine, THF, rt, 20 h; b) 1, DIEA, MeOH, 10 d; c) BOC-Ala-AMP (13),  DIEA, THF, rt, 2 d; d) 
14, propargylchloroformate, pyridine, THF, rt, 2 h; e) 15, TBAF, THF, rt, 4 h; f) 15, hydrazine, THF, 
rt, 2 h; g) 15, DTT, DCM, rt, 2 h; h) Biotin-PCA, DMF, rt, 2 h.  BOC-Ala-AMP-13-see experimental 
for preparation, TBAF = tetrabutylammonium fluoride, DTT = dithiothreitol, Biotin-PCA = 
 78 
amine (Figure 3.2).  Acylation of 13 revealed a change in the chemical shift of the four protons α 
to the secondary amine. 
 
 
 
 
 The attachment of the amino acid analog 13 to dendron 1 gave dendron 14 (Scheme 3.4 
step c).  The reaction was rapid, attesting to the correct assignment of the free secondary amine, 
as primary amines react slowly with monochlorotriazines.  Dendron 14 was used to demonstrate 
the selective and independent modification of each surface group in the presence of the others 
through removal of each protecting group individually (Scheme 3.4). 
 Selective modification or removal of protecting groups can be achieved at the surface of 
the dendron.  To show the selective modification of surface groups, an alkyne was added to the 
free alcohol forming the propargyl carbonate 15.  Alkynes can be used as sites for click 
chemistry.208  Propargyl carbonates (POC) have also found use as protecting groups for amines, 
alcohols, and carboxylates,209 and the introduction of POC at the surface represents the 
incorporation of another orthogonal protecting group.  Indeed it was found the POC group was 
removed during treatment of the dendron with TCEP (Tris(2-carboxyethyl)phosphine 
hydrochloride) in efforts to modify the thiopyridyl site. 
 Previous methods for the removal of the POC group from hydroxyls require the use of a 
heterogeneous solution of tetrathiomolybdate.209c  The use of TCEP or other phosphines to 
remove the POC group is an attractive alternative, however the generality of this method is 
unknown.  The POC group is spectrally simple, atom economical as a protecting group, and 
readily introduced through the use of propargyl chloroformate.  The disulfide was reduced as 
expected under treatment with TCEP and the TBDPS ether and levulinyl ester remained 
untouched during the reaction.  The final reason to incorporate the POC on the free hydroxyls 
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Figure 3.2.  Chemical shift assignments of the α carbons of the piperidine and AMP amides of BOC-
alanine.  Spectra were obtained in, and referenced to CDCl3. 
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was to discriminate between the free hydroxyl and the hydroxyls revealed from subsequent 
removal of the TBDPS and levulinyl protecting groups. 
 The removal of the TBPDS ether was readily accomplished in the presence of the other 
functionality with the use of TBAF (tetrabutylammonium fluoride) to give 16, and no problems 
were encountered with its use. The removal of the levulinyl ester proceeds cleanly with the use 
of hydrazine, giving 17, with no modification of the thiopyridyl disulfide or TBDPS ether.  In 
one case where a large excess of hydrazine was used under concentrated conditions, loss of the 
POC group was evident by mass spectrometry.  This problem was readily remedied through the 
slow addition of a dilute solution of hydrazine. 
 Reduction of the disulfide using TCEP resulted in the loss of the POC group, so another 
route was employed to demonstrate the selective modification at the thiopyridyl disulfide site.  
The disulfide was reduced using and excess of dithiothreitol (DTT), followed with removal of 
the excess DTT using size exclusion chromatography.  The dendron possessing the free thiol was 
immediately reacted as the compound eluted from the column with biotin containing an activated 
disulfide.210  Dendron 18, a G3 dendron with a pendant biotin, was isolated in good yield and 
high purity. 
 
3.4 Outlook 
 The capability of attaching a small molecule of biological significance, such as biotin, 
opens the door for the use of this scaffold in a number of different investigations.  A smaller 
generation, but similar dendron to molecule 1, is used in the assembly of novel macromolecular 
constructs.  The preliminary results of which are described in Chapter V.  
 The substitution of piperazine for the chloride on 1 provides a reactive secondary amine 
handle that has been used for the attachment of the dendron to a trityl-polystyrene resin.  The 
eventual goal is to modify all of the peripheral groups while the scaffold is attached to a solid 
support.  The attachment of multiple different strands of DNA to the scaffold would offer 
potential uses for this scaffold in the construction of novel hybrid DNA-dendrimer assemblies, 
the realization of which has only occurred in the imagination. 
 
3.5 Conclusions 
 It is readily apparent that modification of the dendrimer and production of potentially 
applicable material would be greatly excelled if purification of the intermediates was not 
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required.  The proof-of-concept reactions described provide the basic reaction conditions and 
understanding of the relevant chemistry necessary for the successful modification of the 
dendrimer supported on the solid phase.  The monochlorotriazine provides a selective handle by 
which the scaffold may be attached to a solid support.  The selective deprotection and efficient 
modification of the peripheral functionality of the dendron was demonstrated.   
 Access to highly functionalized dendritic materials on a moderate scale is tractable, and 
the surface groups are amenable to post-synthetic modification.  In keeping with the theme of 
dendrimers as architecturally analogous to trees, the efforts described here have affectionately 
become known as the ‘fruit salad tree’ project.  Fruit trees can be obtained wherein multiple 
different types of fruit have been grafted onto a single trunk (Figure 3.3).211  These single 
orchard or ‘fruit salad’ trees offer multiple varieties of fruit which ripen in a staggered fashion 
throughout the growing season.  The molecular fruit salad tree has been planted as an example of 
the ability to tune and control the composition of large molecules.  While some fruits have been 
plucked from and grafted onto the molecular fruit salad tree the autumnal season of its existence 
is yet to arrive.  
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Figure 3.3.  A drawing of a fruit salad tree and the atomic representation of the molecular fruit salad tree. 
(Picture used with permission from the Fruit Salad Tree Company found at www.fruitsaladtree.com.) 
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3.6 Experimental:  Preparation and Characterization 
 Chemicals were used as received from general chemical suppliers (Aldrich and Acros) 
without further purification.  ACS grade THF and DCM were stored over 4Å sieves and other 
solvents were used as received.  
 NMR spectra were obtained from the use of a Varian Mercury 300 MHz or Inova 500 
MHz spectrophotometer as indicated.  1H and 13C NMR chemical shifts are reported as δ (ppm = 
parts per million) relative to the residual solvent peak appearing from the deuterated solvent 
used.  Thin-layer chromatography (TLC) was performed using EMD silica gel 60 F254 pre-coated 
plates (0.25 mm). Flash chromatography was performed using EMD silica gel 60 (0.040 mm 
particle size). All compounds were judged pure by TLC analysis (single spot/ two solvent 
systems) using a UV lamp and/or ninhydrin staining.  All mass spectral analyses were carried out 
by the Laboratory for Biological Mass Spectrometry (LBMS) at Texas A&M.  
 
 
 
 
 
 
Intermediate 2.  (BisBOCtriamine).  A solution of 3,3'-diaminodipropylamine (8.5 mL, 60.9 
mmol) and Hunig’s base (DIEA, diisopropylethylamine) (30 mL,  172 mmol) in 50 mL THF was 
added to an ice-bath cooled solution of BOC-ON (2-(tert-butoxycarbonyloxyimino)-2-
phenylacetonitrile) (30.0 g, 122 mmol) in 250 mL of THF.  The reaction warmed to room 
temperature over 4 h, and the solvent was then removed by reduced-pressure evaporation.  The 
residue was dissolved in 250 mL of DCM and washed with 2 portions of 200 mL H2O, followed 
by washing with 200 mL of brine.  The organic layer was dried over Na2SO4, filtered, and the 
solvent removed by reduced-pressure evaporation to give a thick oil.  A small portion of MeOH 
was added to the oil, followed by the addition of 200 mL of EtOAc.  After storage of the solution 
overnight at 0 °C the product was isolated by filtration to give a white solid (16.4 g, 81%).   
 1H NMR (300 MHz, CDCl3, δ):  3.16 (br m, 4H), 2.61 (t, J = 6.3Hz, 4H), 1.61 (m, 4H), 
1.39 (s, 18H); 13C NMR (75 MHz, CDCl3, δ):  155.95, 78.89, 47.28, 38.80, 29.64, 28.43; MS 
(ESI) exact mass calcd for C16H33N3O4 = 331.25; found 332.24 [M+H]+. 
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Intermediate 3.  (Free OH-Cl).  Intermediate 2 (10.0 g, 30.2 mmol) was dissolved in 150 mL 
THF, followed by addition of DIEA (16.0 mL, 91.9 mmol).  The solution was cooled in a 
salt/ice-bath.  Cyanuric chloride (5.56 g, 30.2 mmol) was added to the solution and stirred while 
cooled for 1 h.  2-(2-aminoethoxy)ethanol (6 mL, 60.0 mmol) was added to the reaction followed 
by the addition of 25 mL MeOH.  The reaction was stirred for 18 h, followed by removal of the 
salts from solution by filtration, and solvent removal by reduced-pressure evaporation.  The 
residue was dissolved in 200 mL DCM, and washed with 200 mL H2O followed by washing 
with 200 mL of brine.  The organic layer was dried over Na2SO4, followed by removal of the 
solvent by reduced-pressure evaporation.  The product was further purified by silica gel 
chromatography using 9:1 DCM:MeOH as the eluant.  The product was isolated as a white 
hygroscopic solid (16.6g, 100%).   
 1H NMR (500 MHz, CDCl3, δ):  3.76 (m, 2H), 3.56 (m, 2H), 3.49 (m, 2H), 3.43 (m, 8H), 
2.92 (m, 4H), 1.63 (m, 2H), 1.58 (m, 2H), 1.29 (br, 18H); 13C NMR (125 MHz, CDCl3, δ):  
168.10, 164.72, 164.51, 156.41, 156.20, 79.14, 78.90, 72.15, 72.06, 69.45, 68.89, 61.12, 61.00, 
44.02, 43.83, 43.53, 40.56, 40.44, 37.59, 37.42, 37.70, 28.03, 27.41; MS (APCI) exact mass 
calcd for C23H42ClN7O6  = 547.3; found 548.1 [M+H]+. 
 
 
 
 
 
 
 
Intermediate 4.  (TBDPS-Cl).  Intermediate 2 (4.0 g, 7.3 mmol) was dissolved in 50 mL of dry 
THF, followed by addition of tert-butyldiphenylchlorosilane (TBDPS-Cl) (2.2 mL, 8.4 mmol), 
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imidazole (400 mg, 5.9 mmol) and DIEA (1.5 mL, 8.6 mmol).  The reaction stirred for 8 h, 
followed by removal of the solvent by reduced-pressure evaporation, to give a white foam.  The 
product was purified by silica gel chromatography using 9:1 DCM:MeOH as the eluant to give a 
white solid (5.5 g, 95%).   
 1H NMR (500 MHz, CDCl3, δ):  7.57 (m, 4H), 7.29 (m, 6H), 3.69 (m, 2H), 3.48 (m, 
12H), 2.97 (m, 4H), 1.62 (m, 4H), 1.34 (s, 9H), 1.32 (s, 9H), 0.94 (s, 9H); 13C NMR (125MHz, 
CDCl3, δ):  168.37, 164.93, 164.69, 156.47, 156.20, 135.35, 133.27, 129.53, 127.50, 79.25, 
79.02, 72.20, 72.02, 69.60, 69.25, 63.17, 43.92, 43.52, 40.61, 37.36, 36.74, 28.15, 27.42, 26.55, 
18.94; MS (ESI) exact mass calcd for C39H60ClN7O6Si = 785.40; found 786.43 [M+H]+. 
 
 
 
 
 
 
 
 
Intermediate 5.  (Lev-Cl).  Intermediate 2 (5.0 g, 9.1 mmol) was dissolved in 50 mL dry THF.  
Levulinic acid (2.0g, 17.2 mmol), DCC (4.0 g, 19.4 mmol), and DMAP (500 mg, 4.1 mmol) 
were added to the flask and left to stir for 8 h.  The solids were filtered off, and the solvent 
removed by reduced-pressure evaporation.  The product was purified by silica gel 
chromatography using 9:1 DCM:MeOH as the eluant to give a colorless oil (5.7 g, 96%).   
 1H NMR (500 MHz, CDCl3, δ):  4.22 (m, 2H), 3.66 (m, 2H), 3.62 (m, 4H), 3.58 (m, 4H), 
3.08 (m, 4H), 2.78 (t, J = 6.47 Hz, 2H), 2.61 (t, J = 6.47 Hz, 2H), 2.20 (s, 3H), 1.77 (m, 2H), 
1.72 (m, 2H), 1.44 (s, 18H); 13C NMR (125MHz, CDCl3, δ):  206.76, 172.76, 168.69, 165.30, 
165.05, 156.12, 155.84, 79.17, 78.81, 69.74, 69.16, 68.97, 68.78, 43.76, 43.99, 40.67, 37.85, 
37.47, 36.76, 29.82, 28.38, 27.67; MS (ESI) exact mass calcd for C28H48ClN7O8 = 645.32; found 
646.35 [M+H]+. 
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Intermediate 6.  (Free OH-AMP).  Intermediate 2 (5.0 g, 9.1 mmol) was dissolved in 50 mL of 
THF followed by the addition of 4-aminomethyl piperidine (AMP) (3.3 mL, 27.4 mmol).  The 
reaction stirred for 8 h at room temperature.  The solids were filtered off and washed with THF.  
The solvent was then removed by reduced-pressure evaporation and the residue was purified by 
silica gel chromatography using 9:1-8:2 DCM:MeOH with 1% NH4OH as the eluant, to give a 
white hygroscopic solid (5.7 g, 100%).  
 1H NMR (500 MHz, CDCl3, δ):  4.56 (br, 2H), 3.71 (br, 4H), 3.57 ( br t, 2H), 3.49 (br t, 
2H), 3.45 (m, 10H), 2.92 (br s, 4H), 2.66 (t, J = 12.5 Hz, 2H), 2.43 (d, J = 7.0 Hz, 2H), 1.61 (br 
m, 6H), 1.44 (m, 1H), 1.30 (s, 18H), 0.98 (dq, J = 12.5, 3.5 Hz, 2H); 13NMR (125 MHz, CDCl3, 
δ):  166.08, 165.54, 164.64, 156.57, 79.38, 72.46, 70.04, 61.46, 47.54, 43.37, 42.70, 40.51, 
39.49, 37.31, 29.75, 28.48, 27.78; MS (APCI) exact mass calcd for C29H55N9O6 = 625.4; found 
626.3 [M+H]+. 
 
 
 
 
 
 
 
 
Intermediate 7.  (TBDPS-AMP).  Intermediate 4 (5.0 g, 6.4 mmol) was dissolved in 50 mL 
THF followed by addition of AMP (2.3 mL, 19.1 mmol).  The reaction was stirred for 8 h at 
room temperature, after which the salts were filtered off and washed with THF.  The solvent was 
removed by reduced-pressure evaporation and the product was purified by silica gel 
chromatography using 9:1 DCM:MeOH with 1% NH4OH as the eluant, to give a white solid (5.3 
g, 96%).   
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 1H NMR (500 MHz, CDCl3, δ):  7.59 (m, 4H), 7.29 (m, 6H), 4.64 (br s, 2H), 3.71 (t, J = 
5.5 Hz, 2H), 3.50 (m, 10H), 3.39 (br s, 4H), 2.95 (s, 4H), 2.69 (t, J = 12.5 Hz, 2H), 2.47 (d, J = 
6.5 Hz, 2H), 1.64 (m, 6H), 1.47 (m, 1H), 1.34 (s, 18H), 1.02 (dq, J = 12.5, 3.5Hz, 2H), 0.96 (s, 
9H); 13C NMR (125 MHz, CDCl3, δ):  165.69, 165.25, 164.35, 156.03, 135.26, 133.26, 129.34, 
127.36, 78.79, 71.93, 69.83, 63.08, 47.23, 42.91, 42.05, 41.80, 40.31, 40.20, 39.13, 36.86, 36.69, 
36.59, 29.37, 28.12, 27.37, 27.21, 26.47, 18.84; MS (ESI) exact mass calcd for C45H73N9O6Si = 
863.55; found 864.49 [M+H]+. 
 
 
 
 
 
 
 
 
Intermediate 8.  (Lev-AMP).  Intermediate 5 (5.0 g, 7.7 mmol) was dissolved in 50 mL THF 
followed by the addition of AMP (2.8 mL, 23.2 mmol).  The reaction was stirred for 8 h at room 
temperature, after which the salts were filtered off and washed with THF.  The solvent was 
removed by reduced-pressure evaporation and the product was purified by silica gel 
chromatography using 9:1-8:2 DCM:MeOH as the eluant.  The product was isolated as a white 
solid (5.3 g, 94%).   
 1H NMR (500 MHz, CDCl3, δ):  4.66 (br s, 2H), 4.16 (t, J = 4.64 Hz, 2H), 3.60 (t, J = 
4.64 Hz, 2H), 3.54 (br, 6H), 3.01 (br, 4H), 2.86 (br, 2H), 2.78 (br, 2H), 2.69 (t, J = 6.47 Hz, 2H), 
2.53 (t, J = 6.47 Hz, 2H), 2.12 (s, 3H), 2.03 (br, 1H), 1.66 (br, 4H), 1.37 (s, 18H), 1.18 (m, 2H); 
13C NMR (125 MHz, CDCl3, δ):  206.59, 172.56, 164.32, 155.87, 78.90, 69.70, 68.68, 63.52, 
44.81, 43.02, 40.33, 37.73, 37.50, 36.97, 34.42, 29.75, 29.29, 28.36, 27.75; MS (ESI) exact mass 
calcd for C34H61N9O8 = 723.46; found 724.49 [M+H]+. 
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Intermediate 9.  (Pyr-AMP).  Pyridylcysteineamine hydrochloride (2.0 g, 9.0 mmol) was added 
to an ice-bath cooled flask containing 100 mL THF.  DIEA (10.0 mL, 57.5 mmol) was added to 
the solution followed by cyanuric chloride (1.66 g, 9.0 mmol).  The reaction was stirred for 2 h, 
followed by the addition of intermediate 2 (3.0 g, 9.1 mmol).  The reaction was warmed to room 
temperature and stirred for 24 h.  AMP (6.5 mL, 54.1 mmol) was then added to the reaction and 
stirred for an additional 8 h.  The salts were filtered off and washed with THF.  The solvent was 
removed by reduced-pressure evaporation and the residue was purified by silica gel 
chromatography using 9:1 DCM:MeOH with 1% NH4OH as the eluant, giving the product as a 
white solid (5.9 g, 93%).   
 1H NMR (500 MHz, CDCl3-1% CD3OD, δ):  8.32 (br, 1H), 7.60 (br, 1H), 7.55 (m, 1H), 
7.00 (m, 1H), 4.58 (br, 2H), 3.55 (br, 2H), 3.38 (br, 4H), 2.93 (br, 4H), 2.88 (t, J = 6.47 Hz, 2H), 
2.64 (br m, 2H), 2.47 (d, J = 6.35 Hz, 2H), 1.58 (br, 6H), 1.49 (br m, 1H), 1.30 (br s, 18H), 0.97 
(br, 2H); 13C NMR (125 MHz, CDCl3, δ):  165.42, 165.19, 164.35, 159.58, 155.77, 149.43, 
136.78, 120.51, 119.48, 78.64, 47.34, 42.95, 41.97, 39.51, 38.96, 38.30, 37.96, 36.99, 36.79, 
29.46, 28.28, 27.57; MS (ESI) exact mass calcd for C32H54N10O4S2 = 706.38; found 707.38 
[M+H]+. 
 
 
 
 
 
 
 
 
 
Intermediate 10.  (TBDPS-Free OH-AMP).  TBDPS-AMP (7) (4.046g, 4.7 mmol) was 
dissolved in 60 mL of THF at 0 °C.  DIEA (3.0 mL, 17.2 mmol) was added to the cooled 
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solution followed by the addition of a solution of cyanuric chloride (863.3 mg, 4.7 mmol) in 10 
mL THF.  After stirring for 2 h a solution of FreeOH-AMP (6), (3.00g, 4.8 mmol) in 20 mL of 
THF was added and the solution was left to stir for 24 h at rt.  AMP (6.0 mL, 49.9 mmol) was 
then added and the solution left to stir for 18 h.  The salts were filtered off and washed with 
THF.  The solvent was removed by reduced-pressure evaporation and the residue was dissolved 
in 100 mL DCM and washed with 100 mL of H2O followed by washing with 100 mL of brine.  
The organic layer was dried over Na2SO4, followed by filtration to remove the solids and 
reduced-pressure evaporation to remove the solvent.  The product was isolated after silica gel 
chromatography using 9:1-8:2  DCM:MeOH as the eluant to give a white solid (7.7 g, 99%).   
 1H NMR (500 MHz, CDCl3, δ):  7.69 (m, 4H), 7.40 (m, 6H), 4.72 (br, 6H), 3.80 (t, J = 
5.25 Hz, 2 H), 3.74 (t, J = 4.15 Hz, 2H), 3.60 (br m, 20H), 3.28 (br, 4H), 3.06 (br, 8H), 2.77 (br, 
6H), 2.61 (d, J = 6.35 Hz, 2H), 1.87 (br, 2H), 1.77 (br, 6H), 1.71 (br, 8H), 1.55 (m, 1H), 1.44 (br 
s, 36H), 1.19 (m, 6H), 1.05 (s, 9H); 13C NMR (125 MHz, CDCl3, δ):  165.79, 165.31, 164.47, 
164.33, 156.10, 135.39, 133.39, 129.47, 127.47, 79.55, 78.99, 72.19, 72.06, 69.96, 69.75, 63.19, 
61.26, 47.35, 45.87, 43.05, 42.97, 42.12, 40.43, 40.32, 40.23, 39.26, 36.94, 36.66, 29.70, 29.50, 
28.25, 27.41, 26.59, 18.97; MS (MALDI-TOF) exact mass calcd for C83H139N23O12Si = 1678.07; 
found 1680.67 [M+H]+; MS (ESI) found 1679.04 [M+H]+., 840.01 [M+2H]+2. 
 
 
 
 
 
 
 
 
 
 
Intermediate 11.  (Lev-Pyr-AMP).  Pyr-AMP (9) (3.6 g, 5.1 mmol) was dissolved in 60 mL of 
THF, and the solution was cooled in a salt/ice-bath.  DIEA (3 mL, 17.3 mmol) was added to the 
cooled solution followed by the addition of cyanuric chloride (939 mg, 5.1 mmol).  The solution 
stirred for 2 h, then Lev-AMP (8) (3.7 g, 5.1 mmol) in 20 mL THF was added and the solution 
stirred for an additional 18 h at rt.  AMP (5 mL, 41.7 mmol) was added and the solution stirred 
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for an additional 18 h at rt.  The salts were filtered off and washed with THF, followed by 
removal of the solvent by reduced-pressure evaporation.  The residue was dissolved in 100 mL 
DCM and subsequently washed with 100 mL of H2O followed by 100 mL of brine.  The organic 
layer was dried over Na2SO4 followed by filtration to remove the solids and reduced-pressure 
evaporation to remove the solvent.  The product was isolated after silica gel chromatography 
using 9:1-8:2  DCM:MeOH as the eluant to give a white solid (6.5 g, 79%).   
 1H NMR (500 MHz, CDCl3-1% CD3OD, δ):  8.43 (br, 1H), 7.61 (br, 1H), 7.56 (br, 1H), 
4.63 (br, 6H), 4.17 (br, 2H), 3.61 (br, 2H), 3.55 (br, 8H), 3.45 (br, 4H), 3.36 (m, 2H), 3.20 (br, 
4H), 3.00 (br, 8H), 2.70 (br, 2H), 2.70 (br, 8H), 2.62 (br, 2H), 2.55 (br, 2H), 2.13 (s, 3H), 1.72 
(br m, 6H), 1.64 (br, 10H), 1.36 (br s, 36H), 1.10 (br, 12H); 13C NMR (125 MHz, CDCl3, δ):  
207.06, 172.73, 165.76, 165.29, 164.42, 164.34, 165.67, 156.08, 149.33, 137.07, 120.66, 119.64, 
78.95, 69.94, 68.56, 63.54, 47.24, 45.82, 43.01, 42.25, 40.12, 39.08, 38.03, 37.65, 36.93, 30.22, 
29.68, 29.60, 29.49, 28.24, 27.67, 27.49; MS (MALDI-TOF) average mass calcd for 
C75H126N24O12S2 = 1620.12; found 1620.11[M+H]+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dendron 1.  (FST-Cl).  TBDPS-Free OH-AMP (10) (5.5 g, 3.3 mmol) was dissolved in 60 mL 
THF and the solution was cooled in an ice-bath.  Hunig’s base (2 mL, 11.5 mmol) was added to 
the solution followed by the addition of cyanuric chloride (604 mg, 3.3 mmol).  The solution was 
stirred for 2 h followed by the addition of Lev-Pyr-AMP (11) (5.3 g, 3.3 mmol) in 20 mL THF.  
The solution was left to stir for 18 h at rt.  The solvent was removed by reduced-pressure 
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evaporation.  The residue was dissolved in 60 mL of DCM and washed with 100 mL of H2O 
followed by 100 mL of brine.  The organic portion was dried over Na2SO4, followed by removal 
of the solvent by reduced pressure evaporation.  The residue was purified by silica gel 
chromatography using 9:1 DCM:MeOH as the eluant to give a white solid (10.6 g, 95%).   
 1H NMR (500 MHz, CDCl3, δ):  8.46 (br, 1H), 7.65 (m, 5H), 7.58 (m, 1H), 7.36 (m, 
6H), 7.05 (m, 1H), 4.67 (br, 12H), 4.20 (t, J = 4.64 Hz, 2H), 3.77 (t, J = 5.25 Hz, 2H), 3.70 (br t, 
2H), 3.63 (br t, 2H), 3.61-3.43 (br, 34H), 3.24 (br, 12H), 3.03 (br, 16H), 2.98 (br t, 2H), 2.72 (br 
m, 14H), 2.58 (t, J = 6.47 Hz, 2H), 2.16 (s, 3H), 1.80-1.60 (br, 34H), 1.41 (br s, 72H), 1.14 (br, 
12H), 1.02 (s, 9H); 13C NMR (125 MHz, CDCl3, δ):  206.47, 172.56, 166.16, 165.76, 165.37, 
164.52, 155.85, 149.55, 136.84, 135.41, 133.44, 129.46, 127.49, 120.59, 119.54, 78.74, 72.07, 
69.98, 68.61, 63.51, 63.22, 61.41, 45.95, 43.00, 42.13, 40.46, 40.26, 37.72, 37.03, 29.72, 28.37, 
27.73, 27.46, 26.66, 19.01; MS (MALDI-TOF) average mass calcd for C161H263ClN50O24S2Si = 
3410.88; found 3410.50 [M+H]+. 
 
 
 
 
Dendrimer 12. (FST-D)   
 FST-Cl (1) (500 mg, 0.15 mmol) was dissolved in 8 mL of THF.  The solution was 
cooled in an ice-bath, followed by the addition of piperazine (75.8 mg, 0.88 mmol).  The 
reaction stirred for 20 h.  To the solution 10 mL of DCM was added, and the solution was 
washed with 5 mL of H2O, followed by 5 mL of sat. NaHCO3, and finally washed with 5 mL of 
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brine.  The organic layer was passed through a plug of Na2SO4 into a flask containing FST-Cl (1) 
(500 mg, 0.15 mmol).  DIEA (0.1 mL, 0.58 mmol) was added to the reaction followed by 2 mL 
of MeOH.  The reaction was left to stir for 24 h, and then 0.4 mL of Tween 20 was added along 
with an additional 0.4 mL DIEA.  The reaction was left to stir at rt for 10 d.  Piperazine (0.10 g, 
1.16 mmol) was added to the solution to aid in purification of the dendrimer by reacting with any 
FST-Cl left in solution as the FST-Cl (1) and FST-D (12) appeared to have very similar Rfs by 
TLC.  (The FST-piperazine intermediate has a much lower Rf than either 1 or 12).  The salts 
were removed by filtration and the solvent was removed by reduced-pressure evaporation.  The 
off-white solid was dissolved in 8 mL of DCM, and purified by size-exclusion chromatography 
using Bio-Beads (SX-1, Bio-Rad) and DCM as the eluant.  Fractions containing the dendrimer 
were combined, and concentrated followed by further purification with silica gel 
chromatography using 9:1 DCM:MeOH as the eluant to give a white solid (890 mg, 89%).   
 1H NMR (500 MHz, CDCl3, δ):  8.47 (br, 2H), 7.66 (m, 10H), 7.59 (m, 2H), 7.37 (m, 
12H), 7.06 (m, 2H), 4.68 (br, 24H), 4.21 (t, J = 4.64 Hz, 4H), 3.78 (t, J = 5.25 Hz, 4H), 3.71 (br 
t, 4H), 3.64 (br t, 4H), 3.61-3.43 (br, 76H), 3.26 (br, 24H), 3.04 (br, 32H), 2.98 (br t, 4H), 2.73 
(br m, 28H), 2.59 (t, J = 6.47, 4H), 2.17 (s, 6H), 1.80-1.60 (br, 68H), 1.40 (br s, 144H), 1.15 (br, 
24H), 1.03 (s, 18H); 13C NMR (125 MHz, CDCl3, δ):  06.49, 172.6, 166.37, 165.85, 165.51, 
164.56, 155.89, 149.6, 136.88, 135.46, 133.49, 129.51, 127.54, 120.63, 119.66, 78.81, 72.12, 
70.03, 68.66, 63.56, 63.26, 61.43, 46.04, 43.05, 42.14, 40.51, 40.4, 40.31, 37.76, 36.99, 29.81, 
29.77, 28.41, 27.78, 27.58, 26.71, 19.07; MS (MALDI-TOF) average mass calcd for 
C326H534N102O48S4Si2 = 6834.97; found 6833.67 [M+H]+, 6855.52 [M+Na]+. 
 
 
 
 
 
 
tert-Butyl (S)-1-((piperidin-4-yl)methylcarbamoyl)ethylcarbamate, 13.  (BOC-Ala-AMP).  In 
30 mL of THF BOC-Ala-OSu (N-(N-α-tert-BOC-L-alanyloxy)succinimide) (2.0 g, 7.0 mmol) 
was added, followed by stirring and cooling the solution in an ice-bath.  In 10 mL of THF AMP 
(2.52 mL, 21.0 mmol) was dissolved then added over 4 minutes to the solution containing BOC-
Ala-OSu.  The reaction was stirred for 2 h.  The solution was filtered to remove the salts, and the 
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O
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solvent was removed by reduced-pressure evaporation.  The viscous liquid was dissolved in 50 
mL DCM, and washed with 50 mL of H2O, followed by 50 mL of brine.  The aqueous solution 
was back extracted with 50 mL of DCM.  The organic fractions were combined and dried over 
Na2SO4.  The solution was then filtered and the solvent removed by reduced-pressure 
evaporation, and the crude product further purified by silica gel chromatography using 8:2 
DCM:MeOH with 1% NH4OH as the eluant to give a white solid (1.93 g, 97%).   
 1H NMR (500 MHz, CDCl3, δ):  4.08 (m, 1H), 3.06 (m, 2H), 3.00 (m, 2H), 2.53 (m, 2H), 
1.63 (m, 2H), 1.58 (m, 1H), 1.32 (s, 9H), 1.24 (d, J = 6.84 Hz, 3H), 1.14 (m, 2H); 13C NMR (125 
MHz, CDCl3, δ):  = 172.93, 155.42, 79.53, 77.25, 76.75, 49.83, 45.18, 44.66, 35.59, 29.49, 
28.09, 18.44; MS (ESI) exact mass calcd for C14H27N3O3 = 285.20; found 286.20 [M+H]+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dendron 14.  (FST-Ala).  FST-Cl (1) (1.0 g, 0.29 mmol) was dissolved in 20 mL of THF.  In a 
separate vial BOC-Ala-AMP (13) (251.1 mg, 0.88 mmol) was dissolved in 10 mL of THF 
followed by addition of DIEA (0.20 mL, 1.2 mmol); this solution was then added to the solution 
containing FST-Cl.  The solution was stirred for 2 d.  The solvent was removed by reduced 
pressure evaporation and the residue purified by silica gel chromatography using 19:1 to 9:1 
DCM:MeOH as the eluant to give a white solid (1.04 g, 97%).   
 1H NMR (500 MHz, CDCl3, δ):  8.48 (br, 1H), 7.67 (m, 5H), 7.61 (m, 1H), 7.38 (m, 
6H), 7.05 (m, 1H), 4.69 (br, 14H), 4.22 (t, J = 4.64 Hz, 2H), 4.12 (m, 1H), 3.79 (t, J = 5.25 Hz, 
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2H), 3.72 (br t, 2H), 3.65 (br t, 2H), 3.61-3.43 (br, 34H), 3.26 (br, 12H), 3.13 (br, 2H), 3.05 (br, 
16H), 3.00 (br t, 2H), 2.74 (br m, 16H), 2.60 (t, J = 6.47 Hz, 2H), 2.18 (s, 3H), 1.80-1.60 (br, 
37H), 1.41 (br s, 81H), 1.33 (d, J = 7.08 Hz, 3H), 1.16 (br, 14H), 1.03 (s, 9H); 13C NMR (125 
MHz, CDCl3, δ):  206.39, 172.67, 172.49, 166.14, 165.84, 165.31, 164.47, 159.61, 155.79, 
149.49, 136.79, 135.35, 133.38, 129.41, 127.44, 120.53, 119.48, 78.67, 72.17, 72.01, 69.89, 
68.55, 63.45, 63.16, 61.27, 49.91, 45.9, 44.61, 42.95, 42.03, 40.4, 40.21, 37.65, 36.96, 29.66, 
28.31, 28.11, 27.68, 27.52, 26.61, 18.96, 17.99; MS (MALDI-TOF) average mass calcd for 
C175H289N53O27S2Si = 3659.81; found 3658.73 [M+H]+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dendron 15.  (FST-Ala-POC).  In 10 mL of THF was dissolved FST-Ala (14) (950 mg, 0.26 
mmol), followed by the addition of propargylchloroformate (0.036 mL, 0.36 mmol), and 
pyridine (0.059 mL, 0.73 mmol).  The solution stirred for 2 h, and then the solvent was removed 
by reduced-pressure evaporation.  The residue was purified by silica gel chromatography using 
19:1 to 9:1 DCM:MeOH as the eluant to give a white solid (934 mg, 96%).   
 1H NMR (500 MHz, CDCl3, δ):  8.46 (br, 1H), 7.65 (m, 5H), 7.59 (m, 1H), 7.36 (m, 
6H), 7.05 (m, 1H), 4.70 (d, J = 2.44 Hz, 2H),  4.67(br, 14H), 4.29 (t, J = 4.64 Hz, 2H), 4.20 (t, J 
= 4.72 Hz, 2H), 4.12 (m, 1H), 3.77 (t, J = 5.25 Hz, 2H), 3.67 (br, 2H), 3.63 (br, 2H), 3.61-3.43 
(br, 32H), 3.23 (br, 12H), 3.10 (br, 2H), 3.03 (br, 16H), 2.98 (br, 2H), 2.72 (br m, 16H), 2.58 (t, J 
= 6.47 Hz, 2H), 2.53 (t, J = 2.44 Hz, 1H), 2.15 (s, 3H), 1.80-1.60 (br, 37H), 1.39 (br s, 81H), 
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1.31 (d, J = 7.08 Hz, 3H), 1.14 (br, 14H), 1.02 (s, 9H); 13C NMR (125 MHz, CDCl3, δ):  206.48, 
172.56, 166.03, 165.43, 164.53, 159.63, 155.85, 154.39, 149.56, 136.84, 135.42, 133.45, 129.47, 
127.50, 120.59, 119.54, 78.76, 75.72, 72.07, 69.99, 68.61, 68.40, 67.24, 63.52, 63.22, 55.17, 
49.98, 45.98, 44.68, 43.01, 42.06, 40.46, 40.27, 37.72, 37.06, 29.73, 29.54, 28.37, 28.17, 27.74, 
27.44, 26.67, 19.02, 17.98; MS (MALDI-TOF) average mass calcd forC179H291N53O29S2Si = 
3741.87; found 3741.68 [M+H]+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dendron 16.  (FST-Ala-POC/TBDPS).  In 10 mL of THF was dissolved FST-Ala-POC (14) 
(250 mg, 0.067 mmol).  Under a blanket of N2 was added 0.25 mL of a 1M tetrabutylammonium 
fluoride (TBAF) solution in THF (0.25 mmol).  The solution stirred for 4 h, followed by removal 
of the solvent by reduced-pressure evaporation.  The residue was purified by size-exclusion 
chromatography using Bio-Beads (SX-1, Bio-Rad) and DCM as the eluant.  The product was 
further purified by silica gel chromatography using 19:1 to 9:1 DCM:MeOH as the eluant to give 
a white solid (210 mg, 90%).   
 1H NMR (500 MHz, CDCl3, δ):  8.49 (br, 1H), 7.67 (m, 1H), 7.62 (m, 1H), 7.09 (m, 
1H), 4.74 (d, J = 2.44 Hz, 2H),  4.70 (br, 14H), 4.32 (t, J = 4.64 Hz, 2H), 4.23 (t, J = 4.72 Hz, 
2H), 4.13 (m, 1H), 3.73 (br t, 2H), 3.70 (br t, 2H), 3.63 (br t, 2H), 3.61-3.43 (br, 34H), 3.27 (br, 
12H), 3.14 (br, 2H), 3.06 (br, 16H), 3.00 (br t, 2H), 2.75 (br m, 16H), 2.61 (t, J = 6.47 Hz, 2H), 
2.50 (t, J = 2.44 Hz, 1H), 2.19 (s, 3H), 1.80-1.60 (br, 37H), 1.42 (br s, 81H), 1.35 (d, J = 7.08 
Hz, 3H), 1.17 (br, 14H); 13C NMR (125 MHz, CDCl3, δ):  206.60, 172.70, 165.87, 165.52, 
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164.64, 156.01, 154.51, 149.69, 136.95, 120.72, 119.71, 78.92, 75.78, 72.23, 70.13, 68.74, 
68.52, 67.37, 63.65, 61.60, 55.29, 50.09, 46.08, 44.79, 43.13, 42.18, 40.39, 37.84, 37.09, 29.85, 
29.64, 28.48, 28.27, 27.85, 27.55, 18.04; MS (MALDI-TOF) average mass calcd for 
C163H273N53O29S2 = 3503.46; found 3503.22 [M+H]+.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Dendron 17.  (FST-Ala-POC/Lev).  FST-Ala-POC (14) (50 mg, 0.013 mmol) was dissolved in 5 
mL of THF.  In another 5 mL of THF was added 5 drops of anhydrous hydrazine.  Portions of 
the solution containing hydrazine were added over 2 h, while monitoring the reaction by TLC.  
The reaction appeared complete after the addition of 3 mL of the hydrazine solution.  The 
solvent was then removed by reduced-pressure evaporation, and the residue purified by silica gel 
chromatography using 9:1 DCM:MeOH as the eluant, giving a white solid (45 mg, 92%).   
 1H NMR (500 MHz, CDCl3, δ):  8.50 (br, 1H), 7.69 (m, 5H), 7.62 (m, 1H), 7.39 (m, 
6H), 7.09 (m, 1H), 4.74 (d, J = 2.44 Hz, 2H),  4.70 (br, 14H), 4.32 (t, J = 4.64 Hz, 2H), 4.13 (m, 
1H), 3.80 (t, J = 5.25 Hz, 2H), 3.74 (br t, 2H), 3.70 (br t, 2H), 3.61-3.43 (br, 34H), 3.28 (br, 
12H), 3.14 (br, 2H), 3.06 (br, 16H), 3.01 (br t, 2H), 2.76 (br, 14H), 2.55 (t, J = 2.44 Hz, 1H), 
1.80-1.60 (br, 37H), 1.42 (br s, 81H), 1.35 (d, J = 7.08 Hz, 3H), 1.17 (br, 14H), 1.05 (s, 9H); 13C 
NMR (125 MHz, CDCl3, δ):  166.43, 165.99, 165.55, 164.67, 155.97, 154.52, 149.71, 136.95, 
135.56, 133.60, 129.59, 127.62, 127.20, 120.72, 119.87, 78.94, 75.78, 72.21, 70.13, 68.54, 
67.38, 63.35, 61.64, 55.30, 50.11, 46.10, 44.81, 43.15, 42.14, 40.60, 40.43, 37.12, 29.90, 29.67, 
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28.50, 28.29, 27.67, 26.80, 19.16, 18.01; MS (MALDI-TOF) average mass calcd for 
C174H285N53O27S2Si = 3643.76; found 3643.86 [M+H]+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dendron 18.  (FST-Ala-POC-Biotin).  In 8 mL of DCM was dissolved FST-Ala-POC (14) (200 
mg, 0.053 mmol).  To this solution was added dithiothreitol (DTT) (50 mg, 0.32 mmol), 
whereupon the reaction began to turn yellow.  The solution was stirred under a blanket of N2 at rt 
for 2 h.  The solution was directly applied to a size exclusion column (Bio-Beads S-X1, Bio-
Rad) using DCM as the eluant.  The first fractions containing a UV active compound were added 
directly to a solution of Biotin-PCA (Biotinpyridyldisulfidecysteineamine) (50 mg, 0.12 mmol) 
in 5 mL of DMF.  The solution immediately began to turn yellow and the solution was 
concentrated to 6 mL by passing a stream of dry N2 over the reaction vessel, and then left to stir 
under a blanket of N2 for 2h.  The solution was further concentrated by passing a stream of dry 
N2 over the sample.  The solution was then applied to a size exclusion column (Bio-Beads S-X1, 
Bio-Rad) using DCM as the eluant.  Fractions containing the initial UV-active sample were 
combined, and the solvent removed using reduced-pressure evaporation.  The residue was further 
purified by silica gel chromatography using 9:1 DCM:MeOH as the eluant to give a white solid 
(185 mg, 88%).   
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 1H NMR (500 MHz, CDCl3, δ):  7.66 (m, 4H), 7.37 (m, 6H), 4.71 (d, J = 2.44 Hz, 2H), 
4.69 (br, 14H), 4.44 (m, 1H), 4.29 (br t, 2H), 4.25 (m, 1H), 4.20 (br t, 2H), 4.13 (m, 1H), 3.78 (t, 
J = 5.13 Hz, 2H), 3.67 (br t, 2H), 3.64 (br t, 2H), 3.61-3.43 (br m, 32H), 3.24 (br, 12H), 3.10 (br, 
5H), 3.04 (br, 16H), 2.86 (m, 4H), 2.82-2.62 (br m, 18H), 2.59 (t, J = 6.47 Hz, 2H), 2.54 (t, J = 
2.44 Hz, 1H), 2.16 (br s, 5H), 1.80-1.60 (br, 37H), 1.60-1.5 (m, 4H), 1.40 (br s, 83H), 1.32 (d, J 
= 7.08 Hz, 3H), 1.15 (br m, 14H), 1.02 (s, 9H); 13C NMR (125 MHz, CDCl3, δ):  206.55, 173.12, 
172.61, 166.32, 165.80, 165.46, 164.56, 164.49, 163.68, 155.89, 154.42, 135.45, 133.49, 129.50, 
127.53, 78.80, 75.74, 72.11, 70.12, 70.03, 68.65, 68.44, 67.28, 63.56, 63.26, 61.79, 61.67, 60.00, 
59.88, 55.43, 55.21, 49.97, 46.02, 44.71, 43.07, 41.93, 40.50, 40.39, 40.32, 40.19, 38.06, 37.95, 
37.76, 37.56, 37.01, 36.84, 36.71, 36.57, 35.58, 29.80, 29.77, 29.59, 28.40, 28.21, 28.04, 27.97, 
27.78, 27.54, 26.70, 25.28, 19.05, 18.12; MS (MALDI-TOF) average mass calcd for 
C186H307N55O31S3Si = 3934.15; found 3934.03 [M+H]+. 
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CHAPTER IV 
 
INCORPORATION OF A SHORT LINKER INTO MELAMINE DENDRIMERS:   
RAPID ACCESS TO UNIQUE MOLECULES 
 
4.1 Introduction 
 Dendrimers have been pursued academically and commercially since their inception for 
potential applications.  While current commercial applications are limited a steady increase in 
the number of patents filed dealing with dendrimers indicates efforts to identify a niche they may 
be applied to.  More than a thousand patents related to dendrimers are projected to be granted 
between the years 2001 and 2005, up from 51 patents granted a decade earlier.212  The pursuit of 
dendrimers as functional materials stems from their possession of unique physical properties not 
found with linear polymers or other materials.  The cause of many of these unique properties is 
attributed to the highly branched nature of the macromolecules.213   
 The volume occupied by a dendrimer in solution increases cubically with an increase in 
generation; while in contrast the mass increases exponentially with subsequent generations.  
Therefore, solution properties of dendrimers deviate from those of linear counterparts.  
Comparison of macromolecules with exactly the same number of repeat units arranged either in 
a branched or linear sequence reveal surprising differences between the two structures.214  
Dendrimers generally show lower viscosities, smaller hydrodynamic radii, and better solubility 
properties than exact linear analogs.  
 Considerable effort has been applied to the identification of dendrimers with unique 
properties for material applications.  Some applications of unique dendrimer materials include 
light harvesting215, gadolinium III-chelated PAMAM dendrimers for magnetic resonance 
imaging,216 catalysis using dendrimer encapsulated nanoparticles,217 tissue engineering,218 gene 
transfection reagents,219 and drug delivery (Chapter V).220 
 A series of melamine dendrimers were constructed containing the two atom linkage 
molecule hydrazine.  The syntheses of these molecules proved to be rapid, requiring little effort 
for their purification, and tractable at moderate scales exceeding 5 grams of product.  Originally 
pursued as precursors to azo dendrimers, the resulting oxidized products proved to labile to 
isolate and characterize.  The incorporation of a short linker however provides a series of 
dendrimers with limited flexibility and thus a rigid structure.  Rigid dendrimers, or shape 
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persistent dendrimers, have recently found use in conformational studies 221 and the production 
of novel polycyclic aromatic hydrocarbons.222  The low carbon to nitrogen (C:N) ratio of these 
compounds may lend themselves to studies in the production of carbon nitride materials.149  
 Dendrimers can be considered flexible molecules and the use of such descriptors as 
surface groups is somewhat of a misnomer.  Studies have shown that dendrimers of sufficiently 
large generations, generally four or greater assume a globular structure.  However the location of 
dendrimers surface groups is debated.223  The incorporation of rigid linkers limits the 
conformational mobility of the dendrimer structure providing fewer degrees of rotation.  It has 
been conclusively shown using a shape persistent dendrimer that the surface groups of rigid 
dendrimers are truly found at the surface.221   
  
4.2 Rationale 
 Macromolecules containing azobenzene linkage groups have been pursued in the field of 
polymer and dendrimer chemistry for sometime.  The motivation for incorporating azo linkages 
into materials stems from the facile cis to trans isomerization of azobenzenes.  Incorporating the 
azo linkage into macromolecules is done in hopes of producing novel photo-responsive 
materials.  It was proposed that using hydrazine as a linker, followed later by oxidation of the 
linker to an azo group, would provide a route to the site specific incorporation of azo groups into 
melamine dendrimers.  An additional motivation was to produce a dendrimer were every linking 
group was an azo functionality.  It was found that oxidation of hydrazine linked triazines to azo 
groups was not facile as has previously been reported,224 but results in decomposition of the 
starting material. 
 The monochlorotriazine containing two piperidines at the surface can readily be 
obtained in high yields and is easily purified by recrystallization.  The lack of an N-H bond 
contributed by the surface group was attractive for potential UV studies, where the loss of the N-
H bonds corresponding to oxidation of the hydrazine could be monitored, without overlapping 
peaks from the surface groups.  The inability to produce clean oxidation products made the lack 
of N-H bonds on the surface group irrelevant.  However, the piperidines did impart physical 
properties to the dendrimers which greatly aided their purification. 
 The route to the synthesis of the dendrimers was convergent and the products could be 
readily purified by recrystallization from or precipitation with methanol.  The later generations 
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were purified through precipitating the product from the reaction solution with methanol and 
further washing with hot methanol or acetonitrile. 
 
4.3 Materials and Methods 
 The surface group containing two piperidines and a monochlorotriazines was readily 
synthesized on a moderate scale with the product purified by recrystallization using either 
methanol or ethyl acetate.  The synthesis of 78.5 grams of 1 was carried out by careful 
substitution of two positions of cyanuric chloride with piperidine.  The solution was cooled in a 
dry ice/isopropanol bath for two reasons.  First the reaction is exothermic and on such a large 
scale the reaction could readily get out of hand.  Second, the reaction of piperidine with 
monochlorotriazines is rapid, and all three positions of cyanuric chloride can be substituted with 
piperidine in a few hours at 0 °C if enough equivalents of the amine are present.  To ensure only 
disubstitution of cyanuric chloride the reaction was initiated at -78 °C with slow addition of 
piperidine and Hunig’s base (DIEA, diisopropylethylamine) to the THF solution of cyanuric 
chloride.  Completion of the reaction was followed with removal of the salts by filtration, 
reduced pressure evaporation of the solvent and recrystallization of the crude material from ethyl 
acetate or methanol.  A white crystalline product was obtained upon cooling the solution.   
 Subsequent steps of the dendrimer syntheses were conducted through the iterative 
reaction of hydrazine with a monochlorotriazine (Figure 4.1 steps a, c, e), and reaction of the 
hydrazine terminated dendron with half and equivalent of cyanuric chloride to provide the 
monochlorotriazine (Scheme 4.1, steps b and d). 
 The purification of 1 and 2 was accomplished through recrystallization of the crude 
material from hot methanol.  The products are readily soluble in THF, DCM and chloroform.  
Dendrons 3 and 4 are not appreciably soluble in DCM or chloroform, but dissolve slightly in 
solutions of THF at elevated temperatures.  Concentrations of the monochlorotriazine 3 in CDCl3 
suitable for NMR analysis could not be obtained.  The hydrazine analog 4 dissolved in CDCl3 at 
a sufficient concentration to obtain a satisfactory 13C NMR spectrum after several hours.  
Dendrons 5 and 6 are readily soluble in DCM and THF, however the hydrazine terminated 
dendron 6 is less so than the monochlorotriazine 5.  None of the dendrons 3-6 are soluble to any 
appreciable extent in hot methanol or acetonitrile.  Reactions were worked-up and the products 
purified by addition of methanol to the reaction, heating the solution followed by filtration of the 
hot solvent to isolate the products as a white powder. 
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 The resulting six dendrons were utilized in the synthesis of a series of dendrimers.  Two 
strategies were devised which would each result in the synthesis of a dendrimer.  The reactions 
depicted in Scheme 4.1 are illustrative of the approach.  Reaction of a hydrazine terminated 
dendron (2) with the monochlorotriazine of the same generation (1) gave what is referred to as 
the G1-Hyd-dimer (7), the dimer of two G1 dendrons linked by hydrazine (Scheme 4.2a).  The 
reaction proceeds through substitution of the monochlorotriazine of one dendron by the 
hydrazine of the other to give the product 7.  The second strategy was the substitution of three 
hydrazine terminated dendrons around a cyanuric chloride core.  One equivalent of cyanuric 
chloride was mixed with three equivalents of the hydrazine terminated dendron 2, and after 
prolonged heated resulted in the G1-Hyd-trimer 8; three G1 dendrons linked to a triazine core 
through hydrazine linkers (Scheme 4.2b).   
 The reactions producing 7 and 8 were sluggish, and TLC analysis during the course of 
the reaction showed slow consumption of the starting materials.  Steric congestion around the 
reaction centers resulting from the use of short linkers is one factor which may contribute to the 
retarded rate of reaction.  The languid reaction may also be due to electronic effects, stemming 
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Scheme 4.1.  Synthesis of hydrazine dendrons.  a) Hydrazine, THF, 80 °C, 8 h, 96%;  b) CC, DIEA, THF, 
0 °C→rt, 18 h, 96%; c) hydrazine, THF, 80 °C, 24 h, 83%; d) CC, DIEA, THF, 0 °C→40 °C, 24 h, 95%; 
e) hydrazine, THF, 80 °C, 24 h, 96%.  CC = Cyanuric chloride; DIEA = Hunig’s base, 
diisopropylethylamine. 
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from a reduced nucleophilicity of the hydrazine resulting from electron donation into the triazine 
ring.  It was necessary to heat the reactions to 105 °C for 36 hours to achieve any appreciable 
yield. 
 
 
 
 
 The isolation of the products 7 and 8 from the crude reaction turned out to be trivial.  
Dendrimers 7 and 8 are not soluble in hot methanol while the starting materials and other side 
products were.  Following removal of the solvent from the crude reaction, methanol was added.  
Subsequent heating of the solution results in the suspension of a fine white powder, which is 
isolated after filtration of the hot solution.  Although isolated in only moderate yield, the 
products 7 and 8 appear as a single spot by TLC analysis, give one molecular ion peak using 
ESI-MS, and appear clean by 13C and 1H NMR analysis. 
 Construction of higher generation dendrimers was not completely successful.  Utilizing 
the methods described above attempts made to construct the G2-Hyd-dimer and G2-Hyd-trimer 
as well as the G3 analogs did not provide clean products (Scheme 4.3).  ESI-MS of the crude 
material reveled peaks with m/z ratios corresponding to those of the putative products. 
Scheme 4.2.  Syntheses of a G1-hydrazine linked dimer and trimer.  a) 2, THF, 105 °C, 36 h, 66%; b) 
cyanuric chloride, THF, 105 °C, 36 h, 52%. 
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 The goal at the outset of this project was to construct azo linkages through the oxidation 
of the corresponding hydrazine.  Several reagents, including KMnO4, H2O2, N-
bromosuccinimide, bleach, and FeCl3, were tried to effect the oxidation, but none were 
satisfactory in producing the desired products.  In several cases it appeared the oxidation resulted 
in decomposition of the dendrimer to unknown products.  Later it was realized that the structural 
similarity between the hydrazine dendrons and aryl hydrazines could explain the decomposition 
of the starting materials.  Aryl hydrazines have been used as linkers on the solid phase for the 
synthesis of amides, esters, and acids.  Acylation of an aryl hydrazine, followed by mild 
oxidation produces the aryl diazene which readily decomposes under mild conditions to give 
arenes and nitrogen (Scheme 4.4a).225  The nature of the products obtained after oxidation of the 
hydrazine dendrimers is unknown, but the structural similarity between aryl hydrazides and the 
azo linked triazine offers a plausible explanation for the observed decomposition (Scheme 4.4b). 
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Scheme 4.3.  Outline of the synthetic route to higher generation hydrazine linked triazine dendrimers.  In 
the first and third columns coupling of a monochlorotriazine dendron with a hydrazine terminated 
dendron gives the corresponding dimer.  In the second and fourth column substitution by three hydrazine 
terminated dendrons with cyanuric chloride results in the corresponding trimer. 
Scheme 4.4.  Structural similarities between arylhydrazides and hydrazine linked triazines.  The 
similarities may explain the dendrimers susceptibility to degradation under oxidative conditions. 
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4.4 Conclusions  
 The construction of the dendrons 1-6 proceeded rapidly and in high yields, with 
purification using recrystallization or precipitation and washing with methanol.  Efforts to 
construct larger dendrimers were frustrated by incomplete reactions.  Mass spectral analysis of 
the crude reactions identified peaks corresponding to the desired products, but the reactions 
could not be forced to completion.  However, the synthesis of generation 1 dendrons was 
realized.  Efforts to form dendrimers using the bifunctional linker piperazine, and dimerizing the 
monochlorotriazines met with some success but the reactions remain to be optimized and the 
products fully characterized. 
 These materials exhibited several unique properties which are not fully understood.  The 
series of molecule exhibits an interesting solubility trend in organic solvents as described above.  
The series of dendrons and dendrimers turn various colors including green, purple, yellow and 
red upon addition of a strong base such as sodium methoxide to a solution in which they are 
dissolved.  Attempts to remove a slight yellow color from a solution of 8 using activated 
charcoal resulted in an increase in the intensity of the color.  Mass spectral analysis of the 
corresponding sample revealed the appearance of a species containing two less protons than the 
original sample, presumably from the oxidation of the hydrazine.  This hypothesis is not entirely 
unreasonable as activated charcoal results in the oxidation of hydrogen sulfide gas upon its 
adsorption.226  Metal complexation by these materials was investigated, and mass spectral 
analysis of 8, incubated with FeCl3 reveals a product corresponding to 8 plus several iron 
species.   
 Initial attempts to get NMR spectra of the samples resulted in the immediate production 
of a deep yellow colored solution upon addition of CDCl3.  It was discovered the deuterated 
solvent was rather old and chloroform is known to decompose over time, producing phosgene.  
Newer samples of CDCl3 did not result in the yellow solution and the samples remained clear 
and colorless.  
 The C:N ratio of the dendrons can be decreased, meaning a higher N content, through 
replacement of the surface piperidines with molecules containing less carbon or more nitrogen 
(Figure 4.1).  Phenylhydrazine has been attached to the triazine (11) as well as BOC-hydrazine 
(12), but these molecules have not been incorporated into higher dendrons or dendrimers. 
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 The synthesis of melamine dendrons containing the hydrazine linker is efficient, 
producing dendrons in good yield on a multi-gram scale.  The efficiency of the reaction sequence 
is aided by the trivial purification of these materials using recrystallization or precipitation, 
resulting in a variety of dendron building blocks with interesting, but as of yet not understood 
properties. 
 
4.5 Experimental: Preparation and Characterization 
 Solvents used were of reagent grade.  THF was stored over 4Å molecular sieves.  
Piperidine (Advanced Chemtech), cyanuric chloride (Acros), hydrazine (anhydrous), and 
piperazine (Aldrich) were used as received from suppliers.  Reactions conducted at elevated 
temperature were contained in a pressure flask (Chemglass).  
 NMR spectra were obtained from the use of a Varian Mercury 300 MHz  
spectrophotometer.  1H and 13C NMR chemical shifts are reported as δ (ppm = parts per million) 
relative to the residual solvent peak appearing from the deuterated solvent used.  Thin-layer 
chromatography (TLC) was performed using EMD silica gel 60 F254 pre-coated plates (0.25 
mm). Flash chromatography was performed using EMD silica gel 60 (0.040 mm particle size). 
All compounds were judged pure by TLC analysis (single spot/ two solvent systems) using a UV 
lamp and/or ninhydrin staining.  All mass spectral analyses were carried out by the Laboratory 
for Biological Mass Spectrometry (LBMS) at Texas A&M. 
Caution:  Hydrazine is a known carcinogen and care should be taken in handling it.  It is 
recommended that glassware and equipment which come in contact with it be rinsed with a 
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Figure 4.1.  The C:N ratio of various substituted triazines.  The ratio can be decreased by the incorporation 
of phenyl hydrazine at the surface (11), or the BOC-protected hydrazine (12).  Removal of the BOC groups 
reveals the known compound 13.  The C:N ratio between molecules is compared to the theoretical carbon 
nitride species (C3N4, far right) with a C:N ratio of 0.75.    
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bleach solution.  This procedure oxidizes the hydrazine to N2, but care should be exercised as the 
reaction can rapidly evolve gas.  
 
 
 
 
 
 
2-Chloro-4,6-di(piperidin-1-yl)-1,3,5-triazine (Intermediate 1).  Cyanuric chloride (56.0 g, 304 
mmol) was dissolved in 500 mL of THF.  The flask was cooled is a dry ice/acetone bath.  
Piperidine (60 mL, 608 mmol) was mixed with Hunig’s base (DIEA, diisopropylethylamine), 
(110 mL, 634 mmol) and added slowing over five minutes to the cooled solution of cyanuric 
chloride while stirring vigorously.  A white ppt. formed immediately.  After complete addition of 
the piperidine/DIEA 40 mL of methanol was added.  The solution was removed from the dry 
ice/acetone bath and stirred for an additional 6 h.  The salts formed during the reaction were 
removed by filtration and washed with THF.  The solvent was removed by reduce-pressure 
rotary evaporation.  The crude product was dissolved in a minimal amount of hot methanol.  The 
solution slowly cooled to room temperature and then placed in a refrigerator for overnight.  The 
solid was collected as a white crystalline solid (78.5 g, 92% yield). 
 1H NMR (300 MHz, CDCl3, δ):  3.70 (m, 8H), 1.62 (m, 4H), 1.55 (m, 8H); 13C NMR (75 
MHz, CDCl3, δ):  169.35, 163.99, 44.31, 25.57, 24.55; MS (ESI-TOF) exact mass calcd for 
C13H20ClN5 = 281.14; found 282.15 [M+H]+. 
 
 
 
 
 
 
1-(4,6-Di(piperidin-1-yl)-1,3,5-triazin-2-yl)hydrazine (Intermediate 2).  In 50 mL of THF in a 
pressure flask was dissolved 1 (10.0 g, 35.5 mmol).  Anhydrous hydrazine (4.5 mL, 143 mmol) 
was added to the solution and the pressure flask was sealed.  The solution was heated in an oil 
bath at 80 °C for 8 h.  Upon cooling two layers formed, with the bottom layer primarily 
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composed of hydrazine.  The bottom layer was removed with a pipette, and the remaining 
solution was transferred to a round bottom flask.  The solvent was removed by reduced-pressure 
rotary evaporation.  The crude product was dissolved in hot methanol and slowly cooled to room 
temperature, following by placing the flask in a refrigerator for several hours, providing a white 
ppt.  The product was isolated as a white powder (9.45 grams, 96%).   
 1H NMR (300 MHz, CDCl3, δ):  6.20 (s, 1H, NH), 3.91 (s, 2H, NH), 3.70 (m, 8H), 1.60 
(m, 4H), 1.53 (m, 8H); 13C NMR (75 MHz, CDCl3, δ):  168,89, 164.70, 43.92, 25.69, 24.83; MS 
(ESI-TOF) exact mass calcd for C13H23N7 = 277.20; found 278.20 [M+H]+. 
 
 
 
 
 
 
 
Dendron 3.  In 200 mL of THF was dissolved intermediate 2 (12.0 g, 43.3 mmol).  The solution 
was cooled in an ice bath.  Cyanuric chloride (4.00 g, 21.7 mmol) was added to the solution, 
followed by addition of DIEA (15.0 mL, 86.8 mmol).  The reaction was warmed to room 
temperature and stirred for 18 h.  The solvent was removed by reduced-pressure rotary 
evaporation, followed by addition of ~50 mL of hot methanol to the clear tar-like material.  The 
solution was sonicated, and the appearance of a white ppt became evident.  After the tar-like 
material gave way to a white ppt, the solution was again heated, and the product isolated as a 
white powder by hot filtration (13.8 g, 96%). 
 1H NMR (300 MHz, CDCl3, δ):  3.66 (m, 16H), 1.61 (m, 8H), 1.51 (br, 16H); 13C NMR 
(75 MHz, CDCl3, δ):  167.41, 165.93, 164.43, 44.10, 25.73, 24.87; 1H NMR (300 MHz, DMSO-
d6, δ):  9.47-9.30 (m, 2H, NH), 8.69-8.63 (m, 2H, NH), 3.64-3.57 (m, 16H), 1.55 (br s, 8H), 1.43 
(br s, 16H); 13C NMR (75 MHz, DMSO-d6, δ):  169.84, 168.67, 168.34, 167.81, 167.77, 167.26, 
167.07, 166.97, 166.73, 164.80-164.20, 43.44, 25.41, 24.46; MS (ESI-TOF) exact mass calcd for 
C29H44ClN17 = 665.37; found 666.37 [M+H]+, 333.69 [M+2H]2+. 
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Dendron 4.  In a pressure flask was placed dendron 3 (10.0 g, 15.1 mmol) and 200 ml of THF.  
To the suspension was added hydrazine (2.5 mL, 76.6 mmol), the reaction sealed and heated in 
an oil bath at 80 °C for 24 h.  Upon cooling two layers formed, the bottom primarily containing 
hydrazine, which was removed by pipette.  The solution was transferred to a round bottom flask 
and the solvent removed by reduced-pressure rotary evaporation.  The reaction was purified by 
washing the residue in hot methanol, and collecting the white powder after the solution cooled 
(8.24 g, 83%).  This product was also synthesized in a one pot sequence beginning with 
intermediate 2 (4.00 g, 14.4 mmol) and reaction with ½ equivalent of cyanuric chloride (1.33 g, 
7.20 mmol) with DIEA (3 mL, 17.3 mmol).  Upon completion of the reaction as visualized by 
TLC excess hydrazine was added and the reaction heated at 105 °C for 12 h.  The product was 
isolated by filtration of the solution and washing the ppt with methanol, THF, and H2O (3.87 g, 
81%). 
 1H NMR (300 MHz, DMSO-d6, δ):  8.40-8.20 (br, 4H, NH), 8.05-7.95 (br, 1H, NH), 
4.05 (br, 2H, NH), 3.61 (br s, 16H), 1.55 (br s, 8H), 1.41 (br s, 16H); 13C NMR (75 MHz, 
DMSO-d6, δ):  167.83, 167.64, 167.36, 164.62, 164.38, 43.38, 25.40, 24.44; MS (ESI-TOF) 
exact mass calcd for C29H47N19 = 661.43; found 662.40 [M+H]+, 331.72  [M+2H]2+. 
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Dendron 5.  In a round bottom flask with 100 mL of THF was added dendron 4 (6.00 g, 9.07 
mmol).  The solution was cooled in an ice bath and cyanuric chloride (836 mg, 5.43 mmol) was 
added to the solution, followed by slow addition of DIEA (3 mL, 17.3 mmol).  The reaction 
slowly warmed to room temperature and then heated at 40 °C for 24 h.  The solvent was 
removed by reduced-pressure rotary evaporation.  Methanol and a small amount of water was 
added to the crude mixture, the vessel was heated, and the product was isolated as a white 
powder after filtration of the cooled solution (6.18 g, 95%) 
 1H NMR (300 MHz, DMSO-d6, δ):  10.00-8.00 (m, 12H, NH), 3.61(br s, 32H), 1.55 (br 
s, 16H), 1.41 (br s, 32H); 13C NMR (75 MHz, DMSO-d6, δ):  = 168.83, 168.40, 168.11, 167.64, 
167.30, 164.64, 164.37, 43.40, 25.45, 24.48; MS (MALDI-TOF) exact mass calcd for 
C61H92ClN41 = 1433.81; found 1434.62 [M+H]+. 
 
 
 
 
 
 
 
 
 
Dendron 6.  In a pressure flask was placed dendron 5 (4.00 g, 27.9 mmol) with 50 mL of THF.  
Anhydrous hydrazine (0.44 mL, 13.9 mmol) was added to the solution and the vessel was sealed.  
The reaction was heated at 80 °C for 24 h.  Methanol and H2O were added to the reaction and the 
product precipitated.  The white powder was collected by filtration and dried.  (3.83, 96%) 
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 1H NMR (300 MHz, DMSO-d6, δ):  9.00-8.00 (m, 13H, NH), 4.00 (br s, 2H, NH), 3.61 
(br s, 32H), 1.55 (br s, 16H), 1.41 (br s, 32H); 13C NMR (75 MHz, DMSO-d6, δ):  168.02, 
167.32, 164.60, 164.35, 43.40, 25.45, 24.48; MS (MALDI-TOF) exact mass calcd for C61H95N43 
= 1429.88; found 1430.76 [M+H]+. 
 
 
 
 
 
 
 
Dendrimer 7 (G1-dimer).  Intermediate 1 (1.00 g, 3.61 mmol) and intermediate 2 (1.02 g, 3.62)  
were dissolved in 30 mL of THF in a pressure flask.  The vessel was closed and heated in an oil 
bath at 105 °C for 36 h.  The solution was cooled to room temperature before opening the flask, 
and then transferred to a round bottom flask.  The solvent was removed by reduced-pressure 
rotary evaporation.  To purify the crude reaction a recrystallization from hot methanol was 
attempted.  A large portion of the material would not dissolve in the hot methanol, and this was 
collected by conducting a hot filtration.  The white powder collected was the desired product, 
showing a single [M+H]+ peak by ESI-TOF mass spectral analysis and a single spot by TLC 
(1.24 g, 66%). 
 1H NMR (300 MHz, CDCl3, δ):  6.73 (s, 1H, NH) 3.68 (m, 8H), 1.61 (m, 4H), 1.51 (m, 
8H); 13C NMR (75 MHz, CDCl3, δ):  167.98, 164.94, 44.08, 25.71, 24.92; MS (ESI-TOF) exact 
mass calcd for C26H42N12 = 522.37; found 523.37 [M+H]+. 
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Dendrimer 8 (G1-trimer).  Intermediate 1 (1.50 g, 5.41 mmol) was dissolved in 30 mL THF in  
a pressure flask.  The solution was cooled in an ice bath, followed by addition of cyanuric 
chloride (332 mg, 1.80 mmol) and DIEA (1 mL, 5.75 mmol), and then sealed.  The flask was 
removed from the ice bath and warmed to room temperature while stirring.  The flask was then 
heated in an oil bath at 105 °C for 36 h. The solution was cooled to room temperature before 
opening the flask, and then transferred to a round bottom flask.  The solvent was removed by 
reduced-pressure rotary evaporation.  Hot methanol was added to the crude mixture (~30 mL), 
and some material dissolved.  A hot filtration of the solution resulted in the isolation of a white 
powder, which was the desired product (854 mg, 52%). 
1H NMR (300 MHz, CDCl3, δ):  8.00-7.40 (m, 4H, NH), 3.61 (br, 24H), 1.55 (br, 12H), 1.46 (br, 
24H); 13C NMR (75 MHz, CDCl3, δ):  169-167, 165.00, 44.26, 26.00, 25.24; MS (ESI-TOF) 
exact mass calcd for C42H66N24 = 906.59; found 907.59 [M+H]+, 454.30 [M+2H]2+.
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CHAPTER V 
 
MELAMINE DENDRIMERS FOR BIOCHEMICAL INVESTIGATIONS 
 
5.1 Introduction 
 Applications of dendrimers in the field of drug delivery are pursued with the hopes of 
identifying novel macromolecular constructs for the site-specific delivery of therapeutically 
relevant drugs.  Synthetic polymers are currently being pursued as drug delivery vehicles and 
polyethylene glycols (PEGs) have found extensive use as solubilizing and protein modification 
reagents.227  The appending of PEGs to the surface of a protein increases its circulation time 
through reduction of proteolytic susceptibility. 
 For a protein of interest to function as an effective therapeutic agent a balance needs to 
be struck among specificity, potency, and pharmacokinetic parameters.  Glycoproteins are 
notorious for occurring in multiple glycoforms, and the heterogeneity translates into variable 
pharmacokinetic properties when administered.228  Efforts to design polymer-protein constructs 
have resulted in the synthesis of macromolecules of defined covalent structure.  Monodisperse 
polymers have been attached to monodisperse chemically synthesized therapeutically relevant 
proteins.229    
 Dendrimer chemistry has the goal of producing monomolecular compounds, but the 
endeavor tends to be labor intensive.  While advances in methods to speed the synthesis of 
dendrimers have appeared (Chapter II) considerable effort is still expended in the construction of 
large constructs.  Applicability of dendrimers as drug delivery vehicles relies on construction of 
molecules exceeding ~40kDa to take advantage of the enhanced-permeability-retention (EPR) 
effect.230 The EPR effect stems from the ill developed vasculature and lymphatic system 
supplying a rapidly growing tumor.  The vessels supplying the tumor tend to be leaky, allowing 
the passage of large molecules through the vascular walls.  The lymphatic system is under 
developed, and as such large molecules tend to pool in tumors, as routes for their removal are 
limited.  Efforts to construct dendrimers large enough to take advantage of the EPR effect have 
relied on the attachment of large PEG groups to a smaller dendrimer.231  The attachment of 
polydisperse PEGs to a dendrimer negates the monomolecular nature of the dendrimer.  
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 A novel and efficient method for the rapid construction of macromolecular assemblies 
which exceed the minimum threshold for EPR was designed, capitalizing on the synthesis of 
multifunctional dendrimers with chemoselective reactivity and specific protein ligand 
interactions. 
 
5.2 Rationale 
 For rapid access to macromolecules of large molecular mass nature was utilized to 
synthesize the major portion of the construct.  Strepavidin is a homotetrameric protein of 60 kDa 
which shows a remarkably high affinity for biotin of 1014 M-1.  Strepavidin can bind up to four 
biotins, which also serve to stabilize the tetramer.  A dendrimer-peptide-biotin conjugate was 
constructed for the biotin mediated assembly of a protein-dendrimer hybrid.  The protein 
provides the molecular weight while the dendron provides the opportunity to affix molecules of 
interest, such as a florescent label or drug. 
 The project was conducted in collaboration with Ms. Megan McLean of the Simanek 
research group, who synthesized a TAT peptide sequence on the solid support containing a 
biotin at the C-terminus and an isonipecotic (INP) acid located at the N-terminus.  The TAT 
sequence is an arginine-rich protein transduction domain (PTD) derived from HIV-1.  TAT 
sequences show great efficacy in facilitating cellular uptake of attached cargos; for example 
antibodies,232 polymers,233 nanoparticles,234 and proteins235 all exhibit increased cellular uptake 
with a pendant TAT peptide.  The C-terminal biotin was included for the molecular recognition 
and assembly of the construct around the strepavidin core.  Isonipecotic acid, containing a 
nucleophilic secondary amine, was incorporated for attachment to a melamine dendrimer 
containing a monochlorotriazine.207  The resulting construct (Figure 5.1), termed a megamer-
biotin-stepavidin (MBS) dendrimer hybrid, results in a monomolecular protein-biotin-peptide-
dendrimer construct. 
Figure 5.1.  Schematic representation of the MBS dendrimer hybrid.  Picture modified and used with 
the permission of Megan McLean. 
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 The dendrimer was rapidly synthesized, presenting a single fluorescent tag, a protected 
hydroxyl for attachment of a molecule of interest, as well as four BOC-protected amines.  The 
dendron also contained a monochlorotriazine used in the coupling of the dendron to the INP 
terminated peptide.    
 
5.3 Materials and Methods 
 Using heterofunctional building blocks readily accessible through a convergent 
approach, the G2 dendron 1 containing a free hydroxyl group, a tert-butyldiphenylsilyl (TBDPS) 
protected alcohol and four BOC-protected amines was constructed.  The synthesis of 1 started 
with the addition of a G1 triazine monomer containing a free primary amine, a TBDPS protected 
alcohol, and two BOC-protected amines (intermediate 7, Chapter III) to a solution containing 
one equivalent of cyanuric chloride at 0 °C.  The reaction was monitored by TLC, and following 
consumption of the starting material one equivalent of the second G1 dendron containing a free 
primary amine, a free alcohol and two BOC-protected amines (intermediate 6, Chapter III) was 
added at room temperature.  The resulting monochlorotriazine, 1, was isolated using silica gel 
chromatography. 
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Scheme 5.1.  Synthesis of dendron-Oregon green construct.  a) p-nitrophenylchloroformate, DMAP, TEA, 
THF, rt, 90 m; OGC, pyridine, DMF, rt, 4h .  DMAP = 4-dimethylaminopyridine; TEA = triethylamine; 
OGC = Oregon green 488 cadaverine from Molecular Probes #O-10465. 
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 Reaction of the free alcohol of 3 with p-nitrophenylchloroformate gave the activated 
carbonate intermediate 4 (Scheme 5.1).  Intermediate 4 was coupled to the fluorescent 
fluoresceine analog Oregon Green, containing a cadaverine amine linker.  The resulting 
fluorescent labeled dendrimer was purified using silica gel chromatography and isolated in 89% 
yield, giving 19.0 mg of material. 
 Attachment of dendron 3 to the INP terminated peptide constructed on the solid support 
through substitution of the monochlorotriazine using the free secondary amine was accomplished 
and the products characterized by Ms. McLean.  Further characterization and studies surrounding 
the assembly of the MBS dendrimer hybrid were conducted by Ms. McLean also. 
 
5.4 Conclusions 
 Tailored dendrimers offer potential tools for investigation in biological chemistry.  The 
incorporation of multiple functional groups at the terminal position of dendrimers provide sites 
for the incorporation of various molecules for studies of interest.  
 
5.5 Experimental: Preparation and Characterization 
 
 
 
 
Dendron 1.  In a round bottom flask with 40 mL of THF was placed intermediate 4 (4.45 g, 5.15 
mmol).  The solution was cooled in an ice bath, and while stirring cyanuric chloride (950 mg, 
5.15 mmol) was added followed by addition of Hunig’s base (DIEA, diisopropylethylamine) (2.5 
mL, 14.4 mmol).  The solution was stirred and warmed to room temperature over 4 h.  
Intermediate 5 (3.22, 5.15 mmol) was added to the solution and left at room temperature for 24 
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h.  The solvent was removed by reduced-pressure rotary evaporation, and the residue purified by 
silica gel chromatography using 8:2 EtOAc:Hexanes to 100% EtOAc as the eluant.  The product 
was a white foam upon drying  (8.28 g, 89%). 
 1H NMR (300 MHz, CDCl3, δ):  7.53 (m, 4H), 7.24 (m, 6H), 4.56 (br, 4H), 3.67 (m, 
2H), 3.57 (m, 2H), 3.50-3.30 (br m, 18H), 3.18 (m, 4H), 2.91 (br, 8H), 2.62.70-2.60 (br m, 4H), 
1.75-1.50 (br m, 13H), 1.29 (s, 36H), 1.08 (m, 4H), 0.91 (s, 9H); 13C NMR (75 MHz, CDCl3, δ):  
167.19, 165.40, 164.93, 164.06, 155.93, 135.04, 133.01, 129.16, 127.17, 78.75, 71.83, 69.74, 
63.01, 60.91, 46.01, 42.81, 42.11, 40.07, 36.95, 36.42, 29.32, 28.07, 27.41, 26.44, 18.83; MS 
(ESI-TOF) exact mass calcd for C77H126ClN21O12Si = 1599.94; found 1600.93 [M+H]+, 800.98  
[M+2H]2+. 
 
 
 
 
 
 
 
 
 
 
Dendron 2.  In a round bottom flask with 10 mL THF dendron 1 (400 mg, 0.250 mmol) was 
dissolved.  In a vial p-nitrophenylchloroformate (p-NPCF) (75.5 mg, 0.375 mmol) was added 
followed by 5 mL of THF, followed by addition of 0.1 mL of triethylamine (0.717 mmol).  The 
solution containing the p-NPCF was transferred to the flask containing dendron 1.  The solution 
was stirred at room temperature for 1 h.  The solvent was removed by reduced-pressure rotary 
evaporation, and the crude product purified by silica gel chromatography using 8:2 
EtOAc:Hexanes → 100% EtOAc as the eluant.  The product was a white foam upon drying (331 
mg, 75%). 
 13C NMR (75 MHz, CDCl3, δ):  168.56, 166.16, 156.23, 152.71, 135.81, 133.84, 129.85, 
127.88, 126.36, 125.54, 122.01, 115.88, 79.25, 72.49, 70.34, 68.61, 63.61, 46.65, 43.27, 42.46, 
40.86, 37.09, 30.06, 28.73, 28.03, 27.05, 19.41; MS (MALDI-TOF) exact mass calcd for 
C84H129ClN22O16Si = 1764.94; found 1766.53 [M+H]+. 
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Dendron 3.  In a round bottom flask dendron 2 (35.6 mg, .0202 mmol) was dissolved in 1 mL 
DMF.  Oregon Green (5.0 mg, .0101 mmol) was taken up in 1.5 mL of DMF and added to the 
solution of 2.  Four drops of pyridine were added to the solution and left to stir in the dark under 
a blanket of nitrogen.  The solvent was removed by passing a stream of dry nitrogen over the 
solution.  The residue was dissolved in DCM and then dried under vacuum (2X).  The crude 
material was purified by silica gel chromatography giving an orange solid (19.0 mg, 89%). 
 MS (MALDI-TOF) average mass calcd for C104H146ClF2N23O19Si = 2124.00; found 
2125.20 [M+H]+. 
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CHAPTER VI 
 
CONCLUSION 
 
 Tremendous advances have occurred in the field of polymer science in the last century.  
It has developed from an ill defined industrial pursuit to a well defined scientific discipline.  The 
development of dendrimer chemistry was a natural extension in polymer chemist’s pursuit of 
novel architectures and novel materials.  Currently minimal applications for dendrimers exist, 
however the field has remained vibrant since its inception through the conduction of basic 
research into the novel properties of dendrimers.  Dendrimers are a solution looking for a 
problem. 
 Melamine dendrimers fit a unique niche in the dendrimer spectrum.  While their utility 
remains to be demonstrated, along with other types of dendrimers in the field, current 
possibilities for their application exist.  However, the most important information gleaned from 
these studies relates to the identification methods for access to highly functionalized materials. 
 Examples describing control over the composition of the interior linkage groups of 
melamine dendrimers were discussed in Chapter I.  Multiple unique linking groups were 
incorporated in an efficient manner.  The construction of a dendrimer through the convergent 
approach with multiple reactions conducted in a single pot demonstrates the ability to access 
designed dendrimers.  Latent functionality is left unprotected through the entire dendrimer 
synthesis, providing the possibility for further post-synthetic functionalization of the material.  
There was no need for functional group interconversions, all the functionality necessary for the 
dendrimer construction is present using cyanuric chloride and the selected amine.  Cyanuric 
chloride as a tri-electrophilic core provides controlled substitution at each position in a 
temperature dependent manner.  Monochlorotriazines show chemoselective reactivity with 
amine nucleophiles, with secondary amines being much more reactive than primary and primary 
amines more reactive than benzylic and aromatic amines respectively.   
 Examples were described using methods to construct dendrimers containing multiple 
surface functionalities.  The incorporation of multiple functional groups at the dendrimer 
periphery provides a macromolecular scaffold for the attachment of molecules of interest.  The 
ability to tailor the functionality at the terminal groups offers opportunities to post-synthetically 
modify the dendrimers to produce a library of materials for a desired application or study.  The 
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incorporation of such a scaffold on a sold support would greatly accelerate the steps required for 
post-synthetic manipulation of the terminal groups, providing a more rapid route to access 
multifunctional dendrimers.   
 Combination of the techniques employed in Chapters I and II could be combined to 
produce a dendrimer with unique functionality located at each branch point and at each surface 
group.  The methods would be amendable to the construction of a macromolecule where the 
exact atomic connectivity is known, and the compound is truly monomolecular.  The 
imagination could lead one to see the analogy between such dendrimers and proteins.  The 
functional groups of proteins are located with precise atomic connectivity, with multiple 
functional groups per protein, the amide linkage being the common building block.  Proteins, 
through intramolecular interactions, fold to adopt a well defined structure often of a globular 
nature.  In a melamine dendrimer multiple functionality can be placed within the dendrimer 
interior and at the surface with precise atomic placement, the common structural element being 
the triazine ring.  Dendrimers of large enough generations also tend to assume a globular 
structure.  While melamine dendrimers are a long way from offering such a fanciful or functional 
material as proteins now do, they offer a fertile field for the imagination to wander and ponder 
on such potential structures. 
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TRIAZINE DENDRIMER SYNTHESES 
Group Size‡ Method of Synthesis Triazine location C/D
† Journal/Patent Date submitted Page # 
Niederhauser D2 Cycloaddition/cyanoethylation Branching D Patent1 Jan. 18, 1950 118 
Maciejewski D2 Cycloaddition/cyanoethylation Branching D Patent2 Aug. 31, 1994 118 
Keana D2 Cl displacement of CC by aryl N Branching D Patent3 Sept. 29, 1994 119 
Bauer G1 Cl displacement of CC by amines Branching C/D Patent4 Aug. 8, 1995 119-120 
Gluzman G1 Cl displacement of CC by aryl N Branching C/D Patent5 Jan. 27, 1997 120 
Fréchet G4, D4 Cl displacement of CC/cyclization of biuret Core C Poly Mat. Sci. Eng.
6 1997 121 
Kraus G1 Cl displacement of CC by alkyoxy/silyloxy Branching C J. Org. Chem.
7 Feb. 10, 1998 122 
Ellestad G1 Cl displacement of CC by aryl N Branching C/D J. Med. Chem..8   Apr. 20, 1998 120 
Maciejewski D2 Cycloaddition/cyanoethylation Branching D J. Macromol. Sci., Pure Appl. Chem.9 June 24, 1999 118 
Burn G1 Cl displacement of CC by alkyl/ aryl O Branching C J. Mater. Chem.
10 Nov. 5, 1999 122 
Simanek G3 Cl displacement of CC by alkyl/ aryl N Branching C/D Org. Lett.
11 Jan. 26, 2000 123 
Takagi G2,D3 Cl displacement of CC by aryl N Branching/ core C Kobunshi Ronbunshu
12 Mar. 22, 2000 123 
Takagi G2 Cl displacement of CC by aryl N/aryl O/N 
Branching/ 
core C/D 
J. Polym. Sci., Part A: 
Polym. Chem.13 Apr. 20, 2000 125 
Neuman- 
Rodekirch G1 
Phenol displacement of TPOT by 
alkyl N 
Branching/ 
core D Proc. ECSOC-4
14 Aug. 30, 2000 126 
Marsh D2* Cl displacement of CC by alkyl O/N Branching D Tetrahedron. Lett.15 Sept. 6, 2000 127 
Simanek G3 Cl displacement of CC by amines Branching C J. Am. Chem. Soc.16 Dec. 1, 2000 128 
Dehaen G2 Cl displacement of CC by aryl O Core  C J. Org. Chem.
17 Dec. 15, 2000 129 
Simanek D5 Cl displacement of CC by amines Branching/ FP C Tetrahedron. Lett.
18 Mar. 30, 2001 123 
 
‡  Generation of dendrimer (G#) or dendron (D#). 
†  Convergent or divergent route. 
*  Synthesis conducted on a solid support 
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Dehaen G2, D3 Grignard/Cl displacement by aryl O Branching/ Core C Mater. Sci. Eng., C
19 Nov. 7, 2001∇ 130 
Gamez G1 Cl displacement of CC by aryl O/N Branching/ core C Tetrahedron. Lett.
20 May 31, 2002 131 
Simanek G3 Cl displacement of CC by amines Branching C Macromolecules21 July 12, 2002 132 
Simanek G4 Cl displacement of CC by amines Branching C J. Am. Chem. Soc.22 Aug. 15, 2002 133-134 
Su D4* Cl displacement of CC by amines Branching D Anal. Lett.23 Sept. 6, 2002 135 
Simanek D3 Cl displacement of CC by amines Branching C Bioconjugate Chem.24 Sept. 25, 2002 136 
Simanek G3 Cl displacement of CC by amines Branching/ core C 
Supramolecular 
Chemistry25 Nov. 2, 2002 137 
Simanek G3 Cl displacement of CC by amines Branching C Org. Lett.26 Jan. 28, 2003 138 
Bradley D3* Cl displacement of CC by aryl O Surface D Tetrahedron27 Feb. 7, 2003 139 
Gamez/ 
Reedijk G1 Cl displacement of CC by amines 
Branching/ 
core C Inorg. Chim. Acta
28 Feb. 26, 2003 131 
Simanek G3, D3 Cl displacement of CC by amines Branching C Org. Lett.29 Jan. 28, 2003 140 
Simanek D3 Cl displacement of CC by amines Branching C Chem. Mater.30 Feb. 19, 2003 141 
        
OTHER ‘SUGGESTED’ TRIAZINE DENDRIMERS 
Meijer G0 Cyanoethylation/reduction Core  Patent31 Mar. 10, 1994 142 
Tanaka H§ Grignard Branching/ core  Patent
32 May 9, 1996 142 
Viswanathan G0 Cl displacement of CC by aryl N Core  Polym. Prepr. 33 1997 143 
Sanders G1 Ligand chelation to Ru Core  New J. Chem.34 Jan. 11, 1999 142 
Fleet G1 Cl displacement of CC by amines/aryl O Core  Patent
35 Mar. 12, 1999 142 
Constable/ 
Housecroft G0 
Cyclotrimerization/Stille coupling to 
CC Core  Inorg. Chim. Acta
36 Aug. 23, 1999 143 
Balogh-Nair G0 Cl displacement of CC by aryl O Core  Int. J. Mol. Sci.37 June 7, 2002 143 
‡  Generation of dendrimer (G#) or dendron (D#). 
†  Convergent or divergent route. 
*  Synthesis conducted on a solid support 
∇ Date Published 
§ Hyperbranched 
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Group Size Method of Synthesis Triazine location C/D Journal/Patent Date submitted 
Niederhauser D2 Cycloaddition/cyanoethylation Branching D Patent Jan. 18, 1950 
 Niederhauser, W. D.  Tetracyanoethyl benzoguanamine.  US 2577477, Jan. 18, 1950. 
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Maciejewski D2 Cycloaddition/cyanoethylation Branching D Patent Aug. 31, 1994 
Maciejewski D2 Cycloaddition/cyanoethylation Branching D J. Macromol. Sci., Pure Appl. Chem. June 24, 1999 
 Janiszewski, J.; Maciejewski, M. Method of Obtaining Dendritic Oligomers and Polymers Polish Patent 304,985, Aug. 8, 1994. 
 Maciejewski, M.; Bednarek, E.; Janiszewska, J.; Janiszewski, J.; Szczygiel, G.; Zapora, M.  Guanamine dendrimerization.  J. Macromol. Sci., Pure 
Appl. Chem.  2000, 37, 753-783. 
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Keana D2 Cl displacement of CC by aryl N Branching D Patent Sept. 29, 1994 
 Keana, J. F. W.; Martin, V.; Ralston, W. H.  Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core 
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Feb. 10, 1998 
 Kraus, G. A.; Louw, S. V.  Synthesis of the first phthalocyanine-containing dendrimer.  J. Org. Chem.  1998, 63, 7520-7521. 
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Burn G1 Cl displacement of CC by alkyl/ aryl O Branching C J. Mater. Chem. Nov. 5, 1999 
 Lupton, J. M.; Hemingway, L. R.; Samuel, I. D. W.; Burn, P. L. Eletroluminescence from a new distyrylbenzene based triazine dendrimer.  J. 
Mater. Chem.  2000, 10, 867-871. 
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Simanek G3 Cl displacement of CC by alkyl/ aryl N Branching C/D Org. Lett. Jan. 26, 2000 
Simanek D5 Cl displacement of CC by amines Branching/ FP C Tet. Lett. Mar. 30, 2001 
 Zhang, W.; Simanek, E. E.  Dendrimers based on melamine.  Divergent and orthogonal, convergent syntheses of a G3 dendrimer.  Org. Lett.  2000, 
2, 843-845. 
      ●Zhang, W.; Simanek, E. E.  Synthesis and characterization of higher generation dendrons based on melamine using p-aminobenzylamine.  
Evidence for molecular recognition of Cu(II).  Tet. Lett.  2001, 42, 5355-5357. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
N
N
Cl
Cl
Cl
BOCHN
NH2
BOCHN
N
H
BOCHN
N
H
N
N
N
Cl
NH2NH2
RHN
N
H
RHN
N
H
N
N
N
N
H
2
BOCHN
N
H
BOCHN
N
H
N
N
N
N
H
BOCHN
N
H
BOCHN
N
H
N
N
N
N
H
N
H
N
H
N
N
N
N
H
2
R = BOC
R = H
1
TFA
1
2
N
N
N
Cl
Cl
Cl
NH2NH2
NH2
NH2
BOCHN
N
H
BOCHN
N
H
N
N
N
N
H
NH2
BOCHN
N
H
BOCHN
N
H
N
N
N
N
H
BOCHN
N
H
BOCHN
N
H
N
N
N
N
H
N
H
N
H
N
N
N
Cl
C3N3Cl3
C3N3Cl3
1
2p-ABA
p-ABA
D2-p-ABA
D3-Cl
D1-p-ABA
D2-Cl
144 
 
Group Size Method of Synthesis Triazine location C/D Journal/Patent Date submitted 
Takagi G2,D3 Cl displacement of CC by aryl N Branching/ core C Kobunshi Ronbunshu Mar. 22, 2000 
 Takagi, K. Synthesis of triazine dendrimers.  Kobunshi Ronbunshu  2000, 57, 646-651. 
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Takagi G2 Cl displacement of CC by aryl N/aryl O/N 
Branching/ 
core C/D 
J. Polym. Sci., Part A: Polym. 
Chem. Apr. 20, 2000 
 Takagi, K,; Hattori, T.; Kunsada, H.; Yuki, Y.  Triazine dendrimers by divergent and convergent methods.  J. Polym. Sci., Part A: Polym. Chem.  
2000, 38, 4385-4395. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
H
NH
N N
NN
H
R
R R
R = NO2
R = NH2
SnCl2, HCl
EtOH
Cl
N
N
N
NH NH
NO2NO2
R = NO2
R = NH2
SnCl2, HCl
EtOH
N
N
N
NH NH
RR
NH
NN
NN
H
NH
R
R
NH
N
N
N
NH NH
RR
N
NN
NH
NH
NH
N
H
NH
N
N
N
N
H
NH
N
H
N
N
N
NH
N
H
NO2
NO2
N
H
N
N
N
N
H
NH
NO2
NO2
N
H
N
N
N
N
H
N
H
O2N
O2N
N
H
N
N
N
N
H
N
H
O2N
O2N
N
HN
N
N
N
H
N
H
O2N
O2N
N
H
N
N
N
NH
N
H
N
H
N
N
N
NH
N
H
N
N
N
N
N
N
N
H
NH
N
H
N
H
N
H
NH
NO2
NO2
1 1
N
N
N
Cl
Cl
Cl
OH NO2 O NO2
N
N
N
Cl
Cl
NH2
N
H
N
H
N
NN
O
N
H
N
H
N
H
R
N
N
N
N
H
N
H
N
NN
O
R = NO2
R = NH2
N
N
N
Cl
Cl
Cl
N
H
N
H
Cl
N
N
N
N
H
N
H
O R
N
N
N
OH NO2
Fe/FeSO4 R = NO2
R = NH2
Fe/FeSO4
1
1
146 
 
Group Size Method of Synthesis Triazine location C/D Journal/Patent Date submitted 
Neuman- 
Rodekirch G1 
Phenol displacement of TPOT by 
alkyl N 
Branching/ 
core D Proc. ECSOC-4 Aug. 30, 2000 
 Dreyer, C.; Blume, A.; Bauer, M.; Bauer, J.; Neumann-Rodekirch, J.  Triazine based dendrimers.  Proc. ECSOC-3, [and] Proc. ECSOC-4, 2000, 
1196-1213.  Chem. Abstr. 2000, 135, 153157. 
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Marsh D2 Cl displacement of CC by alkyl O/N Branching D Tetrahedron. Lett. Sept. 6, 2000 
 Marsh, A.; Carlisle, S. J.; Smith, S. C.  High-loading scavenger resins for combinatorial chemistry.  Tetrahedron Lett.  2001, 42, 493-496. 
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Simanek G3 Cl displacement of CC by amines Branching C J. Am. Chem. Soc. Dec. 1, 2000 
 Zhang, W.; Nowlan, D. T., III; Thomson, L. M.; Lackowski, W. M.; Simanek, E. E.  Orthogonal, convergent syntheses of dendrimers based on 
melamine with one or two unique surface sites for manipulation.  J. Am. Chem. Soc.  2001, 123, 8914-8922. 
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Dehaen G2 Cl displacement of CC by aryl O Core C J. Org. Chem. Dec. 15, 2000 
 Verheyde, B.; Dehaen, W.  Synthesis of dendrimers containing 1,3,4-oxadiazoles.  J. Org. Chem.  2001, 66, 4062-4064. 
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Dehaen G2, D3 Grignard/Cl displacement by aryl O Branching/ Core C Mater. Sci. Eng., C Nov. 7, 2001 
 Verheyde, B.; Maes, W.; Dehaen, W.  The use of 1,3,5-triazines in dendrimer synthesis.  Mater. Sci. Eng., C 2001, 18, 243-245. 
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Gamez G1 Cl displacement of CC by aryl O/N Branching/ core C Tetrahedron. Lett. May 31, 2002 
Gamez/Reedijk G1 Cl displacement of CC by amines Branching/ core C Inorg. Chim. Acta Feb. 26, 2003 
 de Hoog, P.; Gamez, P.; Driessen, W. L.; Reedijk, J.  New polydentate and polynucleating N-donor ligands from amines and 2,4,6-trichloro-1,3,5-
triazine.  Tehedron. Lett.  2002, 43, 6783-6786. 
      ●Gamez, P.; de Hoog, P.; Lutz, M.; Spek, A. L.; Reedijk, J.  Coordination compounds from 1,3,5-trazine-derived multi-directional ligands:  
application in oxidation catalysis.  Inorg. Chim. Acta  2003, 351, 319-325. 
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Simanek G3 Cl displacement of CC by amines Branching C Macromolecules July 12, 2002 
 Zhang, W.; Gonzalez, S. O.; Simanek, E. E.  Structure-activity relationships in dendrimers based on triazines:  Gelation depends on choice on 
linking and surface groups.  Macromolecules 2002, 35, 9015-9021. 
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Simanek G4 Cl displacement of CC by amines Branching C J. Am. Chem. Soc. Aug. 15, 2002 
 Zhang, W.; Tichey, S. E.; Pérez, L. M.; Maria, G. C.; Lindahl, P. A.; Simanek, E. E.  Evaluation of multivalent dendrimers based on melamine:  
Kinetics of thiol-disulfide exchange depends on the structure of the dendrimer.  J. Am. Chem. Soc.  2003, 125, 5086-5094. 
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Su D4 Cl displacement of CC by amines Branching D Anal. Lett. Sept. 6, 2002 
 Wu, X.; Liu, P.; Pu, Q.; Su, Z.  FAAS determination of platinum using an on-line separation and preconcentration system with a polymelamine 
dendrimer immobilized silica gel.  Anal. Lett.  2003, 36, 2229-2241. 
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Simanek D3 Cl displacement of CC by amines Branching C Bioconjugate Chem. Sept. 25, 2002 
 Bell, S. A.; McLean, M. E.; Oh, S.-K.; Tichy, S. E.; Zhang, W.; Corn, R. M.; Crooks, R. M.; Simanek, E. E.  Synthesis and characterization of 
covalently linked single-stranded DNA oligonucleotide-dendron conjugates.  Bioconjugate Chem.  2003, 14, 488-493. 
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Simanek G3 Cl displacement of CC by amines Branching/ core C Supramolecular Chemistry Nov. 2, 2002 
 Zhang, W.; Jiang, J.; Qin, C.; Pérez, L. M.; Parrish, A. R.; Safe, S. H.; Simanek, E. E. Triazine dendrimers for drug delivery:  Evaluation of 
solubilization properties, activity in cell culture, and in vivo toxicity of a candidate vehicle.  Supramolecular Chem.  2003, 15, 607-616. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
N
N
N
O
N
H
3
boc
N N
N
NH
N
H
O
NH
boc N
N
O
N
H
3
boc
N N
N
NH
N
H
O
NH
3
boc
N
N
N
N
N N
N
N
N
N
N
O
N
H
3
boc
NN
N
NH
N
H
O
NH
bocN
N
O
N
H3
boc
NN
N
NH
N
H
O
NH
3
boc
N
N
N
N
3
N N
N N
N N
O N
H
3 boc
N
N
N
N
H
N
H
O N
H
3
boc
N N
O N
H
3 boc
N
N
N
N
H
N
H
O N
H
3
boc
N
N
N
N N
N N
O N
H
3 boc
N
N
N
N
H
N
H
O N
H
3
boc
N N
O N
H
3 boc
N
N
N
N
H
N
H
O N
H
3
boc
N
N
N
N
N
N
N
NN
NN
NN
NN
ON
H
3boc
N
N
N
N
H
N
H
ON
H
3
boc
NN
ON
H
3boc
N
N
N
N
H
N
H
ON
H
3
boc
N
N
N
NN
NN
ON
H
3boc
N
N
N
N
H
N
H
ON
H
3
boc
NN
ON
H
3boc
N
N
N
N
H
N
H
ON
H
3
boc
N
N
N
N
N
N
N
N
N
N
N
N
NH
N
H
N
H
(From Bell et. al. Bioconjugate 
 Chem.   2003,  14,  488-493.) 
D3-Cl +
158 
 
Group Size Method of Synthesis Triazine location C/D Journal/Patent Date submitted 
Simanek G3 Cl displacement of CC by amines Branching C Org. Lett. Jan. 28, 2003 
 Umali, A. P.; Simanek, E. E.  Thiol-disulfide exchange yields multivalent dendrimers of melamine.  Org. Lett.  2003, 5, 1245-1247. 
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Bradley D3 Cl displacement of CC by aryl O Surface D Tetrahedron Feb. 7, 2003 
 Lebreton, S.; Newcombe, N.; Bradley, M.  Antibacterial single-bead screening.  Tetrahedron  2003, 59, 10213-10222. 
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Group Size Method of Synthesis Triazine location C/D Journal/Patent Date submitted 
Simanek G3, D3 Cl displacement of CC by amines Branching C Org. Lett. Jan. 28, 2003 
 Steffensen, M. B.; Simanek, E. E.  Chemoselective building blocks for dendrimers from relative reactivity data.  Org. Lett.  2003, 5, 2359-2361. 
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Group Size Method of Synthesis Triazine location C/D Journal/Patent Date submitted 
Simanek D3 Cl displacement of CC by amines Branching C Chem. Mater. Feb. 19, 2003 
 Acosta, E. J.; Deng, Y.; White, G. N.; Dixon, J. B.; McInnes, K. J.; Senseman, S. A.; Frantzen, A. S.; Simanek, E. E.  Dendritic surfactants show 
evidence for frustrated intercalation:  A new organoclay morphology.  Chem. Mater.  2003, 15, 2903-2909. 
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OTHER ‘SUGGESTED’ TRIAZINE DENDRIMERS 
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Nobel Prizes awarded for work involving natural and synthetic polymers 
2003 Peter Agre, Roderick MacKinnon "for discoveries concerning channels in cell membranes" "for the discovery of water channels" 
“for structural and mechanistic studies of ion 
channels" 
2002 John B. Fenn, Koichi Tanaka, Kurt Wüthrich 
"for their development of soft desorption ionisation 
methods for mass spectrometric analyses of biological 
macromolecules" 
"for his development of nuclear magnetic 
resonance spectroscopy for determining the three-
dimensional structure of biological 
macromolecules in solution" 
2000 Alan Heeger, Alan G. MacDiarmid, Hideki Shirakawa "for the discovery and development of conductive polymers" 
1997 Paul D. Boyer, John E. Walker, Jens C. Skou 
"for their elucidation of the enzymatic mechanism 
underlying the synthesis of adenosine triphosphate 
(ATP)" 
"for the first discovery of an ion-transporting 
enzyme, Na+, K+ -ATPase" 
1993 Kary B. Mullis, Michael Smith 
"for contributions to the developments of methods within 
DNA-based chemistry""for his invention of the 
polymerase chain reaction (PCR) method" 
"for his fundamental contributions to the 
establishment of oligonucleotide-based, site-
directed mutagenesis and its development for 
protein studies" 
1991 Richard R. Ernst "for his contributions to the development of the methodology of high resolution nuclear magnetic resonance (NMR) spectroscopy" 
1990 Elias James Corey "for his development of the theory and methodology of organic synthesis" 
1989 Sidney Altman, Thomas R. Cech "for their discovery of catalytic properties of RNA" 
1988 Johann Deisenhofer, Robert Huber, Hartmut Michel "for the determination of the three-dimensional structure of a photosynthetic reaction centre" 
1987 Donald J. Cram, Jean-Marie Lehn, Charles J. Pedersen "for their development and use of molecules with structure-specific interactions of high selectivity" 
1985 Herbert A. Hauptman, Jerome Karle "for their outstanding achievements in the development of direct methods for the determination of crystal structures" 
1984 Bruce Merrifield "for his development of methodology for chemical synthesis on a solid matrix" 
1982 Aaron Klug "for his development of crystallographic electron microscopy and his structural elucidation of biologically important nucleic acid-protein complexes" 
1980 Paul Berg, Walter Gilbert, Frederick Sanger 
“for his fundamental studies of the biochemistry of 
nucleic acids, with particular regard to recombinant-
DNA" 
"for their contributions concerning the 
determination of base sequences in nucleic acids" 
1974 Paul J. Flory "for his fundamental achievements, both theoretical and experimental, in the physical chemistry of the macromolecules" 
1972 Christian Anfinsen, Stanford Moore, William H. Stein 
"for his work on ribonuclease, especially concerning the 
connection between the amino acid sequence and the 
biologically active conformation" 
"for their contribution to the understanding of the 
connection between chemical structure and 
catalytic activity of the active centre of the 
ribonuclease molecule" 
1970 Luis Leloir "for his discovery of sugar nucleotides and their role in the biosynthesis of carbohydrates" 
1965 Robert B. Woodward "for his outstanding achievements in the art of organic synthesis" 
1964 Dorothy Crowfoot Hodgkin "for her determinations by X-ray techniques of the structures of important biochemical substances" 
1963 Karl Ziegler, Giulio Natta "for their discoveries in the field of the chemistry and technology of high polymers" 
1962 Francis Crick, James Watson, Maurice Wilkins "for their discoveries concerning the molecular structure of nucleic acids and its significance for information transfer in living material" 
1962 Max F. Perutz, John C. Kendrew 
 "for their studies of the structures of globular proteins" 
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       Dates in: red indicate awards given with a specific emphasis on polymers 
  blue are notable awards given for synthetic chemistry 
  orange are awards given for analytical techniques for the study of polymers 
 
 
 
 
 
 
 
1959 Severo Ochoa, Arthur Kornberg "for their discovery of the mechanisms in the biological synthesis of ribonucleic acid and deoxyribonucleic  acid" 
1958 Frederick Sanger "for his work on the structure of proteins, especially that of insulin" 
1957 Lord Todd "for his work on nucleotides and nucleotide co-enzymes" 
1955 Vincent du Vigneaud "for his work on biochemically important sulphur compounds, especially for the first synthesis of a polypeptide hormone" 
1954 Linus Pauling "for his research into the nature of the chemical bond and its application to the elucidation of the structure of complex substances" 
1953 Hermann Staudinger "for his discoveries in the field of macromolecular chemistry" 
1948 Arne Tiselius "for his research on electrophoresis and adsorption analysis, especially for his discoveries concerning the complex nature of the serum proteins" 
1946 James B. Sumner, John H. Northrop, Wendell M. Stanley "for his discovery that enzymes can be crystallized" "for their preparation of enzymes and virus proteins in a pure form" 
1926 The Svedberg "for his work on disperse systems" 
1913 Alfred Werner "in recognition of his work on the linkage of atoms in molecules by which he has thrown new light on earlier investigations and opened up new fields of research especially in inorganic chemistry" 
1902 Emil Fischer "in recognition of the extraordinary services he has rendered by his work on sugar and purine syntheses" 
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APPENDIX B 
 
SPECTRA RELEVANT TO CHAPTER II 
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Figure B.1a.  The 1H NMR spectrum of 2-Chloro-4,6-dimorpholino-1,3,5-triazine, 1 (300 MHz, CDCl3). 
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Figure B.1b.  The 13C NMR spectrum of 2-Chloro-4,6-dimorpholino-1,3,5-triazine, 1 (75 MHz, CDCl3). 
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Figure B.1c.  The ESI-TOF mass spectrum of 2-Chloro-4,6-dimorpholino-1,3,5-triazine, 1. 
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Figure B.2a.  The 1H NMR spectrum of intermediate 15.  (300 MHz, CD3OD) 
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Figure B.2b.  The 13C NMR spectrum of of intermediate 15.  (75 MHZ, CD3OD)  
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Figure B.2c.  The ESI-TOF mass spectrum of intermediate 15. 
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Figure B.3a.  The 1H NMR spectrum of intermediate 16.  (300 MHz, DMSO-d6) 
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Figure B.3b.  The 13C NMR spectrum of intermediate 16.  (125 MHz, DMSO-d6) 
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Figure B.3c.  The ESI-TOF mass spectrum of intermediate 16. 
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Figure B.4a.  The 1H NMR spectrum of dendron 17.  (500 MHz, DMSO-d6) 
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Figure B.4b.  The 13C NMR spectrum of dendron 17.  (125 MHz, DMSO-d6) 
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Figure B.4c.  The MALDI-TOF mass spectrum of dendron 16. 
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Figure B.5a.  The 1H NMR spectrum of tetraamine core 18.  (300 MHZ, CD3OD)  
 180 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
O
O
O
N
H
N
H
N
N
NN
N
N
N
N
N
N
N
N
N
N
NH2NH2
NH2NH2
 
Figure B.5b.  The 13C NMR spectrum of tetraamine core 18.  (300 MHz, CD3OD) 
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Figure B.5c.  The ESI-TOF mass spectrum of tetraamine core 18. 
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Figure B.6a.  The 1H NMR spectrum of intermediate 19.  (300 MHz, CD3OD) 
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Figure B.6b.  The 13C NMR spectrum of intermediate 19.  (300 MHz, CD3OD) 
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Figure B.6c.  The ESI-TOF mass spectrum of intermediate 19. 
 185 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
N N
N
N
N
H
N
H
O OH
O OH
N N
N
N
N
H
N
H
O OH
O OH
N
N NH
N
N
N
N
N NH
N
H
N
H
O
O
O
O
O N N
N
N
N
H
N
H
O OH
O OH
N N
N
N
N
H
N
H
O OH
O OH
N
N NH
N
N
N
N
N NH
O
O
 
Figure B.7a.  The 1H NMR spectrum of dendrimer 20.  (300 MHz, CD3OD) 
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Figure B.7b.  The 13C NMR spectrum of dendrimer 20.  (300 MHz, CD3OD). 
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Figure B.7c.  The MALDI-TOF mass spectrum of dendrimer 20. 
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APPENDIX C 
 
SPECTRA RELEVANT TO CHAPTER III 
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Figure C.1a.  The 1H NMR spectrum of bisBOCtriamaine, 2.  (300 MHz, CDCl3) 
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Figure C.1b.  The 13C NMR spectrum of bisBOCtriamaine, 2.  (75 MHz, CDCl3) 
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Figure C.1c.  The ESI-TOF mass spectrum of bisBOCtriamaine, 2. 
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Figure C.2a.  The 1H NMR spectrum of Free OH-Cl, 3.  (500 MHz, CDCl3) 
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Figure C.2b.  The 13C NMR spectrum of Free OH-Cl, 3.  (125 MHz, CDCl3) 
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Figure C.2c.  The ESI-TOF mass spectrum of Free OH-Cl, 3. 
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Figure C.3a.  The 1H NMR spectrum of TBDPS-Cl, 4.  (500 MHz, CDCl3) 
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Figure C.3b.  The 13C NMR spectrum of TBDPS-Cl, 4.  (125 MHz, CDCl3) 
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Figure C.3c.  The ESI-TOF mass spectrum of TBDPS-Cl, 4.
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Figure C.4a.  The 1H NMR spectrum of Lev-Cl, 5.  (500 MHz, CDCl3)
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Figure C.4b.  The 13C NMR spectrum of Lev-Cl, 5.  (125 MHz, CDCl3) 
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Figure C.4c.  The ESI-TOF mass spectrum of Lev-Cl, 5.  
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Figure C.5a.  The 1H NMR spectrum of Free OH-AMP, 6  (500 MHz, CDCl3) 
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Figure C.5b  The 13C NMR spectrum of Free OH-AMP, 6  (125 MHz, CDCl3) 
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Figure C.5c.  The ESI-TOF mass spectrum of Free OH-AMP, 6. 
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Figure C.6a.  The 1H NMR spectrum of TBDPS-AMP, 7.  (500 MHz, CDCl3) 
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Figure C.6b.  The 13C NMR spectrum of TBDPS-AMP, 7.  (125 MHz, CDCl3) 
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Figure C.6c.  The ESI-TOF mass spectrum of TBDPS-AMP, 7. 
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Figure C.7a.  The 1H NMR spectrum of Lev-AMP, 8.  (500 MHz, CDCl3) 
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Figure C.7b.  The 13C NMR spectrum of Lev-AMP, 8.  (125 MHz, CDCl3) 
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Figure C.7c.  The ESI-TOF mass spectrum of Lev-AMP, 8. 
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Figure C.8a.  The 1H NMR spectrum of Pyr-Amp, 9.  (500 MHz, CDCl3) 
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Figure C.8b.  The 13C NMR spectrum of Pyr-Amp, 9.  (125 MHz, CDCl3) 
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Figure C.8c.  The ESI-TOF mass spectrum of Pyr-AMP, 9. 
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Figure C.9a.  The 1H NMR spectrum of TBDPS-Free OH-AMP, 10.  (500 MHz, CDCl3) 
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Figure C.9b.  The 13C NMR spectrum of TBDPS-Free OH-AMP, 10.  (500 MHz, CDCl3) 
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Figure C.9c.  The ESI-TOF mass spectrum of TBDPS-Free OH-AMP, 10. 
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Figure C.10a.  The 1H NMR spectrum of Lev-Pyr-AMP, 11.  (500 MHz, CDCl3) 
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Figure C.10b.  The 13C NMR spectrum of Lev-Pyr-AMP, 11.  (125 MHz, CDCl3)   
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Figure C.10c.  The MALDI-TOF mass spectrum of Lev-Pyr-AMP, 11.  
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Figure C.11a.  The 1H NMR spectrum of FST-Cl, 1.  (500 MHz, CDCl3)  
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Figure C.11b.  The 13C NMR spectrum of FST-Cl, 1.  (500 MHz, CDCl3) 
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Figure C.11c.  The MALDI-TOF mass spectrum of FST-Cl, 1.  
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Figure C.12a.  The 1H NMR spectrum of FST-D, 12.  (500 MHz, CDCl3) 
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Figure C.12b.  The 13C NMR spectrum of FST-D, 12.  (500 MHz, CDCl3) 
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Figure C.12c.  The MALDI-TOF mass spectrum of FST-D, 12.  
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Figure C.13a.  The 1H NMR spectrum of tert-Butyl (S)-1-((piperidin-4-yl)methylcarbamoyl)ethylcarbamate, 13 (BOC-Ala-AMP).  
(500 MHz, CDCl3) 
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Figure C.13b.  The 13C NMR spectrum of tert-Butyl (S)-1-((piperidin-4-yl)methylcarbamoyl)ethylcarbamate, 13 (BOC-Ala-
AMP).  (500 MHz, CDCl3)  
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Figure C.13c.  The 13C NMR APT spectrum of tert-Butyl (S)-1-((piperidin-4-yl)methylcarbamoyl)ethylcarbamate, 13 (BOC-Ala-
AMP).  (500 MHz, CDCl3) 
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Figure C.13d.  The ESI-TOF mass spectrum of tert-Butyl (S)-1-((piperidin-4-yl)methylcarbamoyl)ethylcarbamate, 13 (BOC-Ala-
AMP).   
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Figure C.14a.  The 1H NMR spectrum of FST-Ala, 14.  (500 MHz, CDCl3) 
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Figure C.14b.  The 13C NMR spectrum of FST-Ala, 14.  (125 MHz, CDCl3)  
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Figure C.14c.  The MALDI-TOF mass spectrum of FST-D, 14.  
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Figure C.15a.  The 1H NMR spectrum of FST-Ala-POC, 15.  (500 MHz, CDCl3) 
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Figure C.15b.  The 13C NMR spectrum of FST-Ala-POC, 15.  (125 MHz, CDCl3) 
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Figure C.15c.  The MALDI-TOF mass spectrum of FST-Ala-POC, 15. 
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Figure C.16a.  The 1H NMR spectrum of FST-Ala-POC/TBDPS, 16.  (500 MHz, CDCl3) 
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Figure C.16b.  The 1H NMR spectrum of FST-Ala-POC/TBDPS, 16.  (125 MHz, CDCl3) 
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Figure C.16c.  The MALDI-TOF mass spectrum of FST-Ala-POC/TBDPS, 16.  
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Figure C.17a.  The 1H NMR spectrum of FST-Ala-POC/Lev, 17.  (500 MHz, CDCl3) 
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Figure C.17b.  The 13C NMR spectrum of FST-Ala-POC/Lev, 17.  (125 MHz, CDCl3) 
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Figure C.17c.  The MALDI-TOF mass spectrum of FST-Ala-POC/Lev, 17. 
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Figure C.18a.  The 1H NMR spectrum of (+) Biotin-PCA.  (500 MHz, DMSO-d6) 
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Figure C.18b.  The 13C NMR spectrum of (+) Biotin-PCA.  (125 MHz, DMSO-d6) 
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Figure C.20a.  The 1H NMR spectrum of FST-Ala-POC-Biotin, 18.  (500 MHz, CDCl3) 
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Figure C.20b.  The 13C NMR spectrum of FST-Ala-POC-Biotin, 18.  (125 MHz, CDCl3)  
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Figure C.20c.  The MALDI-TOF mass spectrum of FST-Ala-POC-Biotin, 18. 
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SPECTRA RELEVANT TO CHAPTER IV 
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Figure D.1a.  The 1H NMR spectrum of 2-chloro-4,6-di(piperidine-1-yl)-1,3,5-triazine, 1.  (300 MHz, CDCl3) 
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Figure D.1b.  The 13C NMR spectrum of 2-chloro-4,6-di(piperidine-1-yl)-1,3,5-triazine, 1.  (75 MHz, CDCl3) 
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Figure D.1c.  The ESI-TOF mass spectrum 2-chloro-4,6-di(piperidine-1-yl)-1,3,5-triazine, 1. 
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Figure D.2a.  The 1H NMR spectrum of 1-(4,6-di(piperidine-1-yl)-1,3,5-triazine-2-yl)hydrazine, 2.  (300 MHz, CDCl3)
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Figure D.2b.  The 13C NMR spectrum of 1-(4,6-di(piperidine-1-yl)-1,3,5-triazine-2-yl)hydrazine, 2.  (300 MHz, CDCl3) 
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Figure D.2c.  The ESI-TOF mass spectrum of 1-(4,6-di(piperidine-1-yl)-1,3,5-triazine-2-yl)hydrazine, 2. 
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Figure D.3a.  The 1H NMR spectrum of dendron 3.  (300 MHz, CDCl3) 
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Figure D.3b.  The 13C NMR spectrum of dendron 3.  (75 MHz, CDCl3)
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Figure D.3c.  The ESI-TOF mass spectrum of dendron 3. 
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Figure D.4a.  The 1H NMR spectrum of dendron 4.  (300 MHz, DMSO-d6) 
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Figure D.4b.  The 13C NMR spectrum of dendron 4.  (75 MHz, DMSO-d6) 
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Figure D.4c.  The ESI-TOF mass spectrum of dendron 4. 
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Figure D.5a.  The 1H NMR spectrum of dendron 5.  (300 MHz, DMSO-d6) 
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Figure D.5b.  The 13C NMR spectrum of dendron 5.  (75 MHz, DMSO-d6) 
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Figure D.5c.  The MALDI-TOF mass spectrum of dendron 5. 
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Figure D.6a.  The 1H NMR spectrum of dendron 6.  (300 MHz, DMSO-d6) 
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Figure D.6b.  The 13C NMR spectrum of dendron 6.  (75 MHz, DMSO-d6) 
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Figure D.6c.  The MALDI-TOF mass spectrum of dendron 6. 
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Figure D.7a.  The 1H NMR spectrum of dendrimer 7 (G1-dimer).  (300 MHz. CDCl3)
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Figure D.7b.  The 13C NMR spectrum of dendrimer 7 (G1-dimer).  (75 MHz, CDCl3)
  
267 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure D.7c.  The ESI-TOF mass spectrum of dendrimer 7 (G1-dimer). 
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Figure D.8a.  The 1H NMR spectrum of dendrimer 8 (G1-trimer).  (300 MHz, CDCl3)
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Figure D.8b.  The 13C NMR spectrum of dendrimer 8 (G1-trimer).  (75 MHz, CDCl3) 
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Figure D.8c.  The ESI-TOF mass spectrum of dendrimer 8 (G1-trimer). 
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APPENDIX E 
 
SPECTRA RELEVANT TO CHAPTER V 
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Figure E.1a.  The 1H NMR spectrum of dendron 1.  (300 MHz, CDCl3)  
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Figure E.1b.  The 1H NMR spectrum of dendron 1.  (75 MHz, CDCl3) 
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Figure E.1c.  The ESI-TOF mass spectrum of dendron 1. 
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Figure E.2a.  The 1H NMR spectrum of dendron 2.  (300 MHz, CDCl3)  
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Figure E.2b.  The 13C NMR spectrum of dendron 2.  (75 MHz, CDCl3)
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Figure E.2c.  The MALDI-TOF mass spectrum of dendron 2. 
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Figure E.3a.  The 1H NMR spectrum of dendron 3.  500 MHz, CDCl3)  
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Figure E.3b.  The MALDI-TOF mass spectrum of dendron 3. 
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